PREDICATE,SUBJECT_NAME,OBJECT_NAME,Factuality_Score,Cancer_Type,Category
TREATS,trastuzumab|ERBB2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Tamoxifen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Immunologic Adjuvants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Autologous Stem Cell Transplantation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Adriamycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Excision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,trastuzumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Hormone replacement therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Immunologic Adjuvants,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Immunotherapy
TREATS,adjuvant therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Adjuvant Therapy
TREATS,Doxorubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pharmacotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Cytotoxic agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lapatinib,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Targeted Therapy
TREATS,Breast-Conserving Surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Pharmacotherapy,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Pharmacotherapy
TREATS,Cyclophosphamide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Operative Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Phytoestrogens,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Liposomal Doxorubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Endocrine therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Endocrine Therapy
TREATS,Radiation therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Cryosurgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Tamoxifen,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Hormone Therapy
TREATS,"Estrogens, Synthetic",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Anthracyclines,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Breast surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Pharmaceutical Preparations,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,"Chemotherapy, Adjuvant",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pharmacotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Drug Delivery Systems,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Bilateral mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Modified radical mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Operative Surgical Procedures,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Chinese herbal medicine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Alternative Therapy
TREATS,Aromatase Inhibitors,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Mastectomy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,trastuzumab,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Targeted Therapy
TREATS,Neoadjuvant Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Adjuvant Therapy
TREATS,Endocrine therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Endocrine Therapy
TREATS,"Anti-Inflammatory Agents, Non-Steroidal",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Breast-Conserving Surgery,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Aromatase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,antiangiogenesis therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Postoperative chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,high-dose chemotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Radiosurgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,lapatinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Tamoxifen,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Chemoprevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radiofrequency ablation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Radiation therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Dissection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Pharmacotherapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Pharmacotherapy
TREATS,Antineoplastic Agents,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Chemopreventive Agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Aromatase Inhibitors,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,"Surgery, Day",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Mastectomy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Estradiol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Brachytherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Chemotherapy-Oncologic Procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anthracyclines,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Immunotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,bevacizumab,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Targeted Therapy
TREATS,"Vaccines, DNA",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,intraoperative radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Chemotherapeutic agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Acupuncture procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Alternative Therapy
TREATS,Segmental Mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Targeted",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Lung excision,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Mastectomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Pre-operative chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mastectomy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Mastectomy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Estrogens,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,estrone sulfate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Vaccines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,"Acupuncture, Ear",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Alternative Therapy
TREATS,Axillary Lymph Node Dissection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Excision,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,gene therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Epirubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Operative Surgical Procedures,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Herceptin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,intraoperative radiotherapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,bevacizumab,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Targeted Therapy
TREATS,Reconstructive Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Cytotoxic Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Progestins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Antineoplastic Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Hormone replacement therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Operative Surgical Procedures,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Aromatase Inhibitors,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Hormone Therapy
TREATS,Radiation therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Pharmacotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,intraoperative radiotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Cyclophosphamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,radical mastectomy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Extended radical mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Pharmaceutical Preparations,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,Cytotoxic agent,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Combination Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adriamycin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Ifosfamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Etoposide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Doxorubicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Immunologic Adjuvants,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Immunotherapy
TREATS,Lymph node excision,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,high-dose chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fluorouracil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combination Chemotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Chemotherapeutic agent,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Immunologic Adjuvants,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Immunotherapy
TREATS,Pharmacotherapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Pharmacotherapy
TREATS,Epirubicin,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Combination Chemotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Excision,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Estrogen Replacement Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,adjuvant therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Fluorouracil,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,X-Ray Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Excision,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Epirubicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,high-dose chemotherapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Taxol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,radical mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Maxillary left canine abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Progestins,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Raloxifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,cyclophosphamide/fluorouracil/methotrexate protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Chemotherapy, Adjuvant",Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Quadrantectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Skin Transplantation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Radiopharmaceuticals,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Ifosfamide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Diethylstilbestrol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Cytotoxic Chemotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Lymph node excision,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,radical mastectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Cisplatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Autologous Stem Cell Transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Lymph node excision,Carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Dissection,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Gonadotropin-Releasing Hormone Analog,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Endocrine therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Endocrine Therapy
TREATS,Autologous Stem Cell Transplantation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Implantation procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Pharmacotherapy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Pharmacotherapy
TREATS,Group Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Supportive Care
TREATS,Pharmaceutical Preparations,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Brachytherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,Fluorouracil,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Etoposide,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,"Chemotherapy, Adjuvant",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,"Transplantation, Autologous",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Intensity-Modulated",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Excision of neoplasm,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Adjuvant",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Mandibular right third molar abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Chemotherapy-Oncologic Procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Procedures on breast,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Procedures on Breast
TREATS,Mitoxantrone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Non-Steroidal Aromatase Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Neoadjuvant Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,Biological Response Modifiers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Methotrexate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Buserelin|EREG|ESR1,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Medical Castration,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Supportive Care
TREATS,Excision,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Methotrexate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tamoxifen,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,CYCLOPHOSPHAMIDE TREATMENT,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Quadrantectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Vincristine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Estrogens,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,"Mastectomy, Subcutaneous",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Operative Surgical Procedures,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Medroxyprogesterone 17-Acetate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,"Radiation Therapy, Lymphatic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Radiation therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,Dissection,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Adjuvant",Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Radiotherapy
TREATS,Medroxyprogesterone 17-Acetate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,cyclophosphamide/fluorouracil/methotrexate protocol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Simple mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Mitoxantrone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Cyclophosphamide,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,radical mastectomy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,"Mastectomy, Subcutaneous",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Megestrol Acetate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Gonadotropin-Releasing Hormone Analog,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Estrone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Androgen Antagonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,cyclophosphamide/fluorouracil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cisplatin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,External radiotherapy NOS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Quadrantectomy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Mastectomy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Supportive care,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Supportive Care
TREATS,Radiation therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Radiotherapy
TREATS,adjuvant therapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Adjuvant Therapy
TREATS,adjuvant therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Adjuvant Therapy
TREATS,Reconstructive Surgical Procedures,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Buserelin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Buserelin,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,Radiation therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Adriamycin,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Curative Surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Cisplatin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Megestrol Acetate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Operative Surgical Procedures,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Mastectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Modified radical mastectomy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Postoperative chemotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Operative Surgical Procedures,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Modified radical mastectomy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Modified radical mastectomy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Carboplatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oral anticoagulants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Cold Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,bendamustine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Aromatase Inhibitors,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,halstead mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Excision,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Estradiol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,high-dose chemotherapy,stage IIIA breast cancer,0.0,Other,Chemotherapy
TREATS,Local excision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Psychotherapy, Multiple",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Supportive Care
TREATS,cyclophosphamide/fluorouracil/methotrexate/prednisone/tamoxifen protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Antineoplastic Agents, Alkylating",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,Progestins,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Chlorambucil,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Antineoplastic Agents, Hormonal",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Medroxyprogesterone 17-Acetate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Palliative Surgery,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Adriamycin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Group Psychotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Supportive Care
TREATS,cyclophosphamide/doxorubicin/prednisone/teniposide protocol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Regional Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mitoxantrone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Methotrexate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,3-hydroxytamoxifen,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Vincristine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mastectomy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,high-dose chemotherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,"Chemotherapy, Adjuvant",Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Cyclophosphamide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Cyclophosphamide,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,3-hydroxytamoxifen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Tamoxifen,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone Therapy
TREATS,Group Psychotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,Peripheral Stem Cell Transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Modified radical mastectomy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Local excision,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Combination Chemotherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Pharmacotherapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Pharmacotherapy
TREATS,Lymph Node Dissection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Lymph node excision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Bone Marrow Transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Carboplatin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Tamoxifen,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,"Psychotherapy, Multiple",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,Immunologic Adjuvants,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Immunotherapy
TREATS,Medroxyprogesterone 17-Acetate,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Hormone Therapy
TREATS,cyclophosphamide/doxorubicin/prednisone/teniposide protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Reexcision,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Megavoltage radiation therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Pharmacotherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Pharmacotherapy
TREATS,High-Dose Chemotherapy with Autologous Stem Cell Transplant,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Complementary therapies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Alternative Therapy
TREATS,Breast surgery,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Hematopoietic Stem Cell Transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Surgical Procedures, Minor",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Bone Marrow Transplantation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Tamoxifen,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,Taxol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anthracyclines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Endocrine therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Endocrine Therapy
TREATS,Breast surgery,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Fluorouracil,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Operative Surgical Procedures,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Vaccines,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,adrenal transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Immunologic Adjuvants,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Immunotherapy
TREATS,Lung excision,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Endocrine Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Simple mastectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Cobalt 60 brachytherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Radiation therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Intrathecal Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast surgery,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Transplantation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Pharmacotherapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacotherapy
TREATS,Cytotoxic agent,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Tamoxifen,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Hormone Therapy
TREATS,Mastectomy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Steroidal Aromatase Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Hematopoietic Stem Cell Transplantation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Cyclophosphamide,stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,Axillary Lymph Node Dissection,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Herceptin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Targeted Therapy
TREATS,radioimmunoguided surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Supportive care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,bevacizumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,CHEMOTHERAPY CYCLOPHOSPHAMIDE,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Lymph node excision,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Methotrexate,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,high-dose chemotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Breast surgery,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,"Surgical Procedures, Endoscopic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,trastuzumab,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Targeted Therapy
TREATS,Herceptin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Targeted Therapy
TREATS,Radiation therapy,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Photochemotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Operative Surgical Procedures,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Axillary Lymph Node Dissection,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Immunotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,"INSTRUMENT, BIOPSY",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Reexcision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Tamoxifen,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Hormone Therapy
TREATS,Thalidomide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pharmaceutical Preparations,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Pharmacotherapy
TREATS,Tamoxifen,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,trastuzumab,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Targeted Therapy
TREATS,Etoposide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Operative Surgical Procedures,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,"Transplantation, Autologous",Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Neck Dissection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Adjuvant Therapy
TREATS,Thalidomide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Endocrine therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Endocrine Therapy
TREATS,Radiochemotherapy NOS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Axillary Lymph Node Dissection,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Pharmaceutical Preparations,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Pharmacotherapy
TREATS,"Chemotherapy, Adjuvant",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Curative Surgery,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Photochemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Simple mastectomy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Radiation therapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Cosmetic surgery,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Therapy,Inflammatory carcinoma of breast stage III,0.0,Other,Adjuvant Therapy
TREATS,Suicide Gene Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,adjuvant therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Adjuvant Therapy
TREATS,antiangiogenesis therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Targeted Therapy
TREATS,Axillary Lymph Node Dissection,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,"Immunotherapy, Active",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Endocrine therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Endocrine Therapy
TREATS,Pharmacotherapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Pharmacotherapy
TREATS,Operative Surgical Procedures,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Breast surgery,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Excision,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Oral chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,trastuzumab,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Targeted Therapy
TREATS,adjuvant therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Adjuvant Therapy
TREATS,"Radiotherapy, Conformal",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Tamoxifen Citrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Breast radiotherapies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,cisplatin liposomal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Stereotactic radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Reconstructive Surgical Procedures,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Pharmacotherapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Pharmacotherapy
TREATS,Operative Surgical Procedures,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Cancer Vaccines,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,Local excision,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Immunologic Adjuvants,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Immunotherapy
TREATS,"Transplantation, Autologous",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Intravenous chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cyclophosphamide,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Breast-Conserving Surgery,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,cisplatin/doxorubicin/mitomycin protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Doxorubicin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Mitoxantrone Hydrochloride,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Radiotherapy planning,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,adjuvant therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,Excision of neoplasm,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Teleradiotherapy using electrons,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Breast-Conserving Surgery,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Complete excision,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Estrogens,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,"Transplantation, Autologous",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Adjuvant Therapy
TREATS,Aromatase Inhibitors,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,adriamycinol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tamoxifen,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,Radiation therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,MEDROXYPROGESTERONE TREATMENT,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Breast-Conserving Surgery,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Radiation therapy,Carcinoma in situ of breast,0.0,Female Breast Cancer,Radiotherapy
TREATS,Cobalt 60 brachytherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Quadrantectomy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Megestrol Acetate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,"Radiotherapy, Adjuvant",Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,Tamoxifen,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Epirubicin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,"Chemotherapy, Adjuvant",stage IIIA breast cancer,0.0,Other,Chemotherapy
TREATS,chemosensitization/potentiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radiographic-therapeutic unit device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Lumpectomy of breast,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Doxorubicin,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Bypass surgery,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Cyclophosphamide,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Breast radiotherapies,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Radiofrequency Ablation Systems,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Radiation therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Non-Steroidal Aromatase Inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Breast-Conserving Surgery,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Reconstructive Surgical Procedures,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Preoperative Endocrine Therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Endocrine Therapy
TREATS,Operative Surgical Procedures,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Bilateral mastectomy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Breast-Conserving Surgery,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Curative Surgery,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,External radiotherapy NOS,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Cryosurgery,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Liposomal Doxorubicin,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Mastectomy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,lapatinib,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Targeted Therapy
TREATS,adjuvant therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Adjuvant Therapy
TREATS,bevacizumab,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Targeted Therapy
TREATS,Mastectomy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Teleradiotherapy procedure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Operative Surgical Procedures,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,trastuzumab,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Targeted Therapy
TREATS,Endocrine therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Endocrine Therapy
TREATS,radical mastectomy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Conformal",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Excision,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Adjuvant Therapy
TREATS,Dissection,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Local excision,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,high-dose chemotherapy,stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,Radiation therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Radiotherapy
TREATS,CHEMOTHERAPY CYCLOPHOSPHAMIDE,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Thoracic Surgery, Video-Assisted",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,cyclophosphamide/doxorubicin/fluorouracil protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Segmental Mastectomy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Ethinyl Estradiol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Radiation therapy,stage IIIA breast cancer,0.0,Other,Radiotherapy
TREATS,Interleukin-15 therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,Modified radical mastectomy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Whole-Brain Radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,trastuzumab,Stage IIB Breast Cancer,0.0009990009990009,Other,Targeted Therapy
TREATS,Oral chemotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Aromatase Inhibitors,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Hormone Therapy
TREATS,Operative Surgical Procedures,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Postmenopausal Hormone Replacement Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Peripheral Stem Cell Transplantation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,adjuvant therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Adjuvant Therapy
TREATS,"Immunotherapy, Passive",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,External Beam Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Surgical Clips,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Radionuclide therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,bevacizumab,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Targeted Therapy
TREATS,"Radiotherapy, Adjuvant",bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Modified radical mastectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Radiation therapy,Tubular breast cancer,0.0,Other,Radiotherapy
TREATS,Microsurgical anastomosis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Adjuvant",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,major surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Radiation therapy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Radiotherapy
TREATS,Bariatric Surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,trastuzumab,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Targeted Therapy
TREATS,Epirubicin,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,hydroxytamoxifen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Repeat Surgery,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Raloxifene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Tamoxifen 20 MG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,External Beam Radiation Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Bilateral mastectomy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Cytotoxic Chemotherapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Radiosurgery,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Surgical repair,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Estrogens,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Teleradiotherapy procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Cryosurgery,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Reconstructive Surgical Procedures,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Reconstructive Surgical Procedures,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Adjuvant",Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Pharmacotherapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Pharmacotherapy
TREATS,Monoclonal Antibodies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Pharmacotherapy,Stage IIIA Breast Carcinoma,0.0,Other,Pharmacotherapy
TREATS,Surgical Replantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,cancer surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Chemotherapy, Adjuvant",Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Dissection,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,doxorubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Biological Response Modifiers,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,Pharmacotherapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacotherapy
TREATS,Neoadjuvant Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Adjuvant Therapy
TREATS,"Radiotherapy, Image-Guided",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Therapeutic radiology procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Antineoplastic Agents,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Pharmacotherapy
TREATS,Radiotherapy planning,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Neoadjuvant Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Adjuvant Therapy
TREATS,Pharmacotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacotherapy
TREATS,ado-trastuzumab emtansine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Pharmacotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,Hormone Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Pharmaceutical Preparations,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Pharmacotherapy
TREATS,Hormone Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Prophylactic Mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Immunotherapy, Active",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Immunotherapy
TREATS,Breast-Conserving Surgery,Carcinoma breast stage I,0.0,Female Breast Cancer,Surgery
TREATS,trastuzumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,estradiol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Targeted Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Neoadjuvant Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Adjuvant Therapy
TREATS,Chemo-radiotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Post-Adjuvant Therapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Adjuvant Therapy
TREATS,Pharmacotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Pharmacotherapy
TREATS,Segmental Mastectomy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,bevacizumab,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,etoposide,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,ado-trastuzumab emtansine|DMPK|IGHD1-7,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Breast-Conserving Surgery,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Cytotoxic agent (product),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Drug Delivery Systems,Refractory Breast Carcinoma,0.0,Other,Pharmacotherapy
TREATS,trastuzumab,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Targeted Therapy
TREATS,Immunologic Adjuvants,Multicentric Breast Carcinoma,0.0,Other,Immunotherapy
TREATS,Pharmacotherapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Pharmacotherapy
TREATS,"Chemotherapy, Adjuvant",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Pharmacotherapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Pharmacotherapy
TREATS,Immunologic Adjuvants,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Immunotherapy
TREATS,tamoxifen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Aromatase Inhibitors,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,lapatinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Aromatase Inhibitors,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Hormone Therapy
TREATS,Tamoxifen therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Adjuvant Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Adjuvant Therapy
TREATS,Post-mastectomy radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,bevacizumab,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Targeted Therapy
TREATS,Teleradiotherapy procedure,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,"Mastectomy, Subcutaneous",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Operative Surgical Procedures,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Surgery
TREATS,Radioembolization,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,cyclophosphamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immunotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Immunotherapy
TREATS,post surgery radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Pharmacotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Pharmacotherapy
TREATS,Excision of axillary lymph nodes group,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,tamoxifen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Immunologic Adjuvants,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Immunotherapy
TREATS,Therapeutic radiology procedure,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Skin sparing mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,estrogens,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,Pharmaceutical Preparations,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacotherapy
TREATS,Antineoplastic Agents,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Pharmacotherapy
TREATS,doxorubicin liposome,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antineoplastic Agents,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,"Mastectomy, Radical",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,tamoxifen,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,Hypofractionated Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Hormone Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone Therapy
TREATS,Adjuvant Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Adjuvant Therapy
TREATS,Pharmacotherapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Pharmacotherapy
TREATS,"Chemotherapy, Adjuvant",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,low-dose chemotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Surface Guided Radiation Therapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Pharmaceutical Preparations,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,Chemotherapy cycle,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Intraoperative Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,"Radiotherapy, Adjuvant",Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Intraoperative Radiation Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Pharmacotherapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Pharmacotherapy
TREATS,Breast-Conserving Surgery,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Post-mastectomy radiotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Neoadjuvant Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Adjuvant Therapy
TREATS,Segmental Mastectomy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Targeted Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Targeted Therapy
TREATS,cisplatin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Hormone Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,"Mastectomy, Radical",Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,ado-trastuzumab emtansine|DMPK|IGHD1-7,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Postoperative chemotherapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Boost radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Hormone Therapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Hormone Therapy
TREATS,tamoxifen,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,Adjuvant Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Adjuvant Therapy
TREATS,Magnetic Resonance-Guided Radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Radiotherapy planning,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Simple mastectomy,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Reconstructive Surgical Procedures,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Biological Response Modifiers,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Immunotherapy
TREATS,Neoadjuvant Chemotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Post-mastectomy radiotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Neoadjuvant Chemotherapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Hypofractionated Radiation Therapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Pharmacotherapy,Carcinoma breast stage I,0.0,Female Breast Cancer,Pharmacotherapy
TREATS,"Chemotherapy, Adjuvant",Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,Simple mastectomy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Adjuvant Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Adjuvant Therapy
TREATS,Adjuvant Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,doxorubicin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,trastuzumab deruxtecan,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Neoadjuvant Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,estrogens,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Neoadjuvant Chemotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,"Chemotherapy, Adjuvant",Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Targeted Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Mastectomy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,doxorubicin liposome,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,trastuzumab,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Neoadjuvant Chemotherapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Hormone Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Hormone Therapy
TREATS,Immunologic Adjuvants,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,epirubicin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Antineoplastic Agents,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Pharmacotherapy
TREATS,Adjuvant Therapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Adjuvant Therapy
TREATS,"Mastectomy, Subcutaneous",Stage 0 Breast Carcinoma,0.0,Female Breast Cancer,Surgery
TREATS,carboplatin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,"Radiotherapy, Intensity-Modulated",Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,"Radiotherapy, Adjuvant",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Neoadjuvant Chemotherapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Drug Delivery Systems,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacotherapy
TREATS,Hormone Therapy,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Hormone Therapy
TREATS,Bilateral mastectomy,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Systemic Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,External Beam Radiation Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Adjuvant Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Adjuvant Therapy
TREATS,Mastectomy,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,fam-trastuzumab deruxtecan-nxki,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Hypofractionated radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Biological Response Modifiers,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Immunotherapy
TREATS,cyclophosphamide,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Targeted Therapy Agent,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Targeted Therapy
TREATS,Chemotherapy Regimen,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Photochemotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Segmental Mastectomy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Curative Surgery,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Surgery
TREATS,Contralateral Prophylactic Mastectomy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Docetaxel/Cyclophosphamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Therapy,Stage IIIA Breast Carcinoma,0.0,Other,Adjuvant Therapy
TREATS,cisplatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tamoxifen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone Therapy
TREATS,Neoadjuvant Radiotherapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Radiofrequency Ablation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Stereotactic Body Radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Neoadjuvant Chemotherapy,Triple-Negative Breast Carcinoma,0.0029970029970029,Female Breast Cancer,Chemotherapy
TREATS,Carboplatin/Paclitaxel,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Segmental Mastectomy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Surgery
TREATS,Cryosurgery,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Breast-Conserving Surgery,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Aromatase Inhibitors,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone Therapy
TREATS,Segmental Mastectomy,Carcinoma breast stage I,0.0,Female Breast Cancer,Surgery
TREATS,Palliative Care,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Supportive Care
TREATS,Wide excision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,ado-trastuzumab emtansine,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Transarterial Chemoembolization,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,post surgery radiation therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Targeted Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Excision,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Immunologic Adjuvants,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Immunotherapy
TREATS,Cancer Vaccines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,"Chemotherapy, Adjuvant",Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Hypofractionated radiation therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Partial excision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,cyclophosphamide,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,capecitabine/cyclophosphamide,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Stereotactic Ablative Radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Molecular Targeted Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Adjuvant Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Adjuvant Therapy
TREATS,Cytotoxic Chemotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,post surgery radiation therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,post surgery radiation therapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,Epirubicin Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Chemotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Hypofractionated radiation therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Mastectomy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Immunologic Adjuvants,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Immunotherapy
TREATS,lapatinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Neoadjuvant Chemotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Reconstructive Surgical Procedures,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,bevacizumab,Refractory Breast Carcinoma,0.0,Other,Targeted Therapy
TREATS,External Beam Radiation Therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Radiotherapy
TREATS,Excision of axillary lymph nodes group,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Mastectomy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Complete excision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Aromatase Inhibitors,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Hormone Therapy
TREATS,Mastectomy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,doxorubicin,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Operative Surgical Procedures,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,fluorouracil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immune Checkpoint Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Stereotactic Body Radiotherapy,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,trastuzumab,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Targeted Therapy
TREATS,Immune Checkpoint Inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,SARS-CoV-2 inactivated vaccines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Excision of axillary lymph nodes group,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Cyclophosphamide Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Segmental Mastectomy,Stage III Breast Cancer AJCC v6,0.0,Other,Surgery
TREATS,Elective Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Anthracyclines,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Accelerated Radiation Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Dose-dense Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hormone Therapy,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Hormone Therapy
TREATS,doxorubicin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Chemoradiotherapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Mastectomy,Carcinoma breast stage I,0.0,Female Breast Cancer,Surgery
TREATS,"Mastectomy, Subcutaneous",Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Drug Delivery Systems,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Pharmacotherapy
TREATS,Mastectomy,Right-Sided Breast Neoplasms,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Chemotherapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,tamoxifen,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,ado-trastuzumab emtansine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Neoadjuvant Chemotherapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Drug Delivery Systems,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,doxorubicin,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Chemotherapy
TREATS,Reconstructive Surgical Procedures,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Photoimmunotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,interleukin-7,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Immunotherapy
TREATS,carboplatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Herceptin,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Targeted Therapy
TREATS,Mastectomy,"Breast Cancer, Familial",0.0,Female Breast Cancer,Surgery
TREATS,Chemoimmunotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,"Psychotherapy, Multiple",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Supportive Care
TREATS,Accelerated Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Bevacizumab/Paclitaxel,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Transarterial Radioembolization,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,doxorubicin liposome,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Procedures on breast,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Procedures on Breast
TREATS,"Radiotherapy, Adjuvant",Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,Minimally Invasive Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Chemotherapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Docetaxel/Trastuzumab,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Conventional Radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Neoadjuvant Chemotherapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,post surgery radiation therapy,Carcinoma breast stage I,0.0,Female Breast Cancer,Radiotherapy
TREATS,"Psychotherapy, Multiple",estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Supportive Care
TREATS,Radiation therapy following chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Excision of axillary lymph nodes group,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Surgery
TREATS,Pharmaceutical Preparations,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Pharmacotherapy
TREATS,Breast-Conserving Surgery,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Surgery
TREATS,Metronomic Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Chemotherapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Aromatase Inhibitors,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,Pertuzumab/Trastuzumab Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Hormone Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Brachytherapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,Therapeutic radiology procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Chemotherapy Regimen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Bevacizumab/Paclitaxel,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Targeted Therapy
TREATS,Cryosurgery,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Surgery
TREATS,Carboplatin/Etoposide/Melphalan Regimen,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Pharmacotherapy,Refractory Breast Carcinoma,0.0,Other,Pharmacotherapy
TREATS,Mastectomy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,vincristine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Operative Surgical Procedures,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Surgery
TREATS,Reexcision,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,post surgery radiation therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Immunologic Adjuvants,Multifocal breast carcinoma,0.0,Other,Immunotherapy
TREATS,Targeted Therapy Agent,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Targeted Therapy
TREATS,Radioimmunotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Contralateral Prophylactic Mastectomy,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Pre-operative chemotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Hormone Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,Intraoperative Radiation Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,New medications,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Adjuvant Radiation Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,trastuzumab,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Targeted Therapy
TREATS,"Chemoradiotherapy, Adjuvant",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Mastectomy, Subcutaneous",Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Targeted Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Targeted Therapy
TREATS,Conventional Radiotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Operative Surgical Procedures,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Lymph node excision,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Biological Response Modifiers,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Immunotherapy
TREATS,neoplasm immunotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Breast-Conserving Surgery,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Immune Checkpoint Inhibitors,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Immunotherapy
TREATS,trastuzumab deruxtecan,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Stereotactic Body Radiation Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Breast-Conserving Surgery,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Hormone Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Hormone Therapy
TREATS,Pharmacotherapy,Mucinous breast cancer,0.0,Other,Pharmacotherapy
TREATS,Operative Surgical Procedures,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Surgery
TREATS,trastuzumab deruxtecan,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Targeted Therapy
TREATS,Hormone Therapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Hormone Therapy
TREATS,Chemoembolization,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,External Beam Radiation Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Breast-Conserving Surgery,Primary malignant neoplasm of breast with axillary lymph node invasion,0.0,Other,Surgery
TREATS,Dose-dense Chemotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Curative Surgery,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,High dose brachytherapy (procedure),Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Dose-dense Chemotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Radical excision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Contralateral Prophylactic Mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Checkpoint Blockade Immunotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,cyclophosphamide,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Aromatase Inhibitors,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Hormone Therapy
TREATS,Immunotherapy for cancer,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Immunotherapy
TREATS,Adjuvant Radiation Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,"Radiosurgery, Stereotactic",Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,carmustine/cytarabine/etoposide/melphalan regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast Cancer Radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,"Deep radiation therapy, 200-300 KVP",Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,carboplatin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Complete Lymph Node Dissection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,photon radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Tamoxifen,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Hormone Therapy
TREATS,radioactive agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Ultrasonic dissection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,bevacizumab,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Targeted Therapy
TREATS,Segmental Mastectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Pharmaceutical Preparations,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Pharmacotherapy
TREATS,Tamoxifen,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Surgical Navigation Systems,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Targeted",Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
METHOD_OF,Pharmacotherapy,breast cancer prevention,0.0,Other,Pharmacotherapy
TREATS,Vaccines,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Immunotherapy
TREATS,Methotrexate,Malignant neoplasm of female breast NOS,0.0,Other,Chemotherapy
TREATS,Immunologic Adjuvants,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,Brachytherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,radical mastectomy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Antineoplastic Agents,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Pharmacotherapy
TREATS,Surgical Manipulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Epirubicin,Stage IIB Breast Cancer,0.0009990009990009,Other,Chemotherapy
TREATS,Lumpectomy of breast,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Antineoplastic Agents,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,Mastectomy,stage IIIA breast cancer,0.0,Other,Surgery
TREATS,high-dose chemotherapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Interstitial brachytherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Skin Transplantation,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Immunotherapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Immunotherapy
TREATS,4'-deoxydoxorubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cyclophosphamide/fluorouracil/methotrexate/prednisone protocol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,cyclophosphamide/fluorouracil/methotrexate/prednisone protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,estradiol 3-benzoate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Diethylstilbestrol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Estrogens,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Extended radical mastectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Tamoxifen Citrate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Buserelin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,cyclophosphamide/fluorouracil,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Chemotherapy-Oncologic Procedure,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Ambulatory chemotherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Total excision of pancreas NOS,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Bilateral mastectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Chemotherapy-Oncologic Procedure,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Interleukin-2 therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Cytotoxic Chemotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,trastuzumab|ERBB2,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Targeted Therapy
TREATS,Immunotherapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Immunotherapy
TREATS,Cytotoxic Chemotherapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Breast surgery,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Immunotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Immunotherapy
TREATS,Peripheral Stem Cell Transplantation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Medroxyprogesterone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Combined radiotherapy NOS,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,Reconstructive Surgical Procedures,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Extended radical mastectomy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Pharmacotherapy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Pharmacotherapy
TREATS,17-Hydroxycorticosteroids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,4-hydroxytamoxifen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Cyclophosphamide,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Simple mastectomy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Anthracyclines,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Doxorubicin,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Liposomal Doxorubicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Modified radical mastectomy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Intensity-Modulated",Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Chemotherapeutic agent,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Lung excision,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Radiofrequency ablation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Chemopreventive Agent,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Mastectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Neck Dissection,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,"Estrogens, Non-Steroidal",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Pharmacotherapy,stage IIIB breast cancer,0.0,Other,Pharmacotherapy
TREATS,Radiation therapy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,"Radiotherapy, Intensity-Modulated",bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Cisplatin,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Immunotherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Immunotherapy
TREATS,"Transplantation, Autologous",Inflammatory carcinoma of breast stage III,0.0,Other,Surgery
TREATS,Operative Surgical Procedures,Familial cancer of breast,0.0,Female Breast Cancer,Surgery
TREATS,Dissection,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,CHEMOTHERAPY DOXORUBICIN,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immunotherapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Immunotherapy
TREATS,Dissection,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,"Psychotherapy, Multiple",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Supportive Care
TREATS,gene therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Gene Therapy
TREATS,high-dose chemotherapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,"Chemotherapy, Adjuvant",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,pyrrolidino-4-iodotamoxifen,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Methotrexate,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
METHOD_OF,Tamoxifen,breast cancer prevention,0.0,Other,Hormone Therapy
TREATS,Chemotherapy-Oncologic Procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Segmental Mastectomy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Lung excision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Myeloablative Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Group Psychotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Supportive Care
TREATS,Taxol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Oral chemotherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Photochemotherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Breast radiotherapies,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Pharmacotherapy,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Pharmacotherapy
TREATS,Gynecologic Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Operative Surgical Procedures,Carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Radiochemotherapy NOS,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Preoperative Endocrine Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Endocrine Therapy
TREATS,Bone Marrow Transplantation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Breast surgery,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Immunologic Adjuvants,Stage IIA Breast Cancer,0.0019980019980019,Other,Immunotherapy
TREATS,Plastic Surgical Procedures,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,"Psychotherapy, Brief",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,Reconstructive Surgical Procedures,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Radioimmunotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
METHOD_OF,adjuvant therapy,breast cancer prevention,0.0,Other,Adjuvant Therapy
TREATS,Preventive surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Chemotherapy-Oncologic Procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Cryosurgery,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Breast interstitial brachytherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,"Deep radiation therapy, 200-300 KVP",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Breast surgery,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Ambulatory Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Psychotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,Lymph node excision,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Mitoxantrone,stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,"Vaccines, Peptide",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Tamoxifen,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Hormone Therapy
TREATS,Neoadjuvant Therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Adjuvant Therapy
TREATS,Curative Surgery,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Progestogen hormone therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Carboplatin,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Chemotherapy
TREATS,Doxorubicin Hydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,1-hexylcarbamoyl-5-fluorouracil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Unnecessary Surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Mastectomy,Carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Stereotactic radiotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,BR96-doxorubicin immunoconjugate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Radiopharmaceuticals,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Complete excision,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Fluorouracil,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Repeat Surgery,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Lymph node excision,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Repeat Surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Epirubicin,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Estrogens,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Hormone Therapy
TREATS,Electroacupuncture,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Alternative Therapy
TREATS,Complete excision,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Mastectomy,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Breast surgery,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Excision,Carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Breast-Conserving Surgery,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Modified radical mastectomy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,antiangiogenesis therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Targeted Therapy
TREATS,Total excision of stomach NOS,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Taxol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Adjuvant Radiation Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,doxorubicin liposome,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Reconstructive Surgical Procedures,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Surgery
TREATS,Stereotactic Ablative Radiotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Trastuzumab Biosimilar ABP 980|AOC1|SHBG,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Mastectomy,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Cytotoxic Chemotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Contralateral Prophylactic Mastectomy,contralateral breast cancer,0.0,Female Breast Cancer,Surgery
TREATS,Radiopharmaceuticals,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Molecular Targeted Therapy,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Targeted Therapy
TREATS,Preoperative Endocrine Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Endocrine Therapy
TREATS,"Chemotherapy, Adjuvant",Malignant neoplasm of female breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Cyclophosphamide/Epirubicin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Bevacizumab/Capecitabine,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Targeted Therapy
TREATS,cyclophosphamide,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Carboplatin/Paclitaxel,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Breast-Conserving Surgery,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,"Chemotherapy, Adjuvant",Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,"ESTROGENS,VAGINAL",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Additional Surgical Procedure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,bevacizumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Sentinel Lymph Node Dissection,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Tamoxifen therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,trastuzumab,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Targeted Therapy
TREATS,Whole brain radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,New medications,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,Cryosurgery,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Intraoperative Radiation Therapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,Radiotherapy fractionation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Adjuvant Therapy,Carcinoma breast stage I,0.0,Female Breast Cancer,Adjuvant Therapy
TREATS,Hormone Therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,trastuzumab,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Targeted Therapy
TREATS,"interleukin-1, beta",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,ado-trastuzumab emtansine|DMPK|IGHD1-7,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,doxorubicin,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Anthracyclines,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Cyclophosphamide Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,estradiol,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Interstitial Radiation Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Cyclophosphamide therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,carboplatin,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Chemotherapy Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Aromatase Inhibitors,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Anthracyclines,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,tamoxifen,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,post surgery radiation therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Drug Delivery Systems,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Pharmacotherapy
TREATS,Operative Surgical Procedures,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Chemotherapy,Carcinoma breast stage I,0.0,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Therapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Adjuvant Therapy
TREATS,cyclophosphamide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Targeted Therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Targeted Therapy
TREATS,Conventional Surgery,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Immunologic Adjuvants,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Immunotherapy
TREATS,Carboplatin/Paclitaxel/Trastuzumab Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,AC Followed by Docetaxel/Trastuzumab Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Adjuvant Radiation Therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,"Radiotherapy, Intensity-Modulated",Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,raloxifene hydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Immunologic Adjuvants,Luminal B Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Immunotherapy
TREATS,Reconstructive Surgical Procedures,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,"Mastectomy, Radical",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Surgery
TREATS,Bilateral mastectomy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Chemotherapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Liposomal Doxorubicin Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immunotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,Operative Surgical Procedures,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Surgery
TREATS,Stereotactic Body Radiotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Interstitial Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Adoptive Immunotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,Targeted Therapy Agent,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Antineoplastic Combined Chemotherapy Protocols,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,post surgery radiation therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Chemotherapy Drugs Adminstered,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mastectomy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Surgery
TREATS,cyclophosphamide,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Eribulin/Trastuzumab Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,bendamustine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Excision of axillary lymph nodes group,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Therapeutic radiology procedure,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Neoadjuvant Radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,bendamustine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Breast-Conserving Surgery,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Chemotherapy cycle,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Chemotherapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,surgical section,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,estrogens,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Modified radical mastectomy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Surgery
TREATS,"Radiotherapy, Adjuvant",Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Vaccines,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,cancer surgery,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,ethinyl estradiol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Patey Mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Chemoimmunotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hypofractionated radiation therapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Skin sparing mastectomy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Excision of axillary lymph nodes group,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Surgery
TREATS,Chemotherapy Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Segmental Mastectomy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,epirubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radiotherapy fractionation,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Radioimmunoguided surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Pharmacotherapy,Right-Sided Breast Neoplasms,0.0019980019980019,Female Breast Cancer,Pharmacotherapy
TREATS,"Radiosurgery, Stereotactic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,neoplasm immunotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,Therapeutic radiology procedure,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Modified radical mastectomy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Surgery
TREATS,Shaving - surgical procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Adjuvant Therapy
TREATS,Hormone Therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Modified radical mastectomy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Therapeutic radiology procedure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,trastuzumab,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Targeted Therapy
TREATS,Interstitial Radiation Therapy,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,COVID-19 Vaccines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Breast-Conserving Surgery,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Surgery
TREATS,Breast-Conserving Surgery,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Surgery
TREATS,Contralateral Prophylactic Mastectomy,"Breast Cancer, Familial",0.0,Female Breast Cancer,Surgery
TREATS,Immunologic Adjuvants,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Immunotherapy
TREATS,fluorouracil,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,post surgery radiation therapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Anthracyclines,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Mastectomy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Surgery
TREATS,Surface Radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Stereotactic Body Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Excision of axillary lymph nodes group,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,carboplatin/gemcitabine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Cancer Vaccines,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,Breast-Conserving Surgery,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Biopsy Clip,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Bilateral mastectomy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,post surgery radiation therapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Radiotherapy
TREATS,Plastic Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Trastuzumab Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,fluorouracil,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,tamoxifen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,"Vaccines, Peptide",Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Immunotherapy
TREATS,Immunotherapy,Triple-Negative Breast Carcinoma,0.0029970029970029,Female Breast Cancer,Immunotherapy
TREATS,Biological Response Modifiers,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Immunotherapy
TREATS,interleukin-12,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Intensity modulated radiation therapy plan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Capecitabine/Lapatinib Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Boost radiation therapy (procedure),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Chemoradiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chemoprevention,"Breast Cancer, Familial",0.0,Female Breast Cancer,Chemotherapy
TREATS,Pharmaceutical Preparations,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Pharmacotherapy
TREATS,"Radiotherapy, Adjuvant",Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Breast-Conserving Surgery,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Surgery
TREATS,"Radiotherapy Systems, Linear Accelerator",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,"Mastectomy, Subcutaneous",Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Metronomic Chemotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Adjuvant Therapy
TREATS,Hypofractionated radiation therapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Mastectomy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Surgery
TREATS,tamoxifen,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Hormone Therapy
TREATS,Intraoperative Radiation Therapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Pharmacotherapy,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Pharmacotherapy
TREATS,hydroxytamoxifen,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Hormone Therapy
TREATS,"Radiotherapy, Conformal",Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,doxorubicin liposome,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,doxorubicin,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,"4-hydroxy-N-desmethyltamoxifen, (Z)-isomer",Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Antineoplastic Agents,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Pharmacotherapy
TREATS,estradiol,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Radiotherapy
TREATS,"Chemotherapy, Adjuvant",estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Unnecessary Surgery,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Intensity-Modulated",Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Trastuzumab Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Non-Steroidal Aromatase Inhibitor,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone Therapy
TREATS,Local excision,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Pharmacotherapy,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Pharmacotherapy
TREATS,Group Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,cyclophosphamide/fluorouracil/methotrexate protocol,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,doxorubicin-HPMA conjugate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Infrared radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Drug Delivery Systems,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Curative Surgery,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Fluorouracil,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,doxorubicin-heparin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Surgical Procedures, Elective",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Drug Delivery Systems,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacotherapy
TREATS,Carboplatin,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Suicide Gene Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Gene Therapy
TREATS,Epirubicin,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,Fluorouracil,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,Cyclophosphamide,Stage IIB Breast Cancer,0.0009990009990009,Other,Chemotherapy
TREATS,Axillary Lymph Node Dissection,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,adjuvant therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Adjuvant Therapy
TREATS,Doxorubicin,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Chlorambucil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,1-(phenoxycarbonyloxymethyl)-5-fluorouracil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cisplatin,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Fluorouracil,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,MEDROXYPROGESTERONE TREATMENT,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,cancer radioimmunotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Electron radiation therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Excision of axillary lymph nodes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,radiosensitization,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,X-Ray Therapy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Radiotherapy
TREATS,Segmental Mastectomy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,cyclophosphamide/fluorouracil,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,cyclophosphamide/fluorouracil/methotrexate protocol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Teleradiotherapy procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Teleradiotherapy using electrons,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,Doxorubicin Hydrochloride,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,radical mastectomy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Procedures on breast,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Procedures on Breast
METHOD_OF,Chemoprevention,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Estradiol Antagonists,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Tamoxifen 20 MG,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,cisplatin/cyclophosphamide/doxorubicin/etoposide chemotherapy protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Replacement Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Steroidal Aromatase Inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,External Beam Radiation Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Surgical incisions,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,External radiotherapy NOS,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Photon radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Local excision,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Curative Surgery,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Diethylstilbestrol,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,Conjugated Equine Estrogens,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Functional surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,bendamustine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Pharmacotherapy,Familial cancer of breast,0.0,Female Breast Cancer,Pharmacotherapy
TREATS,Chemotherapy cycle,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Estrogen hormone therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Vincristine Sulfate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bilateral simple mastectomy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Chemoembolisation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Brachytherapy implant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Pharmaceutical Preparations,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Pharmacotherapy
TREATS,Endocrine therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Endocrine Therapy
TREATS,Exogenous Hormone Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Operative Surgical Procedures,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Surgery
TREATS,Excision,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Hormone replacement therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Pharmacotherapy,Malignant neoplasm of female breast NOS,0.0,Other,Pharmacotherapy
TREATS,Radioimmunoconjugates,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,"Transplantation, Homologous",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Chemotherapeutic agent,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Chemotherapy-Oncologic Procedure,Familial cancer of breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,"Transplantation, Homologous",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Etoposide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Cyclophosphamide,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Epirubicin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Dissection,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,doxorubicin/fluorouracil/mitomycin protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast surgery,Carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Pharmaceutical Preparations,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Pharmacotherapy
TREATS,fluorouracil/leucovorin calcium/mitoxantrone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Excision of neoplasm,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Vincristine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Autologous Stem Cell Transplantation,stage IIIB breast cancer,0.0,Other,Surgery
TREATS,"Radiotherapy, Adjuvant",stage IIIA breast cancer,0.0,Other,Radiotherapy
TREATS,Methotrexate,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,radical mastectomy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Gamma Knife Radiosurgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Intrathecal Chemotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Cytoreductive surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Electron radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Cisplatin,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Autologous Stem Cell Transplantation,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Bilateral mastectomy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Diethylstilbestrol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Modified radical mastectomy,Stage IIB Breast Cancer,0.0009990009990009,Other,Surgery
TREATS,"Radiotherapy, Intensity-Modulated",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Methotrexate,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Mastectomy,Stage IIB Breast Cancer,0.0009990009990009,Other,Surgery
TREATS,Reexcision,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Brachytherapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,trastuzumab,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Targeted Therapy
TREATS,Operative Surgical Procedures,Tubular breast cancer,0.0,Other,Surgery
TREATS,Breast external beam radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Chemoembolisation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Tamoxifen 40 MG,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Transplantation,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Teleradiotherapy procedure,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,Whole-Brain Radiotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Endocrine therapy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Endocrine Therapy
TREATS,"Modified radical mastectomy, unilateral",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Adjuvant",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,"Staple, Surgical",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Reconstructive Surgical Procedures,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Biological Response Modifiers,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,radical mastectomy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Endocrine therapy,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Endocrine Therapy
TREATS,Intraoperative Radiation Therapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Simple mastectomy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,tamoxifen,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Hormone Therapy
TREATS,Support Group Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,Breast Cancer Radiotherapy,contralateral breast cancer,0.0,Female Breast Cancer,Radiotherapy
TREATS,Pre-operative chemotherapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Excision of axillary lymph nodes group,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Complete excision,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Pre-operative chemotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Simple mastectomy of left breast,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Adjuvant Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Adjuvant Therapy
TREATS,carmustine/cytarabine/etoposide/melphalan regimen,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Chemotherapy
TREATS,Post-mastectomy radiotherapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Chemo-radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Psychotherapy, Multiple",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Supportive Care
TREATS,Adjuvant Radiation Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Radiotherapy
TREATS,cyclophosphamide,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Hypofractionated Radiation Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,epirubicin,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,gene therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Gene Therapy
TREATS,Palliative Care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,"Radiotherapy, Conformal",Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,doxorubicin,Stage IIIA Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,tamoxifen citrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Neoadjuvant Chemotherapy,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Immunologic Adjuvants,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Immunotherapy
TREATS,fluorouracil,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Segmental Mastectomy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Surgery
TREATS,Reconstructive Surgical Procedures,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Surface Guided Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Simple mastectomy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Intra-operative electron radiation therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,cisplatin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,doxorubicin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Operative Surgical Procedures,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Surgery
TREATS,trastuzumab,Carcinoma breast stage I,0.0,Female Breast Cancer,Targeted Therapy
TREATS,Modified radical mastectomy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Targeted Therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Targeted Therapy
TREATS,Chemotherapy Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Systemic Chemotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Bevacizumab Regimen,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Targeted Therapy
TREATS,Pre-operative chemotherapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Repeat Surgery,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
METHOD_OF,Hormone Therapy,Breast Cancer Prevention,0.0009990009990009,Other,Hormone Therapy
TREATS,doxorubicin liposome,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Boost radiation therapy,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Excision of axillary lymph nodes group,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Photoimmunotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Immunotherapy
TREATS,Trastuzumab Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Electrochemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cyclophosphamide/doxorubicin protocol,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,epirubicin,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Cryosurgery,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Contralateral Prophylactic Mastectomy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Targeted Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Targeted Therapy
TREATS,Anthracyclines,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,doxorubicin,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Biological Response Modifiers,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Immunotherapy
TREATS,tamoxifen,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Hormone Therapy
TREATS,Minor Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Adjuvant",Right-Sided Breast Neoplasms,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Excision of axillary lymph nodes group,Carcinoma breast stage I,0.0,Female Breast Cancer,Surgery
TREATS,Excision of axillary lymph nodes group,Stage IIA Breast Carcinoma,0.0,Other,Surgery
TREATS,Pharmacotherapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Pharmacotherapy
TREATS,Conventional Surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Vaccines,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Immunotherapy
TREATS,Curative Surgery,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Reconstructive Surgical Procedures,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Segmental Mastectomy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Curative Surgery,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Cyclophosphamide therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mastectomy,Stage IIIA Breast Carcinoma,0.0,Other,Surgery
TREATS,Homeopathy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Alternative Therapy
TREATS,Drug Delivery Systems,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Pharmacotherapy
TREATS,Gemcitabine-Taxol Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Concurrent Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Radiosurgery, Stereotactic",Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,trastuzumab,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Targeted Therapy
TREATS,Bilateral mastectomy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Anthracyclines,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,trastuzumab deruxtecan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,breast: excisions,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Cyclophosphamide/Paclitaxel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Therapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Adjuvant Therapy
TREATS,Targeted Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Targeted Therapy
TREATS,Partial excision,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,etoposide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Hormone Therapy,Carcinoma breast stage I,0.0,Female Breast Cancer,Hormone Therapy
TREATS,Breast-Conserving Surgery,Stage IIIB Breast Carcinoma,0.0,Other,Surgery
TREATS,"Chemotherapy, Adjuvant",estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Chemotherapy
TREATS,Chinese herbal medicine,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Alternative Therapy
TREATS,Robot-assisted Nipple Sparing Mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Carbon Ion Radiotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,High Dose Chemotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Excision of skin,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,breast: excisions,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Operative Surgical Procedures,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Operative Surgical Procedures,Stage 0 Breast Carcinoma,0.0,Female Breast Cancer,Surgery
TREATS,Palliative Care,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Supportive Care
TREATS,methotrexate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ado-trastuzumab emtansine,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Targeted Therapy
TREATS,"Radiotherapy, Adjuvant",Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,"Mastectomy, Subcutaneous",Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Drug Delivery Systems,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,fluorouracil,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Contralateral Prophylactic Mastectomy,Unilateral Breast Neoplasms,0.0,Other,Surgery
TREATS,Metronomic Chemotherapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Diethylstilbestrol,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,Interpersonal psychotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,Video-Assisted Surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Teleradiotherapy procedure,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,Gamma Knife Radiosurgery,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Gonadotropin-Releasing Hormone Analog,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,"Estrogens, Synthetic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Psychodynamic psychotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,Implantation procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,trastuzumab,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Targeted Therapy
TREATS,Cyclophosphamide,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,Partial excision,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Immunologic Adjuvants,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Immunotherapy
TREATS,Allogeneic bone marrow transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Etoposide,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Laser Surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Estradiol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,adjuvant therapy,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Adjuvant Therapy
TREATS,Combination Chemotherapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Recombinant Interleukin-2,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,Progestogen hormone therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Ablative hormone therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Ethinyl Estradiol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Radiosurgery,Carcinoma in situ of breast,0.0,Female Breast Cancer,Radiotherapy
TREATS,cyclophosphamide/fluorouracil/methotrexate protocol,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Transplantation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"Gene Therapy, Somatic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,"Transplantation, Autologous",Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Fluorouracil,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Therapy,stage IIIB breast cancer,0.0,Other,Adjuvant Therapy
TREATS,Immunologic Adjuvants,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Immunotherapy
TREATS,cyclophosphamide/fluorouracil/methotrexate protocol,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Breast surgery,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Regional Chemotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Fine-needle biopsy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Medroxyprogesterone 17-Acetate,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone Therapy
TREATS,Heart Transplantation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Endocrine therapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Endocrine Therapy
TREATS,Methotrexate,stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,Suicide Gene Therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Gene Therapy
TREATS,2-methoxyestradiol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Doxorubicin,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Taxol,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Mastectomy,Familial cancer of breast,0.0,Female Breast Cancer,Surgery
TREATS,N-desmethyltamoxifen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Neoadjuvant Therapy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Adjuvant Therapy
TREATS,Bypass surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Radiation therapy,Familial cancer of breast,0.0,Female Breast Cancer,Radiotherapy
TREATS,"Transplantation, Autologous",Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,"Vaccines, DNA",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,Aromatase Inhibitors,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone Therapy
TREATS,Skin Transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Immunotherapy, Adoptive",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Recombinant Interleukin-8|CXCL8,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Mastectomy,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Surgery
TREATS,antiangiogenesis therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Targeted Therapy
TREATS,Raloxifene Hydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,radioimmunoguided surgery,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Axillary Lymph Node Dissection,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Radiolabeled Monoclonal Antibodies,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Radiofrequency ablation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Epirubicin Hydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Estrone,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Hormone Therapy
TREATS,"Mastectomy, right, radical",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Mitoxantrone Hydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ethinyl Estradiol,stage IIIA breast cancer,0.0,Other,Radiotherapy
TREATS,Total excision of pancreas NOS,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,"Chemotherapy, Adjuvant",bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,trastuzumab,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Targeted Therapy
TREATS,Percutaneous needle biopsy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,adjuvant therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Adjuvant Therapy
TREATS,bevacizumab|VEGFA,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Estrogens,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Estradiol,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Local excision,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Pharmacotherapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Pharmacotherapy
TREATS,intraoperative radiotherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,Radiosurgery,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Raloxifene,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Myeloablative Chemotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Chinese herbal medicine,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Alternative Therapy
TREATS,Simple mastectomy,Carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,intraoperative radiotherapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Aromatase Inhibitors,Carcinoma in situ of breast,0.0,Female Breast Cancer,Hormone Therapy
TREATS,Radiofrequency ablation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Implantation procedure,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Reexcision,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Pharmacotherapy,Breast Carcinoma Metastatic to the Skin,0.0009990009990009,Other,Pharmacotherapy
TREATS,[V]Radiotherapy session,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Segmental Mastectomy,Carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Adjuvant Therapy
TREATS,Tamoxifen therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Complete excision,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Herceptin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Adjuvant Therapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Adjuvant Therapy
TREATS,Immunologic Adjuvants,Mucinous carcinoma of breast,0.0,Other,Immunotherapy
TREATS,Repeat Surgery,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Biological Response Modifiers,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Immunotherapy
TREATS,Antineoplastic Agents,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Pharmacotherapy
TREATS,Breast Cancer Radiotherapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,"Mastectomy, Subcutaneous",Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,doxorubicin,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Chemotherapy
TREATS,Cancer Radiotherapy treatment planning,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,post surgery radiation therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Carboplatin/Paclitaxel,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Maxillary left canine abutment,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Hormone Therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Hormone Therapy
TREATS,Excision of axillary lymph nodes group,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Breast Cancer Radiotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Targeted Therapy,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Targeted Therapy
TREATS,New medications,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Pharmacotherapy
TREATS,Hormone Therapy,Hormone-Resistant Breast Carcinoma,0.0,Other,Hormone Therapy
TREATS,cyclophosphamide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,cancer surgery,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Targeted",Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Post-mastectomy radiotherapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Radiotherapy
TREATS,estradiol,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,cyclophosphamide,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Adjuvant Therapy,Stage IIIA Breast Carcinoma,0.0,Other,Adjuvant Therapy
TREATS,Implantation procedure,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Contralateral Prophylactic Mastectomy,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Surgery
TREATS,Radiosurgery,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Radiotherapy
TREATS,Whole brain radiation therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Contralateral Prophylactic Mastectomy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Lymph node excision,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
METHOD_OF,Chemoprevention,Breast Cancer Prevention,0.0009990009990009,Other,Chemotherapy
TREATS,Breast-Conserving Surgery,Stage III Breast Cancer AJCC v6,0.0,Other,Surgery
TREATS,Oral chemotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,lapatinib,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Targeted Therapy
TREATS,Complementary and alternative medicine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Alternative Therapy
TREATS,Complementary therapies,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Alternative Therapy
TREATS,Pharmaceutical Preparations,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Pharmacotherapy
TREATS,Radiofrequency Ablation,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,spatially fractionated radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Anti-Inflammatory Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Operative Surgical Procedures,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Trastuzumab/Nab-paclitaxel Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Brachytherapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Excision of axillary lymph nodes group,Primary malignant neoplasm of breast with axillary lymph node invasion,0.0,Other,Surgery
TREATS,Antineoplastic Combined Chemotherapy Protocols,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Paclitaxel/Trastuzumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,doxorubicin liposome,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Hypofractionated radiation therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Radiotherapy
TREATS,Radiofrequency Ablation,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Segmental Mastectomy,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Surgery
TREATS,Hormone Therapy,Stage IIIA Breast Carcinoma,0.0,Other,Hormone Therapy
TREATS,Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Bevacizumab/Paclitaxel,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Targeted Therapy
TREATS,Chemoradiotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Radiosensitization,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Radiotherapy fractionation,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Carbon Ion Radiotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,"interleukin-1, beta",Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Immunotherapy
TREATS,Palliative Care,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Supportive Care
TREATS,Neoadjuvant Radiotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Modified radical mastectomy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Surgery
TREATS,Segmental Mastectomy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Drug Delivery Systems,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Pharmacotherapy
TREATS,Combined radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Modified radical mastectomy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Involved-Field Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Hypofractionated radiation therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Trastuzumab Regimen,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Targeted Therapy
TREATS,Skin sparing mastectomy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Carboplatin/Paclitaxel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic radiology procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Skin sparing mastectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Operative Surgical Procedures,"Breast Cancer, Familial",0.0,Female Breast Cancer,Surgery
TREATS,Hormone Therapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Hormone Therapy
TREATS,Dose-dense Chemotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,4-hydroxy-N-desmethyltamoxifen,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,cellular immunotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Robotic Surgical Systems,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Contralateral Prophylactic Mastectomy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Hypofractionated whole breast radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Immunologic Adjuvants,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Immunotherapy
TREATS,Pharmacotherapy,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Pharmacotherapy
TREATS,Stereotactic Body Radiotherapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Post-mastectomy radiotherapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Thyroid hormone replacement therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Molecular Targeted Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Hormone Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,cyclophosphamide/methotrexate/prednisone/vincristine protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cyclophosphamide,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,carboplatin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Palliative Care,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Supportive Care
TREATS,Molecular Targeted Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Targeted Therapy
TREATS,Mastectomy,contralateral breast cancer,0.0,Female Breast Cancer,Surgery
TREATS,Radiosurgery,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Segmental Mastectomy,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Adjuvant",Carcinoma breast stage I,0.0,Female Breast Cancer,Radiotherapy
TREATS,Implantation procedure,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Surgery
TREATS,Anthracyclines,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Concurrent Chemotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Docetaxel/Trastuzumab Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Segmental Mastectomy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Adoptive Immunotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Chemotherapy Regimen,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Chemoembolization,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,"Mastectomy, Radical",Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Androgen Antagonists,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Chemoembolization,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,raloxifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,"Radiotherapy, Adjuvant",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,doxorubicin,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Therapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Adjuvant Therapy
TREATS,Breast-Conserving Surgery,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,"Radiotherapy Systems, Cobalt",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,"Chemotherapy, Adjuvant","Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Chemotherapy
TREATS,Reconstructive Surgical Procedures,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,trastuzumab,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Targeted Therapy
TREATS,Heart Transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Patey Mastectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Epirubicin Injectable Solution,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anthracyclines,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,In vivo gene therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Implantation procedure,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Ifosfamide,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Pharmacotherapy,Stage IIB Breast Cancer,0.0009990009990009,Other,Pharmacotherapy
TREATS,Transplantation,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Simple mastectomy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Pre-operative chemotherapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Perioperative Adjuvant Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Adjuvant Therapy
TREATS,4'-deoxydoxorubicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,High dose brachytherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Buserelin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Ethinyl Estradiol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Endocrine therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Endocrine Therapy
TREATS,Teleradiotherapy using electrons,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Regional Chemotherapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,Excision of axillary lymph nodes,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Megavoltage radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Interleukin-2 therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Immunotherapy
TREATS,Interstitial brachytherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,Pharmaceutical Preparations,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Pharmacotherapy
TREATS,Antineoplastic Agents,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Pharmacotherapy
TREATS,Fluorouracil,stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,radical mastectomy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,gene therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Gene Therapy
TREATS,Teleradiotherapy procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Herceptin,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Targeted Therapy
TREATS,"Mastectomy, Subcutaneous","Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Doxorubicin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Raloxifene,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,Photochemotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Pharmacotherapy,stage IIIA breast cancer,0.0,Other,Pharmacotherapy
TREATS,External Beam Radiation Therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Axillary Lymph Node Dissection,Stage IIB Breast Cancer,0.0009990009990009,Other,Surgery
TREATS,Vaccines,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Immunotherapy
TREATS,radiosensitization,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,existential psychotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,Repeat Surgery,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Radioimmunotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Endocrine therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Endocrine Therapy
TREATS,Simple mastectomy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Simple mastectomy,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Surgery
TREATS,"Chemotherapy, Adjuvant",Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Chemotherapy
TREATS,Estradiol,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,"Surgical Procedures, Laparoscopic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Radiation therapy,Malignant neoplasm of female breast NOS,0.0,Other,Radiotherapy
TREATS,Chinese herbal medicine,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Alternative Therapy
TREATS,cancer surgery,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Radiation therapy management,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Herceptin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Targeted Therapy
TREATS,Fine-needle biopsy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Non-Steroidal Aromatase Inhibitor,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Hormone Therapy
TREATS,Cytotoxic Chemotherapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,trastuzumab,stage IIIB breast cancer,0.0,Other,Targeted Therapy
TREATS,Subtotal mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Cryosurgery,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Transplantation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Axillary Lymph Node Dissection,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Radiation therapy,Breast Carcinoma Metastatic to the Skin,0.0009990009990009,Other,Radiotherapy
TREATS,Modified radical mastectomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,"Surgery, Image-Guided",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Eribulin/Trastuzumab Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Hepatic arterial infusion chemotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Homeopathy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Alternative Therapy
TREATS,"Chemotherapy, single agent",Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,High Dose Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immunologic Adjuvants,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Immunotherapy
TREATS,megestrol acetate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Boost radiation therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Pharmacotherapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Pharmacotherapy
TREATS,Therapeutic radiology procedure,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,Simple mastectomy,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Surgery
TREATS,Pharmacotherapy,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Pharmacotherapy
TREATS,Biological Response Modifiers,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Immunotherapy
TREATS,Post-mastectomy radiotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Bevacizumab Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Gene Therapy Agent,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Gene Therapy
TREATS,Lymph Node Dissection,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Cytotoxic Chemotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic radiology procedure,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Radiotherapy
TREATS,Preoperative Chemotherapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Modified radical mastectomy,Stage IV Inflammatory Breast Carcinoma,0.0,Female Breast Cancer,Surgery
TREATS,Palliative Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Breast-Conserving Surgery,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,lapatinib,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Targeted Therapy
TREATS,Contralateral Prophylactic Mastectomy,Malignant neoplasm of male breast,0.0,Other,Surgery
TREATS,Anastrozole/Trastuzumab Regimen,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Targeted Therapy
TREATS,post surgery radiation therapy,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Modified radical mastectomy,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,gene therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Gene Therapy
TREATS,Docetaxel/Trastuzumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Whole brain radiation therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Radioimmunotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,estrogens,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,lapatinib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Targeted Therapy
TREATS,Metronomic Chemotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Pharmaceutical Preparations,Triple-Negative Breast Carcinoma,0.0029970029970029,Female Breast Cancer,Pharmacotherapy
TREATS,"Chemotherapy, Adjuvant",Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Excision of axillary lymph nodes group,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Targeted Therapy Agent,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Adriamycin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Immunotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Immunotherapy
TREATS,cyclophosphamide/doxorubicin protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Simple mastectomy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Myelosuppressive Chemotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,doxorubicin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Post-mastectomy radiotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,"Radiotherapy, Targeted",Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Oral chemotherapy,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Excision,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Yttrium-90 Microsphere Radioembolization,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Paclitaxel/Trastuzumab Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Pharmacotherapy,Luminal B Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Pharmacotherapy
TREATS,Intraoperative Radiation Therapy,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Organ Transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Breast-Conserving Surgery,Stage IIA Breast Carcinoma,0.0,Other,Surgery
TREATS,Bilateral mastectomy,Carcinoma breast stage I,0.0,Female Breast Cancer,Surgery
TREATS,Immunologic Adjuvants,Carcinoma breast stage I,0.0,Female Breast Cancer,Immunotherapy
TREATS,Individual psychotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Supportive Care
TREATS,Mastectomy,Multifocal breast carcinoma,0.0,Other,Surgery
TREATS,Sentinel Lymph Node Dissection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Surface Radiotherapy,Right-Sided Breast Neoplasms,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Immunotherapy for cancer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,tamoxifen,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Hormone Therapy
TREATS,"Psychotherapy, Multiple",Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Supportive Care
TREATS,Interstitial Radiation Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,carboplatin,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Postoperative chemotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Breast-Conserving Surgery,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Surgery
TREATS,Intraoperative Radiation Therapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Modified radical mastectomy,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Radioembolization,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,trastuzumab,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Targeted Therapy
TREATS,Cryosurgery,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Surgery
TREATS,Myelosuppressive Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Photochemotherapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Immune Checkpoint Inhibitors,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Immunotherapy
TREATS,"Radiotherapy, Intensity-Modulated",Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Brachytherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,trastuzumab deruxtecan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Targeted Therapy
TREATS,spinal Radiosurgery,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Neoadjuvant Chemotherapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Acupuncture procedure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Alternative Therapy
TREATS,Neoadjuvant Therapy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Adjuvant Therapy
TREATS,Carboplatin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Tissue Transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,chemoprotection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lymph Node Dissection,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Autologous Stem Cell Transplantation,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Excision,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Ifosfamide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Coronary Artery Bypass Surgery,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Buserelin|EREG|ESR1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Megestrol Acetate,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Hormone Therapy
TREATS,cyclophosphamide/doxorubicin protocol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,halstead mastectomy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Biliary Tract Surgical Procedures,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,cyclophosphamide/doxorubicin/fluorouracil protocol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Bone Marrow Stem Cell Transplantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,3-hydroxytamoxifen,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Doxorubicin,stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,Radical excision of lymph nodes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Peripheral Stem Cell Transplantation,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,4'-deoxy-4'-iododoxorubicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Immunotherapy, Active",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Immunotherapy
TREATS,"Immunotherapy, Adoptive",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,pyrrolidino-4-iodotamoxifen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Miscellaneous Chemoprotective Agent,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Electrosurgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Herceptin,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Targeted Therapy
TREATS,Herceptin,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Targeted Therapy
TREATS,Carboplatin,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,lapatinib,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Targeted Therapy
METHOD_OF,Bilateral mastectomy,breast cancer prevention,0.0,Other,Surgery
TREATS,Radiation therapy administration,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Modified radical mastectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Conformal",Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,2-methoxyestradiol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,trastuzumab|ERBB2,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Targeted Therapy
TREATS,adjuvant therapy,stage IIIB breast cancer,0.0,Other,Adjuvant Therapy
TREATS,Adriamycin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,"Chemotherapy, Adjuvant",Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Vaccines,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Immunotherapy
TREATS,bevacizumab,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Targeted Therapy
TREATS,Complementary therapies,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Alternative Therapy
TREATS,Cisplatin,Familial cancer of breast,0.0,Female Breast Cancer,Chemotherapy
METHOD_OF,Endocrine therapy,breast cancer prevention,0.0,Other,Endocrine Therapy
TREATS,Implantation procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,etoposide phosphate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lymph Node Dissection,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Herceptin|EREG|ESR1,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Targeted Therapy
TREATS,Isogenic transplantation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Preventive surgery,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,major surgery,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,"Surgical Procedures, Elective",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Radionuclide therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
METHOD_OF,Mastectomy,breast cancer prevention,0.0,Other,Surgery
TREATS,Breast surgery,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Unilateral radical mastectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Radiotherapy planning,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Surgical template,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Brachytherapy device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Brachytherapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,"Psychotherapy, Brief",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Supportive Care
TREATS,Coronary Artery Bypass Surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Hydroxyestrones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Implantation procedure,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,"Radiotherapy, Targeted",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,adjuvant therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Adjuvant Therapy
TREATS,Curative Surgery,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Adjuvant Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Carbon Ion Radiotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,bevacizumab,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Targeted Therapy
TREATS,Adjuvant Therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Adjuvant Therapy
TREATS,Biological Response Modifiers,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Immunotherapy
TREATS,Reconstructive Surgical Procedures,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Adjuvant Radiation Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Reexcision,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,tamoxifen,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Yttrium-90 Microsphere Radioembolization,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,New medications,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacotherapy
TREATS,Chemotherapy Regimen,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Repeat Surgery,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Surgery
TREATS,Adriamycin,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,tamoxifen,Stage 0 Breast Cancer AJCC v6 and v7,0.0,Female Breast Cancer,Hormone Therapy
TREATS,Breast-Conserving Surgery,Stage 0 Breast Cancer AJCC v6 and v7,0.0,Female Breast Cancer,Surgery
TREATS,Boost radiation therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Antineoplastic Agents,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacotherapy
TREATS,Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure,Multifocal breast carcinoma,0.0,Other,Surgery
TREATS,Chemotherapy Regimen,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Targeted Therapy Agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Doxorubicin Regimen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,bendamustine,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Postoperative chemotherapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Adjuvant Therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Adjuvant Therapy
TREATS,Antineoplastic Agents,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Pharmacotherapy
TREATS,tamoxifen,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Hormone Therapy
TREATS,Simple mastectomy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Mastectomy,Stage 0 Breast Carcinoma,0.0,Female Breast Cancer,Surgery
METHOD_OF,Targeted Therapy,Breast Cancer Genetics,0.0,Other,Targeted Therapy
TREATS,doxorubicin,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Boost radiation therapy (procedure),Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Radiosensitization,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Reconstructive Surgical Procedures,Carcinoma breast stage I,0.0,Female Breast Cancer,Surgery
TREATS,Hormone Therapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,methotrexate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Biological Response Modifiers,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Immunotherapy
TREATS,Neoadjuvant Chemotherapy,Luminal B Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,post surgery radiation therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Radiotherapy
TREATS,Capecitabine/Lapatinib Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Targeted Therapy
TREATS,Neoadjuvant Chemotherapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Chemotherapy
TREATS,"Chemotherapy, single agent",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Reconstructive Surgical Procedures,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Surgery
TREATS,Autologous Hematopoietic Stem Cell Transplantation,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Breast-Conserving Surgery,Stage IIIA Breast Carcinoma,0.0,Other,Surgery
TREATS,Photochemotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Excision of axillary lymph nodes group,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Surgery
TREATS,High Dose Chemotherapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Segmental Mastectomy,Right-Sided Breast Neoplasms,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Trastuzumab/Vinorelbine,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Targeted Therapy
TREATS,bevacizumab,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Targeted Therapy
TREATS,Breast-Conserving Surgery,Multifocal breast carcinoma,0.0,Other,Surgery
TREATS,ado-trastuzumab emtansine,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Targeted Therapy
TREATS,Neoadjuvant Chemotherapy,Primary malignant neoplasm of breast with axillary lymph node invasion,0.0,Other,Chemotherapy
TREATS,Bilateral mastectomy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Mastectomy,Luminal B Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Bilateral mastectomy,Stage 0 Breast Carcinoma,0.0,Female Breast Cancer,Surgery
TREATS,Systemic Chemotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,estrone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,"Radiosurgery, Stereotactic",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Iodine 125 brachytherapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,"Radiotherapy, Adjuvant",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,"Chemotherapy, Adjuvant",Primary malignant neoplasm of breast with axillary lymph node invasion,0.0,Other,Chemotherapy
TREATS,Active Breathing Coordinator-Mediated Radiation Therapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,"Staple, Surgical",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Hypofractionated radiation therapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,Curative Surgery,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Biological Response Modifiers,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Immunotherapy
TREATS,breast: excisions,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Mastectomy, Subcutaneous",Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Therapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Adjuvant Therapy
TREATS,"Radiosurgery, Stereotactic",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Nucleic Acid-Based Vaccines,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,Neoadjuvant Therapy,Stage IIB Breast Cancer,0.0009990009990009,Other,Adjuvant Therapy
TREATS,Postoperative chemotherapy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Chemotherapy
TREATS,Radiochemotherapy NOS,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Chemotherapy
TREATS,chemoprotection,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Modified radical mastectomy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Hematopoietic Stem Cell Transplantation,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Radical excision,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Breast surgery,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Ifosfamide,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Immunologic Adjuvants,stage IIIA breast cancer,0.0,Other,Immunotherapy
TREATS,Combination Chemotherapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Recombinant Interleukin-2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Oral form medroxyprogesterone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Tamoxifen,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,"Psychotherapy, Multiple",Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Supportive Care
TREATS,Chlorambucil,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Implantation procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Mastectomy,Lobular carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Medroxyprogesterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,17 alpha-ethinyl-3-isopropylsulfonyloxyestradiol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Combined radiotherapy NOS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Taxol,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Mastectomy,Stage IIA Breast Cancer,0.0019980019980019,Other,Surgery
TREATS,Chemoprevention,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Chemotherapy cycle,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,X-Ray Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
METHOD_OF,"Mastectomy, Subcutaneous",breast cancer prevention,0.0,Other,Surgery
TREATS,Antineoplastic Agents,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Pharmacotherapy
TREATS,Oral chemotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Megestrol Acetate,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Immunotherapy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Immunotherapy
TREATS,Chemotherapy-Oncologic Procedure,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Thoracic Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Doxorubicin,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Chemotherapy
TREATS,cyclophosphamide/fluorouracil,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Tamoxifen Citrate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Modified radical mastectomy,stage IIIB breast cancer,0.0,Other,Surgery
TREATS,Local excision,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Regional Chemotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Brachytherapy device,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Axillary Lymph Node Dissection,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,lapatinib,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Targeted Therapy
TREATS,Chemotherapy-Oncologic Procedure,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Carboplatin,stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,lapatinib,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Targeted Therapy
TREATS,"Chemotherapy, Adjuvant",Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Gamma Knife Radiosurgery,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,major surgery,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Whole-Brain Radiotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Cosmetic surgery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Breast-Conserving Surgery,Carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Chemotherapy care education,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Skin sparing mastectomy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Trastuzumab Regimen,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Targeted Therapy
TREATS,Cytotoxic Chemotherapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Anthracyclines,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Non-Steroidal Aromatase Inhibitor,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Complementary and Alternative Therapies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Alternative Therapy
TREATS,Purpose of radiotherapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,4-hydroxy-N-desmethyltamoxifen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,trastuzumab,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Targeted Therapy
TREATS,"interleukin-1, beta",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,Brachytherapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Radiotherapy
TREATS,Aromatase Inhibitors,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Lyso-Thermosensitive Liposome Doxorubicin,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,cyclophosphamide,Stage IIIA Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,"Gene Therapy, Somatic",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Gene Therapy
TREATS,cancer surgery,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Targeted Therapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Targeted Therapy
TREATS,Cisplatin/Gemcitabine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Immunotherapy for cancer,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,Simple mastectomy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,fluorouracil,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Chemotherapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,ADO-TRASTUZUMAB,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Hepatic arterial infusion chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Targeted Therapy Agent,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Targeted Therapy
TREATS,Breast Cancer Radiotherapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Radiosensitization,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Molecular Targeted Therapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Targeted Therapy
TREATS,Pharmacotherapy,Hormone-Resistant Breast Adenocarcinoma,0.0,Other,Pharmacotherapy
TREATS,Prescribed medications,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,post surgery radiation therapy,Mucinous breast cancer,0.0,Other,Radiotherapy
TREATS,oral anticoagulants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Pharmacotherapy Discontinuation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,cyclophosphamide,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Chemotherapy
TREATS,Conventional Surgery,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Acupuncture and Oriental Medicine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Alternative Therapy
TREATS,gene therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Gene Therapy
TREATS,Limited Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Mastectomy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Surgery
TREATS,Interferon Beta/Interleukin-2,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Immunotherapy
TREATS,Steroidal Aromatase Inhibitor,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,"Chemotherapy, Adjuvant",Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,"Radiotherapy, Adjuvant",Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Drug Delivery Systems,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Pharmacotherapy
TREATS,Simple mastectomy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Surgery
TREATS,cyclophosphamide/doxorubicin protocol,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Concurrent Chemotherapy,Primary malignant neoplasm of breast with axillary lymph node invasion,0.0,Other,Chemotherapy
TREATS,Excision of axillary lymph nodes group,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Targeted Therapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Targeted Therapy
TREATS,Targeted Therapy Agent,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Targeted Therapy
TREATS,tamoxifen,Carcinoma breast stage I,0.0,Female Breast Cancer,Hormone Therapy
TREATS,Surgical incisions,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Chemoradiotherapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,breast: excisions,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Surgery
TREATS,Cold Therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Supportive Care
TREATS,Chemotherapy cycle,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Methotrexate,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Photochemotherapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Block dissection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Etoposide,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Chemopreventive Agent,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Adriamycin,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,"Portacaval Shunt, Surgical",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Endocrine Surgical Procedures,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Brachytherapy implant,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Cytotoxic agent,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Lymph node excision,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Free estradiol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Chemotherapeutic agent,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Postoperative chemotherapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Transplantation,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Adriamycin,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Radiotherapy planning,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Chemoprevention,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Monoclonal Antibodies,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,Quadrantectomy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Curative Surgery,stage IIIA breast cancer,0.0,Other,Surgery
TREATS,Endocrine Surgical Procedures,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Miscellaneous Chemoprotective Agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Endocrine therapy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Endocrine Therapy
TREATS,Interleukin-6 therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,Axillary Lymph Node Dissection,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Operative Surgical Procedures,Inflammatory carcinoma of breast stage III,0.0,Other,Surgery
TREATS,Pulmonary Surgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Cancer Vaccines,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Immunotherapy
TREATS,Intravenous chemotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Bilateral mastectomy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,cyclophosphamide/doxorubicin/fluorouracil protocol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,adjuvant therapy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Adjuvant Therapy
TREATS,Liposomal Doxorubicin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Pharmacotherapy,Stage IIA Breast Cancer,0.0019980019980019,Other,Pharmacotherapy
TREATS,"Transplantation, Autologous",Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,"Surgical Procedures, Thoracoscopic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Cryosurgery,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Doxorubicin,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,vincristine liposomal,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Excision,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Quadrantectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Taxol,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,"Mastectomy, Subcutaneous",Stage IIA Breast Cancer,0.0019980019980019,Other,Surgery
TREATS,Lymphatic excision NOS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Segmental Mastectomy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Peptide Receptor Radionuclide Therapy,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Chemotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Targeted Therapy,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Targeted Therapy
TREATS,Excision of axillary lymph nodes group,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,"4-hydroxy-N-desmethyltamoxifen, (Z)-isomer",estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,Anthracyclines,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Biopsy gun,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,cancer radiation therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Tamoxifen 10 MG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Cytotoxic Chemotherapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,New medications,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Pharmacotherapy
TREATS,cyclophosphamide,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Chemotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Lapatinib/Trastuzumab Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,doxorubicin,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,"Radiosurgery, Stereotactic",estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Radiotherapy
TREATS,Gene Therapy Agent,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Gene Therapy
TREATS,Biochemotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Adjuvant Radiation Therapy,Carcinoma breast stage I,0.0,Female Breast Cancer,Radiotherapy
TREATS,Curative Surgery,Carcinoma breast stage I,0.0,Female Breast Cancer,Surgery
TREATS,Reexcision,Carcinoma breast stage I,0.0,Female Breast Cancer,Surgery
TREATS,Adriamycin-Cytoxan Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,epirubicin,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,"Chemotherapy, Adjuvant",HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Adjuvant Therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Adjuvant Therapy
TREATS,Paclitaxel/Trastuzumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Anastrozole/Trastuzumab Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Trastuzumab Biosimilar SB3,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Chemopreventive Agent,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Chemotherapy
TREATS,cancer radiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Implantation procedure,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Neurosurgical Procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Surgical reduction of fracture,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Mastectomy, Subcutaneous",Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Active Breathing Coordinator-Mediated Radiation Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Photochemotherapy,Refractory Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,Adriamycin,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,doxorubicin hydrochloride liposome,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,cyclophosphamide,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Radioimmunotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Excision of axillary lymph nodes group,Stage IIIB Breast Carcinoma,0.0,Other,Surgery
TREATS,Antineoplastic Chemotherapy Protocols,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,diethylstilbestrol,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Therapeutic radiology procedure,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Aromatase Inhibitors,Carcinoma breast stage I,0.0,Female Breast Cancer,Hormone Therapy
TREATS,Excision of axillary lymph nodes group,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Hypofractionated Image-Guided Radiation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Androgen Antagonists,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,High dose brachytherapy (procedure),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,post surgery radiation therapy,Stage IIB Breast Carcinoma,0.0,Other,Radiotherapy
TREATS,Herceptin,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Targeted Therapy
TREATS,Intravenous chemotherapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Targeted Therapy,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Targeted Therapy
TREATS,Stereotactic Ablative Radiotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Aromatase Inhibitors,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Hormone Therapy
TREATS,anastrozole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ERBB2 gene|ERBB2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,antagonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tannic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,docetaxel,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,UCN 01,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Angiogenesis Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,taxane,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prolactin|PRL,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Treatment Protocols,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,everolimus,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,mesylate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Toremifene,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Taxanes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,halichondrin B,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Screening mammography,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Toremifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Molecular Target,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,soy protein isolate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pertuzumab,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Paclitaxel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,taxane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bortezomib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hydroxychloroquine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Antagonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Placebos,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,educational intervention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Manual lymphatic drainage,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"EPIDERMAL GROWTH FACTOR, HUMAN",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Detection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,resveratrol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cancer Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oleic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,amrubicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,zoledronic acid,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,deguelin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,exemestane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,intervention program,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pharmacologic Substance,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Xenograft procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"2,5-dichloro-4-bromophenol",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,zoledronic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ovarian Stimulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gonadotropins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Treatment Protocols,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Paclitaxel,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Thioridazine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Goserelin Acetate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Amputation,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Therapeutic Intervention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,pemetrexed,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Breast Cancer Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,capecitabine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,deracoxib,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Systemic Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,fluoropyrimidine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Vaccination,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Sirolimus (substance),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Supplementation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Simvastatin,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,peer intervention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anti-Progestin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prolactin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Topoisomerase 1 inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"7,3'-dihydroxy-4'-methoxyisoflavone",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,letrozole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mTOR Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pancreatic resection,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,inhibitors,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone Therapy
TREATS,piperine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,artemisinine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Diphosphonates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Induced Hyperthermia,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Leuprolide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antioxidants,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Endostatins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Agent,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Vinca Alkaloids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anastrozole,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Metformin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,plasmepsin II,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Taxanes,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Oestrogen therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Therapeutic procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Adoptive Cell Transfer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,ixabepilone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Retinoids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,artesunate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,capecitabine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,resistance education,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cyclooxygenase 2 Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Prevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Paclitaxel,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,everolimus,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,Advice,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,small molecule,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Disulfiram,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Curcumin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,pertuzumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lead compound,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,hepatic arterial infusion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,Therapeutic procedure,breast cancer prevention,0.0,Other,Radiotherapy
TREATS,Advance,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tegafur-uracil,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,AR gene|AR,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Injection procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Therapeutic agent (substance),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Berberine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Combination Drug Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Dalteparin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,17-Ketosteroids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Drainage procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Vaccination,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,trichostatin A,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,Antimetabolites,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Leukapheresis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tubulin Binding Agent,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Detection,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Transsphenoidal hypophysectomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Induction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fadrozole Monohydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interferon-beta,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mitomycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Epidermal Growth Factor Receptor|EGFR,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bilateral adrenalectomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Pancreaticoduodenectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,radiation immunosuppression,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Autologous bone marrow transplant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,amidronate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Intra-Arterial Infusions,stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,Intramedullary Nailing,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Leucovorin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Hypophysectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Antibodies,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,chloroquine diphosphate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Amino Acids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Oestrogen therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,Docosahexaenoic Acids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fenretinide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Filgrastim,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,vinorelbine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Hypophysectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Taxoids,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Salvage procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Treatment Protocols,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Adrenalectomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Laser Therapy, Low-Level",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Autologous bone marrow transplant,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Hypophysectomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Melphalan|PAM,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mullerian-inhibiting hormone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Premarin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Proton therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Prophylactic treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Radicals (chemistry),Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,G207,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Estrogen Progestin Replacement Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Trifluoperazine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Thyrotropin-Releasing Hormone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Levamisole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hormones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Masteril,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Mitomycin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Masteril,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,dietary intervention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,edatrexate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,rhizoxin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic Corynebacterium Parvum,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Prolactin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Manipulation procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Radical mastoidectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Clodronate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fusion procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,epigallocatechin gallate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Succinates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anesthesia procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,CB-154,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,antitumor agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Folic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,METHYLATE,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Nolvadex,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Prodrugs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Argipressin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Placebos,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BLUE DYE,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Guide device,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Cell Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Premarin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ethanol,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Bands,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Boards,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ovariectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Microbicides,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,PS-K,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Aspiration-action,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,limonene,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Ovarian ablation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,fluoropyrimidine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Premedication,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Intra-Arterial Infusions,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Stem cell transplant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Ovariectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Carmustine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fine needle,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Melatonin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bisantrene,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Mitolactol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Citrate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,disorder control,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radicals (chemistry),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Corticotropin|POMC,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cyproterone Acetate,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,CGS-16949A,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Conservative therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,"Contraceptives, Oral",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vindesine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Acetate,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Hormone Therapy
TREATS,Intra-Arterial Infusions,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Dextran,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,dihydroxy-vitamin D3,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytostatic Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,agonists,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Aminoglutethimide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Nimorazole,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Antipsychotic Agents,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,prednisolone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Implants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pirarubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,formestane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Serum cortisol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mepitiostane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,artery infusion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Polyamines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,norethindrone acetate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Aclarubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytostatic Agents,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Steroid hormone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Antipyrine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combination Drug Therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Esters,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Systemic Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Dexamethasone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,bisantrene,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Progesterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Testosterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combination Drug Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Hormones,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Estrogen Antagonists,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Augmentation mammoplasty,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Therapeutic procedure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Ablation,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,CGS-16949A,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dopamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Medical therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Dipyridamole,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Omental flap,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Polyamines,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,agonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hemopoietic stem cell transplant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,chlorozotocin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,treatment method,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,particle,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Total hypophysectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Mitogens,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Misonidazole,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Progesterone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Steroids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oral contraception,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytostatic Agents,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,Aminoglutethimide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Thiotepa,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Artificial pneumothorax for collapse of lung,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,vorozole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adrenalectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dehydroepiandrosterone Sulfate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Etiocholanolone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Castration,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ovariectomy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Alendronate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ftorafur,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Futraful,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Serpins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Free thyroxin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prednisone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Rubidazone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Aminoglutethimide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Calcitonin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CAP combination,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Etiocholanolone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,alpha 1-Antitrypsin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Caffeine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Amsacrine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,oxaliplatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vitrectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Alternative Therapies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Androstenedione,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sterically Stabilized Liposome,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Glucocorticoids,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,parathyroid hormone-related protein|PTHLH,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Dietary Modification,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Idarubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vitamin E,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,vinorelbine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pemetrexed,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Isoflavones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Iodine-131,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Goserelin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,RC 160,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Somatomedins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fadrozole Monohydrochloride,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Histone Deacetylase Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Radiotherapy
TREATS,Frame,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gusperimus,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Conservative therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Urokinase|PLAU|PRAP1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hemibody Irradiation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Gossypol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Combination Drug Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,"Oncologic procedure, NOS",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oestrogen therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Adjuvant Therapy
TREATS,Orchiectomy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Paclitaxel,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,camptothecin-11,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,doxifluridine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Stem cell transplant,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,anthrapyrazole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Methenolone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,docetaxel,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Triiodothyronine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pericardiocentesis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,triphenylethylene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thiobarbituric Acid Reactive Substances,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Radicals (chemistry),Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,"SULFUR,COLLOIDAL",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Mesna,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Peptichemio,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,OK-432,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,doxifluridine,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Oxidants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alkylating Agents,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,CYTOKERATINS,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Melphalan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chest wall reconstruction,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Interferon-beta,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Ibuprofen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Urokinase|PLG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Beta Carotene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Futraful,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Stimulator,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interferon-alpha,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Mitomycin,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Monoclonal Antibody Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Toremifene,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Ovarian ablation,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Imidazole,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Antagonists,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,CEF regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Laser photocoagulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Antioxidants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Expression procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Antibodies, Bispecific",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,ukrain,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bilateral adrenalectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Melphalan,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Salvage Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,TRYPSIN,Breast Mucinous Carcinoma,0.0,Female Breast Cancer,Chemotherapy
TREATS,Antioestrogen therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Reinfusion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Biological Response Modifier Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Immunotherapy
TREATS,azetepa,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adrenalectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,capecitabine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Analog,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Computer Aided Detection Systems,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Blood Component Removal,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Scalp cooling,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,LU 103793|BCAM,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Xeloda,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,exemestane,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Methandriol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Continuous infusion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Acetate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Sterically Stabilized Liposome,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hepatectomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,fulvestrant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anastrozole,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Intra-Arterial Infusions,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cognitive Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,vinorelbine,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,miltefosine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ZD1839,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anti-Anxiety Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,doxifluridine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Aromatase inhibition therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,exemestane,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Irrigation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Antibodies, Bispecific",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mabthera,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Androgens,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Estrogenic,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Doxil,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,anastrozole,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Prophylactic substance,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Testosterone,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Operative procedure on hand,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,intradermal injection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Diphosphonates,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Ibandronate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gefitinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gonadal Steroid Hormones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Shield,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Urokinase,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Testosterone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Monoclonal Antibody Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Pharmacological Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Abraxane,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Hip Replacement, Total",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Treatment Guidelines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,butein,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Taxotere,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Carotenoids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cabergoline,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,667 coumate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Histone Deacetylase,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,KW 2307,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Ovarian ablation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Methylene blue,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
USES,research,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Phytate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Paclitaxel,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Mitogen-Activated Protein Kinase Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Angiogenesis Inhibitors,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Epothilones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anti-Anxiety Agents,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Leptin|LEP,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fixation of pendulous breast,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,arsenic trioxide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Psychosocial care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sterically Stabilized Liposome,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,breast cancer prevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tretinoin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Receptor Modulators,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Molecular Target,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,CYTOKERATINS,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Automation Systems,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sitosterol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Total abdominal hysterectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Fusion procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,letrozole,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Tumor Antigens,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radiation-Sensitizing Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
USES,Clinical Research,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Enzyme Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Alternative medicine preparation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Radiotherapy
TREATS,therapeutic use,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,inhibitors,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Protein-tyrosine kinase inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,gefitinib,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Cosmetic procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Pituitary Hormones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Risk Reduction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Erythropoietin|EPO,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Goserelin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sulfhydryl Compounds,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Exercise, Aerobic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Biological Products,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,ixabepilone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,nimesulide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Proteasome inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Reflexology,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Boron Neutron Capture Therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Adjuvant Therapy
TREATS,FAVOR,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thrombin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hormones,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Centchroman,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Contraceptive methods,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Secondary prevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Adrenergic Antagonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glycol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Implants,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Chondroitin Sulfates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Epothilones,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Epidermal growth factor receptor inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antiemetics,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pylorus-sparing Whipple operation,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Angiotensin-Converting Enzyme Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Tissue Expanders,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,Dietary Modification,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Cannabinoids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,GLUCOCORTICOID THERAPY,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Melatonin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Local anesthesia,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Toremifene,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,tetramethylpyrazine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,phenethyl isothiocyanate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anti-Anxiety Agents,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Radiotherapy
TREATS,Pain management,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Gold,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Heparin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,cetrorelix,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,oxaliplatin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Biological Response Modifier Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Immunotherapy
TREATS,scriptaid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,protoporphyrin IX,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mandibular right first molar abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Microscope,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vitamin D,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fulvestrant,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Avastin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,methylselenic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cordycepin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Superoxide Dismutase,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Relate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,dihydroxyacetone sulfate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Toremifene,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,docetaxel,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,treatment method,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Bilateral adrenalectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Recombinant Erythropoietin|EREG|ESR1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sorafenib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fluoxetine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,sorafenib,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,duloxetine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Innovative Therapies,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,curdione,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,autohypnosis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Analog,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,PD 0332991,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,resistin|RETN,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Polymers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Scanning Systems, Gamma Camera, Mobile",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,venlafaxine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,dehydroepiandrosterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ERBB2 gene|ERBB2,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,pristimerin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,polyetheretherketone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Paraffin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Drainage procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Environmental Estrogen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pegfilgrastim,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Polysaccharides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Proton therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,sphingosine 1-phosphate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Insulin|INS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anthracycline Antibiotics,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Coagulation procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,lobaplatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,suberoylanilide hydroxamic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Recombinant Transforming Growth Factor-Beta 1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hydrocortisone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,baicalein,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,oxaliplatin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Compete,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lenograstim,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glucose,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Dental Implants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ivermectin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,osthol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Preservative free ingredient,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,scalpel,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Carglumic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Photosensitizing Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,RAD 001,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,stem cell therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Antithyroid Agents,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Therapeutic procedure,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,cancer rehabilitation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prodrugs,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Digoxin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tipifarnib,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Caloric Restriction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sensors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fertility care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Erianin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lactate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast neoplasm screening,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Hyaluronic Acid,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Drug Combinations,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Spiritual Therapies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fraxetin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gambogic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Familial cancer of breast,0.0,Female Breast Cancer,Radiotherapy
TREATS,Imaging Device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Therapeutic agent (substance),Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Clozapine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mandibular right canine abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Thyroid Hormones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CCNA2 gene|CCNA2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Antiandrogen therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Daunorubicin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Chitosan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,Ablation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,oridonin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,human leukocyte interferon|IFNA1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,perfluoropentane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mandibular right lateral incisor abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Mammaplasty,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,heme 1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,treatment method,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Physical restraint equipment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dendritic Cell Vaccine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Breast neoplasm screening,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Preservative free ingredient,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,beta-lapachone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Femara,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alkylating Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Oncolytic Virotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,methyl group,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Benzodiazepines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,arzoxifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ferrocene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neutron Capture Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Emotional support,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Detection,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,capecitabine,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Saline,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,catechol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Epidermal growth factor receptor inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,peer intervention,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Vaccine Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Tocotrienols,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,puerarin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ibandronate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Cancer Treatment,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,fulvestrant,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Benzimidazoles,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Estriol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Granulocyte-macrophage colony stimulating factor therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,combretastatin A-4 disodium phosphate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,ORALIT,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Linoleic Acids, Conjugated",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fadrozole Monohydrochloride,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Insulin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Fluorodeoxyglucose F18,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Screening mammography,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Navelbine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Omental flap,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,reboxetine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Enzymes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vitamins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Ablation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Bilateral oophorectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Sclerosing Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Melphalan,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,cancer care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vinblastine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Gonadorelin|GNRH1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tegafur,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Leucovorin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vinca Alkaloids,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Termination of pregnancy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Leuprolide Acetate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,letrozole 2.5 MG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BLUE DYE,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,taxane,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Repositioning,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Radiotherapy
TREATS,rituximab,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,VP-16,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Pentoxifylline,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,ibandronic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Distal subtotal pancreatectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Reproductive Techniques,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Stabilizing Agents,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Electric Stimulation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Prophylactic treatment,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,OGX-011,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,erlotinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,5-aza-2'-deoxycytidine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mesylate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,stage IIIA breast cancer,0.0,Other,Radiotherapy
TREATS,"Rehabilitation, physical",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Physical therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Microbubbles,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bombesin Antagonist,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sponges,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Inosine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,"Diet, Fat-Restricted",breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Systemic Therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Induction of neuromuscular blockade,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Blood Transfusion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tegafur,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Agent,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Bilateral oophorectomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Ondansetron,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Induction,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,vinorelbine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Cyclosporine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,troglitazone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Goserelin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Combination Drug Therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,tibolone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic immunosuppression,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Collimator,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,R115777,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Compression procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Folic Acid Antagonists,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Sex Therapy,Carcinoma in situ of breast,0.0,Female Breast Cancer,Radiotherapy
TREATS,Indocyanine Green,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,SSM,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bupropion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Procedure on axilla,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Leptin|LEP,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Intravenous infusion procedures,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,celecoxib,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Respiratory Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
METHOD_OF,educational intervention,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,PET protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,everolimus,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Therapeutic tactile stimulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Triptorelin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Agent,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Symptom Management,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,PHYSICAL PERFORMANCE,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Choline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Multivitamin preparation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bortezomib,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Pancreatectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Dolasetron,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vaccination,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Mammaplasty,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,triciribine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Paclitaxel,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,"Cam, topical lotion",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Stage IIA Breast Cancer,0.0019980019980019,Other,Radiotherapy
TREATS,Drainage procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
METHOD_OF,intervention program,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,2-(4-morpholinoanilino)-6-cyclohexylaminopurine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Selective Estrogen Receptor Modulators,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Carcinoma in situ of breast,0.0,Female Breast Cancer,Radiotherapy
TREATS,Folate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gefitinib,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Antiperspirants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Charts,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,B mode ultrasound,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Serotonin Uptake Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,imatinib,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,oxaliplatin,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Salvage procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,"Nanotubes, Carbon",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,celecoxib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,orlistat,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,olanzapine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Contraception counseling,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Advance,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Detection,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Imaging Techniques,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Biological treatment,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,vinflunine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bypass,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Thyrotropin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Clip,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Carnitine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Stereotactic device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,amsonic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Genistein,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dexamethasone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tetrathiomolybdate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Follicle Stimulating Hormone|BRD2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Exploration procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Thiotepa,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Mandibular left second premolar abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Acetylcysteine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Leads,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fluimucil|XK|NLRP1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Gastrin|GAST,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pancreatic resection,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Local Therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,Recombinant human granulocyte colony stimulating factor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,fulvestrant,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Etidronate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CYTOKERATINS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Probes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Copper,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Weight maintenance regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,FEC protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,POMEGRANATE FRUIT EXTRACT,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Massage,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pancreaticoduodenectomy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Freund's Adjuvant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pleurodesis,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,letrozole,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Steroid therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Metformin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,lobaplatin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Liposomes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Reduction mammaplasty,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Hormone Antagonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,"Therapy, Relaxation",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Active Ingredients,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Muscular strength development exercise,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hill Brand 2 of Fluocinolone Acetonide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Stress management,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anthracycline Antibiotics,Stage IIB Breast Cancer,0.0009990009990009,Other,Chemotherapy
TREATS,Fertilization in Vitro,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Recombinant Transforming Growth Factor-Beta 1|TGFB1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Maintenance therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,Complete axillary lymphadenectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,aprepitant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Amitriptyline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Paclitaxel,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Dexrazoxane,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Exploration procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Reduction mammaplasty,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Surgery
TREATS,Operation on liver,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Inositol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Phantoms, Imaging",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Zea mays preparation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Dietary Supplementation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,temozolomide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Iron,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Homologous Gene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,letrozole,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,irinotecan,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Prevention,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,pertuzumab,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Implantable venous access port,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,daidzein,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bicalutamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fluimucil|XK|NLRP1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pemetrexed,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,invasive treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Mammaplasty,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Camellia sinensis extract,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,"Breast Prosthesis, Internal",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oxytocin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Injection procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,RPI.4610,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Neulasta,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Imaging Techniques,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,steviol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tegafur-uracil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Clinical Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Behavior Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Pigment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Iron Chelating Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,breast implant procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Ultrasonic Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,T cell therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Hypnosis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Communication interventions,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Aspirin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,INHIBIN,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interstitial Collagenase|MMP1,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Morphine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Caelyx,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Augmentation mammoplasty,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fadrozole,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,maspin|SERPINB5,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Implants,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Psychosocial care,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Pain management,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anastrozole,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Moxifloxacin hydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Splenectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,PTPN1 gene|PTPN1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Epidermal Growth Factor Receptor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Retreatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,zoledronic acid,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
USES,"Clinical Trials, Phase II",breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Cholecalciferol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anastrozole,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,osthol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Agent,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Chemotherapy
TREATS,Hyaluronic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Art Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,erlotinib,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Antimetastatic Agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Protein-tyrosine kinase inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Citrates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lingzhi,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Protein-tyrosine kinase inhibitor,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Cations,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Metric,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,"Drugs, Investigational",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mind-body interventions,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Guidelines,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,stepholidine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Drain device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Therapeutic regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,cepharanthine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Opioids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Luteolin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Proanthocyanidins,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Health education - diet,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antibiotic Prophylaxis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Proton therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,"1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
USES,Treatment Protocols,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Lipid-lowering therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,everolimus,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Mechlorethamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Probes,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,pump (device),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,systemic administration,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,verapamil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tubulin Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Ascorbic Acid,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Lesion Localization Wires,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Physical therapy exercises,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Tubulin Modulators,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Thoracoplasty,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,First line treatment,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,capecitabine,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Lipids,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,EndoTAG-1,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,taxane,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Taxanes,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,tao hong si wu decoction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,opium alkaloids and derivative combination cough suppressants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,rutin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Antibodies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,atezolizumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Placebos,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adjuvant Analgesic,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,eribulin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,everolimus,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Micelles,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,atezolizumab,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,zoledronic acid,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,eribulin mesylate,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,pertuzumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Abraxane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,130-nm albumin-bound paclitaxel,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,dasatinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,EC Breast Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,First line treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,denosumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,glycine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CTCb regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Luteinizing Hormone-releasing Hormone Agonist,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,removal technique,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Genetic Counseling,"Breast Cancer, Familial",0.0,Female Breast Cancer,Chemotherapy
TREATS,Interventional procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Reduction mammaplasty,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,exemestane,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Taxanes,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,palbociclib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fertility Preservation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,novel AODU treatment method,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,decitabine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Probes,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Prescription Drugs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,eribulin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,EC Breast Regimen,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,pentoxifylline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pgp Inhibitor HM30181AK,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,palbociclib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,epidermal growth factor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Kinesio Tape,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Polysaccharides,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,removal technique,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Intensity-Modulated Proton Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,pembrolizumab,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Jinqi,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sativan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Detection,"Breast Cancer, Familial",0.0,Female Breast Cancer,Chemotherapy
TREATS,"2-(4-chlorophenyl)-1-(4-(7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Immobilization,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,letrozole,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,removal technique,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Partial Breast Irradiation,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,shogaol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Detection,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,paclitaxel protein-bound,Refractory Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,First line treatment,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
METHOD_OF,Fluorescent in Situ Hybridization,Breast Cancer Genetics,0.0,Other,Surgery
TREATS,Liposomes,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,First line treatment,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,pirarubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Treatment Protocols,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,stattic,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,quercetin,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,chitosan,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Duration,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,First line treatment,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,mannose,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dose-dense AC Regimen,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Accelerated Partial Breast Irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Whole Breast Irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Single Agent Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tucatinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Nanosomal Docetaxel Lipid Suspension,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,aspirin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Poly(ADP-ribose) Polymerase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,triclocarban,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cancer Therapeutic Procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Proteasome inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,therapeutic autologous dendritic cells,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,vinorelbine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Fulvestrant/Palbociclib Regimen,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,acetazolamide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Agent,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,palbociclib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Breast Cancer Therapeutic Procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Mandibular left second molar abutment,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Surgery
TREATS,capivasertib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,ribociclib,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Triterpenes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,rosmarinic acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,neratinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,systemic administration,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Probes,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Rehabilitation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,vinorelbine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Accelerated Partial Breast Irradiation,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Everolimus/Exemestane Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Irreversible Electroporation,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,abemaciclib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adrenergic beta-Antagonists,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,capecitabine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Screening for malignant neoplasm of breast,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,10-gingerol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ibandronate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,palbociclib,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Poly(ADP-ribose) Polymerase Inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,Operative ultrasound,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Everolimus/Exemestane Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Cancer Therapeutic Procedure,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Conventional Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,neratinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Genetic Counseling,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Whole Breast Irradiation,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Atezolizumab/Nab-paclitaxel Regimen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Hydrogel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Agent,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,novel AODU treatment method,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Magnetic resonance imaging contrast media,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,alpelisib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,ambrisentan,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Selective Estrogen Receptor Down Regulator,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,arctigenin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,abiraterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Basis,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,talazoparib,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Basis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hepatitis B Surface Antigens,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ferric oxide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Accelerated Partial Breast Irradiation,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,BARRIER,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,novel AODU treatment method,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,130-nm albumin-bound paclitaxel,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,meloxicam,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Recombinant human granulocyte colony stimulating factor,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Systemic Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Adjuvant Therapy
TREATS,"Analgesics, Opioid",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Selective Estrogen Receptor Modulators,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,olaparib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,alpelisib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,usnic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Medical Devices,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,sirolimus,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sunitinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Photothermal Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Adoptive Transfer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Phosphatidylinositide 3-Kinase Inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Current Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Acceptance and Commitment Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
METHOD_OF,Stratification,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,gemcitabine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Whole Breast Irradiation,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Letrozole/Palbociclib Regimen,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,130-nm albumin-bound paclitaxel,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Phytochemicals,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Primary operation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Radiotherapy
TREATS,capecitabine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Anthracycline Antibiotics,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Genetic Counseling,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Photothermal Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Molecular Target,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,talazoparib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Accelerated Partial Breast Irradiation,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,oxaliplatin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,galactose,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Assisted Reproductive Technologies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,acetylcysteine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Conventional Treatment,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Phosphatidylinositide 3-Kinase Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tempol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Platinum Antineoplastic Compound,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Drug Repositioning,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,"Therapies, Investigational",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,abemaciclib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,elacestrant,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Exploration procedure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Dose-dense AC Regimen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Antibody-Drug Conjugates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Precision Medicine,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Adrenergic beta-Antagonists,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Bilateral subcutaneous mammectomy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Whole Breast Irradiation,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,digoxin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,neoplasm therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Anthracycline Antibiotics,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Psychosocial Intervention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cannabitriol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Antibodies, Bispecific",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Diphosphonates,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,eupafolin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,NVP BEZ235,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Innovative Therapies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ketogenic Diet,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Luteinizing Hormone-releasing Hormone Agonist,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Endotracheal tube,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,morin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Primary operation,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Yoga,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Partial Breast Irradiation,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Single Agent Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,removal technique,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,pembrolizumab,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,sacituzumab govitecan-hziy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,postoperative rehabilitation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Exploration procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Second line treatment,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Precision Medicine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,metformin,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Microwave destruction - action,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,apigenin,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,"Condoms, Male",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,carbamazepine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Hook,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alisertib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Flavonoids,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Volumetric-Modulated Arc Therapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Psychosocial procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Stellate ganglion neurolysis,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,fluorescein,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Proton Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,atezolizumab,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ribociclib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Antibody-Drug Conjugates,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Radiation dose,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,calcifediol,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Current Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,fulvestrant,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Deep Inspiration Breath Hold,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,selinexor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,dasatinib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,tissue markers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,veliparib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,removal technique,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Serratus Plane Block,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Precision Medicine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,metformin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,nedaplatin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,apple extract,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Agent,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
METHOD_OF,Analysis,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,Fertility preservation procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Biosimilars,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,"Therapies, Investigational",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Proton Pump Inhibitors,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Ganetespib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Microspheres,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Extraction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Peptides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,abemaciclib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Tubulin Binding Agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Drug Combinations,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Capsaicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Aminolevulinic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Histone deacetylase inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Structural Modifier,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Polysaccharides,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,oral supplement,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cancer Therapeutic Procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Genetic Counseling,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,fulvestrant,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,"Tubes, Blood Collection",Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,abemaciclib,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,oleanolic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Histone deacetylase inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,abemaciclib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Platinum Antineoplastic Compound,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,Volumetric-Modulated Arc Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Single Agent Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,IBL-302,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tace,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,taxane,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,chlorodihydroxypyridine/potassium oxonate/tegafur,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ribociclib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,orteronel,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Local perfusion of kidney,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Metastasectomy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Prophylactic treatment,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Surgery
TREATS,Poly I-C,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,AKT Inhibitor,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Photothermal Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,navitoclax,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,fulvestrant,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,PD-L1 Inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,Pulmonary Metastasectomy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Combination Drug Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Cold Plasma,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pertuzumab,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Mcl-1 Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,apatinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel liposome,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,curcumin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,stattic,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Oral Medication,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Toyocamycin,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Controlled ovarian stimulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,FTY-720,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Metric (substance),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Current Therapy,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Pencil Beam Scanning,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,vinorelbine,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Detection,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,ginsenoside Rg2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,taxane,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Triple-Negative Breast Carcinoma,0.0029970029970029,Female Breast Cancer,Chemotherapy
TREATS,Plastic operation on the breast,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,resveratrol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,novel AODU treatment method,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Selective Estrogen Receptor Modulators,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Selective Serotonin Reuptake Inhibitors,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Placebos,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Poly(ADP-ribose) Polymerase Inhibitors,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Protein-tyrosine kinase inhibitor,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,Carcinoma breast stage I,0.0,Female Breast Cancer,Radiotherapy
TREATS,tetrahydrodiferuloylmethane,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Poly(ADP-ribose) Polymerase Inhibitors,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,ergocalciferol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,fulvestrant,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Transcutaneous Electric Nerve Stimulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Hormone Therapy
TREATS,Camptothecin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,blood modification,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Chimeric Antigen Receptor T-Cell Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Gold Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,Thermal techniques,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hepatectomy,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,ganciclovir,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Epidermal growth factor receptor inhibitor (product),HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Leukocyte Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,inhibitors,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone Therapy
TREATS,Lymphatic Reconstruction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Volumetric-Modulated Arc Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,common procedures,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,sacituzumab govitecan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
METHOD_OF,Study,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,TAC Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
METHOD_OF,Validation,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,VP-16,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,crizotinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,removal technique,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Isolation procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,STING Agonist,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,common procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,E7389 Liposomal Formulation,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Endurance Training,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Triterpenoid saponins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fondaparinux,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Biosimilars,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,quercetin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Influenza virus vaccine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Histone deacetylase inhibitor,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Radiation dose,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,130-nm albumin-bound paclitaxel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Retreatments,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,goserelin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immune checkpoint inhibitor therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,Mammaplasty,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,vandetanib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,curcumol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,lobaplatin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Luteolin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Extraction,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Medical Devices,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,beta sitosterol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Image-Guided Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,anastrozole,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Imbrication (procedure),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Breast Cancer Therapeutic Procedure,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Single Agent Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,chitosan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anticarcinogenic Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Coordination Complexes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,eribulin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pyrotinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,"N',N''-diacetylspermine",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,apatinib,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,First line treatment,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,pembrolizumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,therapeutic autologous dendritic cells,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Second line treatment,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,ferumoxides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pessaries,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Frame (physical object),Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Drug Repositioning,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,Transection (procedure),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,toremifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,olaparib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Radiation dose,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Volumetric-Modulated Arc Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Anti-HER2 Monoclonal Antibody|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,gonadorelin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,melatonin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Application procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,"3,3'-diindolylmethane",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,taxane,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,chitosan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Lead compound,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,"Breast Cancer, Familial",0.0,Female Breast Cancer,Radiotherapy
TREATS,Salpingo-oophorectomy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Systemic Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Adjuvant Therapy
TREATS,caffeic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anlotinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,"Diet, Mediterranean",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,hyaluronic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,Exercise on prescription,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dalpiciclib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chalcone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ribociclib,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,taxane,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,tanespimycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prehabilitation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Previous and Current Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,neratinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,systems therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,naringenin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,protodioscin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,arginine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tucatinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Antibody-Drug Conjugates,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Coordination Complexes,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Hand implantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Conservative Treatment,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Salvage Therapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,AKT Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,removal technique,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,vinorelbine,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Phytochemicals,"Breast Cancer, Familial",0.0,Female Breast Cancer,Chemotherapy
TREATS,Definitive Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ultrasound destruction,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,edetic acid,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Particle,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antibiotics,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Lipid Nanoparticles,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel liposome,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,pertuzumab,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Mandibular right second premolar abutment,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,metformin,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Pogostone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Selective Estrogen Receptor Down Regulator,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,hydrogen peroxide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Selective Estrogen Receptor Down Regulator,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,letrozole,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,adrenergic block,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ribociclib,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,novel AODU treatment method,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Educational therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Estrogen Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,monitoring systems,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,prevention through information dissemination,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,First line treatment,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,gingerol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anlotinib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,benzothiophene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"1-((2-((2-chloropyridin-4yl)amino)-4'-(cyclopropylmethyl)-(4,5'-bipyrimidin)-2'-yl)amino)-2-methylpropan-2-ol",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,betulinic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tumour treating fields therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,paclitaxel,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Proton Pump Inhibitors,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone Therapy
TREATS,Family support,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sesquiterpenes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,nebivolol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,Real-Time Polymerase Chain Reaction,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,urelumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Depression screen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BPS,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,durvalumab,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,letrozole,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,apatinib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Medical therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Radiotherapy
TREATS,curcumin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,gefitinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,etravirine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Radiation education,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Mammaplasty,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Reduction mammaplasty,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,interferon type II,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,simvastatin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Stem Cell Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,osimertinib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,eribulin,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,taxane,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,zinc pyrithione,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Anti-HER2 Monoclonal Antibody|ERBB2,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,belinostat,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,camrelizumab,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,treatments and procedures,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,"Tubes, Blood Collection",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,medical treatment method,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Boron Neutron Capture Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Interventional procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Ginsenosides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,olaparib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Systemic Therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Adjuvant Therapy
TREATS,pyrotinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Active monitoring,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Letrozole/Palbociclib Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Fertility Preservation,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Therapeutic procedure,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,"3,3',4,5'-tetrahydroxystilbene",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Screening for malignant neoplasm of breast,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Combination Drug Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,soluplus,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lasofoxifene,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Proton Therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,Single Agent Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,polyphenols,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Drug Combinations,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,margetuximab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Scanning Systems,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Camptothecin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,natural polymers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,exemestane,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Today,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interventional procedure,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Surgery
TREATS,thymoquinone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sacituzumab govitecan,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,crystal healing,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tumor Necrosis Factor Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Clinical Treatment,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,gold,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sacituzumab govitecan,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Local anesthesia,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Estrogen Antagonists,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Chk1 Inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,scalpel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,abemaciclib,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Hormone Therapy
TREATS,cabazitaxel,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Protac,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Silicone implant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Poly(ADP-ribose) Polymerase Inhibitors,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Hormone Therapy
TREATS,Antibody-Drug Conjugates,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Scalp cooling system,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,directive therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Therapeutic regimen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,adalimumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Naloxone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Induction,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Antiandrogen therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,-plasty,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Granisetron,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Verteporfin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,paricalcitol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Avastin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Morinda citrifolia extract,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Forequarter amputation,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Hemodialysis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Topotecan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cetuximab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adenosine Triphosphate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Repositioning,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Metformin,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Metformin,Lobular carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Hydrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alkylphosphocholine Compound,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,dihydroquinghaosu,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,oleuropein,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,patent blue violet,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gamma Cameras,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,cucurbitacin B,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CATHEPSIN D|CTSD,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fludarabine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Detection,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Hormone manipulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Paclitaxel,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Chemotherapy
TREATS,Microdochectomy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Plasminogen Activator Inhibitor 1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Iodine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pterostilbene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Binder,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,diindolylmethane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,health risk assessment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Granulocyte colony stimulating factor prophylaxis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Detection,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Ablation,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,ICRF-159,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Regulators,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,exemestane,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Apigenin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytoxan,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Estramustinphosphate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Adrenal Cortex Hormones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,EGF-genistein,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Laparotomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Salvage Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Drug Combinations,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Nafoxidine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Transethmoidal hypophysectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prosthesis,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"1,4-dioxin",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ovariectomy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Depostat,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Vaccination,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Methylnitrosourea,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Steroids,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Transsphenoidal hypophysectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Thrombolytic Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Danazol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Carbidopa+levodopa,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Castration,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Cytembena,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vinblastine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Fadrozole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ablation,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Radiotherapy
TREATS,Idarubicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Paclitaxel,Stage IIB Breast Cancer,0.0009990009990009,Other,Chemotherapy
TREATS,piritrexim,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,safflower yellow,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytadren,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mesna,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Carbogen Breathing,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,lonidamine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Mitomycin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Leucovorin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,bleomycetin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Existential therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,doxifluridine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Bisoprolol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,TNP 470,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ovarian ablation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Biomedical Monitors,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Biological treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Aclarubicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,WR-2721,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Interferon Type II,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Endopeptidases,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Flutamide,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Mitolactol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,elmustine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Gonadorelin|GNRH1,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,agonists,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Radiotherapy
TREATS,R-38486,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tryptophan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mechlorethamine,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Prednimustine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Vindesine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BW 12C,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,artery infusion,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Cytoxan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Menogaril,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Spectacle telescope,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Plates,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Exposure technique,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immunoglobulins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hydrocortisone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Pirarubicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Interferon-alpha,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Flutamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oral contraception,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,formestane,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Ketoconazole,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Treatment Protocols,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Epidermal Growth Factor|EGF,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Interferons,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Radiotherapy
TREATS,Combination Drug Therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Cortisone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Catheterization,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Aspiration-action,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Vitamin A,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Peplomycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hydralazine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Flutamide,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Levamisole,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Hormones,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,SMS 201-995|SMS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hyaluronan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prednisone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Methylprednisolone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Implantable venous access port,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Stage IIB Breast Cancer,0.0009990009990009,Other,Radiotherapy
TREATS,Menogaril,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Peptichemio,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Ablation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Leukovorin rescue,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Gonadorelin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Furosemide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Spermidine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radicals (chemistry),Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,blastolysin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Filgrastim,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Castration,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Androgens,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Ether, Ethyl",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Advance,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,particle,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"Fracture Fixation, Internal",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Vaccination,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,human leukocyte interferon,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,diaziquone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Conservative therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,Epidermal Growth Factor|EGF,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Gonadorelin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,5-ethynyluracil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Relaxation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lenograstim,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Megestrol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Estrogen Replacements,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Autoclave,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Ethanol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Erythropoietin|EPO,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Erythropoietin|EPO,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Vitamin supplementation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Laser Therapy, Low-Level",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Detectors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Faslodex,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Zinc Oxide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Epidermal Growth Factor|EGF,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Acetate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Anthracycline Antibiotics,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Irinotecan hydrochloride,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Melphalan,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Xeloda,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Non-oral contraceptive,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ospemifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Detection,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Guide device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Thioguanine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Toremifene,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Streptokinase,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,hydroxy-methyl-ellipticinium,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bombesin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fiber,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Psychiatric therapeutic procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,"Transfusion, Autologous",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,TETROFOSMIN,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytokine therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,Indole Alkaloids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Propolis,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Basin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Detection,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Mistletoe preparation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tegafur,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,Patient referral,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Bilateral oophorectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Cortisone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Androgens,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Heterocyclic Amines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sodium Bicarbonate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Curettage procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Cytokine therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,3MC,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Methylprednisolone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Dichlorodiphenyldichloroethane,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,High-energy beam therapy NOS,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,FHIT gene|FHIT,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Farnesyl Transferase Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Erythrocyte Transfusion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Somatomedins,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,DaunoXome,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
METHOD_OF,Placebos,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Goserelin|EREG|ESR1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Growth Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Nucleoside Analogs,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,EPO gene|EPO,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Gene Therapy
TREATS,Alkylphosphocholine Compound,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,EM 800,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ZD1839,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,agonists,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,ecteinascidin 743,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fixation of pendulous breast,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Abortion, Induced",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,antitumor agent,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,FK228,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Medical counseling NOS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tumor destruction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Markers, Bone",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Detection,Familial cancer of breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Myocet,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,vinorelbine,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Finasteride,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Technetium Tc 99m Sestamibi,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Taxotere,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,related compounds,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Closure by wire,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Relaxin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,TT 232,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,nursing therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Paclitaxel,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,VEGF gene|VEGFA,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Insulin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fatigue management,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,zoledronate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Arsenal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Folk Remedies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bexarotene,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Sequential Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Histone Deacetylase Inhibitor,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Iressa,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,psychopharmacological therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Cell Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Sterically Stabilized Liposome,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,fluorophore,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chronotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Phantoms, Imaging","Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Oestrogen therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Adjuvant Therapy
TREATS,Radium,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Administration, Oral",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dextrorphan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cotinine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Primary Prevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,Intervention regimes,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Transjugular intrahepatic portosystemic shunt procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Eno,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Lactams,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thermographs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Biological Products,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,CCI 779,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,methyl group,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Ultraviolet Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
METHOD_OF,Treatment Protocols,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,preventive health care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Molecular Target,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,roscovitine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cilengitide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,LBH589,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,kinase inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Coronary revascularisation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Percutaneous coronary intervention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,mTOR Inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,atorvastatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Diphenhydramine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lignans,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Symptom control,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Phosphorylcholine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Phytotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,prohibitin|PHB,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sphingosine 1-phosphate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,TEC regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Copolymer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Follicle Stimulating Hormone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Adrenergic beta-Antagonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Insulin, injectable",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mandibular right second premolar abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,glyceollin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Injection procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,STAT3 gene|STAT3,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Leptin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tace,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Calcitriol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Serine Proteinase Inhibitors,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Estrogen Receptors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,hyperthermia treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Distal subtotal pancreatectomy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Topoisomerase 1 inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Esophagectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,disorder control,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Antagonists,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,erbB-2 Receptor|ERBB2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lenalidomide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,desflurane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Detection,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Erythropoietin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Clomiphene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mifepristone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lymph node revealing solution,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Thiourea,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,azaspirane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,corrigendum,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fisetin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Structural modification,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Headlights,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Molecular Target,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,3-bromoacetoxyandrostan-17-one,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Inflammatory carcinoma of breast stage III,0.0,Other,Chemotherapy
TREATS,Antimitotic Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,delta-tocopherol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ginsenoside Rh4,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,plumbagin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,isoliquiritigenin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Phototherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pyridine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Heparin, Low-Molecular-Weight",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,15alpha-methoxypuupehenol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Nipple reconstruction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ovulation Induction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Breast Carcinoma Metastatic to the Skin,0.0009990009990009,Other,Radiotherapy
TREATS,chlorin e6,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Guidelines,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Fludarabine phosphate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytostat,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,DELIVER,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,minoxidil topical,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gamma-tocotrienol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Flavonoids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,PS 341,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Maintenance therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Piroxicam,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Taxanes,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Antibiotics,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Extraction,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Soy Proteins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cancer care,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,isoliquiritigenin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Warfarin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Endopeptidases|ERVK-7|ERVK-8|ERVK-10|ERVK-9|ERVK-21|ERVK-18|ERVK-25|ERVK-24|ERVK-19,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Clodronic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,enzastaurin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Technetium Tc 99m Sestamibi,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Immunization,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,alpha Tocopherol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antidiabetics,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Balloon dilatation catheter,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Metformin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Outpatient procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,DDAVP,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Dilatation and Curettage,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bexarotene,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Pharmacologic Substance,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Human Chorionic Gonadotropin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,1-dodecylpyridoxal,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,rhenium-186 HEDP,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tissue Inhibitor of Metalloproteinases,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Hyperthermia, Local",Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Recombinant human granulocyte colony stimulating factor,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,amidronate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Taxanes,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Paclitaxel,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Chromogranin A|CHGA,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tube drain,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Reduction mammoplasty, bilateral",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Therapeutic regimen,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,selective intervention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vertebroplasty,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Analyte,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,4'-N-benzoylstaurosporine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dexverapamil,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Biomedical Monitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vinblastine,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Cytarabine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Agent,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Premarin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,edatrexate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Human Chorionic Gonadotropin|CGA|HTC2|CGB5,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dexrazoxane,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,ABI007,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Guided imagery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Induced Hyperthermia,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Combined Modality Therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Inflammation Mediators,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Detection,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Risk Reduction,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Pyrimidine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Compression Bandages,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,heme 1,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Chemotherapy
TREATS,Cyclosporine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Antidiabetics,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Insulin, Glargine, Human",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"Markers, Bone",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Therapeutic procedure,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Gold,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Goserelin 10.8 MG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Daunorubicn liposome,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cytarabine liposomal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Medium chain triglycerides,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,palonosetron,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,4-chlorophenyl methyl sulfide,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,vinflunine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,N-terminal pro-B-type natriuretic peptide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Routine procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,VASCULAR ACCESS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Clipping,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,internal radiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Elevation procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Topotecan,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Open approach,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ophthalmic examination and evaluation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,OK-432,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,CMF regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,8-hydroxy-2'-deoxyguanosine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Imatinib mesylate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Dexrazoxane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Agent,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,Ascorbic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,wound care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,VEGF Trap|VEGFA,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Myofascial release,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thrombolytic Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Maxillary left second molar abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"3,4-Methylenedioxyamphetamine",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,thermal ablation therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,"SULFUR,COLLOIDAL",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thomsen-Friedenreich antibodies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hook,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Rifampin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,thiopurine,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,TUMOR REMOVAL,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,beta-Glucans,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glutamic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,B mode ultrasound,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Paroxetine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Paclitaxel,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,AZD2171,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Desipramine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Arimidex,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone Therapy
TREATS,Oral supplement,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Zinc,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Moxibustion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Erbium:YAG laser device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Catheter placement,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Herbal Drugs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,amidronate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Insulin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Extraction,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Contraceptive Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Spironolactone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,SESTAMIBI,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CyberKnife,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Compression procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Omental flap,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Digitoxin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,artesunate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Receptor alpha,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Indwelling Catheter,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Salpingo-oophorectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,celecoxib,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Tobacco,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pancreatectomy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,physcione,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,zoledronic acid,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Ethylene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,citral,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,imiquimod,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Lidocaine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Risedronate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Screening mammography,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,nimbolide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Biosensors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Citalopram,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fulvestrant,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Fluphenazine Hydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Postoperative analgesia,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"EPIDERMAL GROWTH FACTOR, HUMAN",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Thioctic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Simvastatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Testosterone,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,frullanolide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pyruvaldehyde,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,exemestane 25 MG,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"tocotrienol, delta",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dendrimers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,irinotecan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Preservative free ingredient,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,carboapatite,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Navelbine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,dihydroxy-vitamin D3,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,equol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immunoglobulin G,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Analyzers, Laboratory, Immunoassay, Chemiluminescent",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thiosemicarbazones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,oxymatrine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Analgesics,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vascular Access Devices,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Imaging Techniques,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,treatment method,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,cabergoline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Induced Hyperthermia,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Infusion procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Activated Charcoal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,VENOUS ACCESS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,polylactic acid-polyglycolic acid copolymer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,imatinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lesion Localization Wires,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tumor destruction,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,FTY 720,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,candesartan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,High-Throughput Nucleotide Sequencing,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,Ovarian Stimulation,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Dialysis procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Harmine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cognitive Therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Primary operation,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Current Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Psychological therapies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,ABT-737,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,methyl jasmonate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dose Fractionation,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,CAPTURE,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,adecatumumab,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,DS-8201a,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,mirtazapine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,68Ga-NOTA-RM26,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,nitric oxide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ANG1005,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,nivolumab,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Blood Transfusion,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,cycloserine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antibodies,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Chemotherapy
TREATS,folic acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,daunorubicin liposomal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,immune checkpoint inhibitor therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Immunotherapy
TREATS,Operation on breast,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,bicalutamide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Traction,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,pertuzumab,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Taxanes,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Immune Checkpoint Inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,BYL719,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Operation on lymph node,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Lucitanib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Bisphosphonate therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Estrogen Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Second line treatment,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Conventional Treatment,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Imagery technique,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Capecitabine/Vinorelbine,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,desmopressin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,ibrutinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,treatment guideline,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,guar gum,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Emodin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,CDK4/6 Inhibition,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Antagonists,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,sirolimus,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,cabozantinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"immunoglobulins, intravenous",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Stage 0 Breast Carcinoma,0.0,Female Breast Cancer,Radiotherapy
TREATS,chlorodihydroxypyridine/potassium oxonate/tegafur,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Anti-HER2 Antibody-drug Conjugate|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,loratadine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interventional procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,zoledronic acid,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Estring,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Current Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,CB-839,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Deep Inspiration Breath Hold,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic Device,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,GSK1210151A,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,"glutamate carboxypeptidase II, human",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Retrieval - procedure,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,troxerutin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ginseng preparation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Stop brand of fluoride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Taxotere,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,arctigenin,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,emu oil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fatostatin,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,laser irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Taxanes,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Microspheres,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Sequential Treatment,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Proteins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sulforafan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Traditional Chinese Medicine Formulation,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Radiotherapy
TREATS,Phosphatidylinositide 3-Kinase Inhibitor,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,LY3022855,Refractory Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,liquiritigenin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,blood lipid,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Tucatinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,treatment guideline,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Complete axillary lymphadenectomy (procedure),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,indocyanine green,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Stabilization,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,filgrastim,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,methyl acrylate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Standardized technique,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,"Injections, Intraperitoneal",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,metformin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Receptor Inhibitor [EPC],estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,bazedoxifene,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Induced Hyperthermia,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,cinobufagin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,First line treatment,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Bicarbonates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Docetaxel Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,disorder control (procedure),Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,poly(ethylene glycol)-co-poly(ethyleneimine),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic regimen,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Proton Therapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,berbamine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,dihydroartemisinin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Hormone-Resistant Breast Carcinoma,0.0,Other,Hormone Therapy
TREATS,complex (molecular entity),Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,AKT Inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Progesterone Antagonist,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Ovarian ablation,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Cannabinoids,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Exercise Intervention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,zoledronic acid,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Histone deacetylase inhibitor|HDAC9,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ruxolitinib,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Phosphatidylinositide 3-Kinase Inhibitor,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Hand endodontic technique,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Eosinum, eosin, Homeopathic preparation",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic regimen,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Nicotine replacement therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Zoledronic acid therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,dendrophenol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,methylene blue,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,therapeutic autologous dendritic cells,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,PD-L1 Inhibitors,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,ursodiol,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,fenofibrate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,disease prevention,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Radical prostatectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Microwave destruction - action,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Local Therapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,salinomycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,vemurafenib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,neratinib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Primary operation,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Qigong,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pyrotinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,General Anesthesia,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CDK4/6 Inhibitor FCN-437,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,antagonists,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,pembrolizumab,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,"Tubes, Blood Collection",Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,zoledronate,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Cardiac rehabilitation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gedatolisib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Deep Inspiration Breath Hold,Right-Sided Breast Neoplasms,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,calcium,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast Cancer Therapeutic Procedure,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,nilotinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,erbB-2 Receptor|ERBB2,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Anti-Anxiety Agents,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Immunotherapy
TREATS,irinotecan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,CTCb regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Metal Chelator,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Anti-Anxiety Agents,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Pharmacotherapy
TREATS,Prebiotics,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Drainage of lymphatics,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Selenite,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mind-Body Medicine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,directive therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Fulvestrant/Ribociclib Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Compound Kushen Injection,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,palbociclib,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Hormone Therapy
TREATS,First line treatment,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Angiogenesis Inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,Pain relief,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,4-coumaric acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Guanidines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,calcitriol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hypnotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Angiotensin II receptor antagonist,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,systemic administration,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Agent,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,"Imidazole derivatives, antimycotic for systemic use",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Breast Cancer Therapeutic Procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Prosthesis Implantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,PD-L1 Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,crizotinib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Parabens,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interventional procedure,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,enzalutamide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Lipidome,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,systemic administration,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Partial Breast Irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Prophylactic treatment,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Indoles,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,cinnamic acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,directive therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Cancer Therapeutic Procedure,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Radiotherapy
TREATS,Oxylipins,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,palbociclib,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Understanding behavior,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Histone deacetylase inhibitor|HDAC9,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,pegfilgrastim,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,vexibinol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,BET Inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Detection,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Percutaneous Administration,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Re-Irradiation,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,diallyl trisulfide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Metabolic therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Coumestrol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Concomitant Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Mammaplasty,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Prophylactic treatment,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Surgery
TREATS,Cancer Therapeutic Procedure,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Dose Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,INVESTIGATIONAL AGENTS,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Pharmacotherapy
TREATS,TAC,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,celastrol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Therapies, Investigational",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
USES,research,Breast Cancer Prevention,0.0009990009990009,Other,Chemotherapy
TREATS,Screening mammography,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,AQ4N,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,aspirin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Nitroglycerin/Sodium Citrate/Ethanol Solution,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Oocyte Retrieval,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,directive therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Polysaccharides,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,PD-1-PD-L1 Blockade,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,talazoparib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Detection,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Organ Preservation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,lidocaine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pigment blue 16,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,tretinoin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sacituzumab govitecan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Electric stimulation technique,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Atrial Ablation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Combined Modality Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Combined Modality Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Radiotherapy
TREATS,Neoadjuvant Systemic Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Adjuvant Therapy
TREATS,myricetin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Detection,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,naltrexone,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Nonesterified Fatty Acids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Third line treatment,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Abdominoplasty (procedure),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,atezolizumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,irradiation modality,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docosahexaenoic acid,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,plasmid vaccine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,"Medicine, Folk",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,chlorogenic acid,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Family support,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,sodium cantharidate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,nafamostat mesilate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,astragaloside IV,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prodrugs,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,"Tubes, Blood Collection",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Extraction,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Detection,contralateral breast cancer,0.0,Female Breast Cancer,Surgery
TREATS,margetuximab,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,130-nm albumin-bound paclitaxel,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,fluorophore,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Photothermal Therapy,Stage 0 Breast Carcinoma,0.0,Female Breast Cancer,Adjuvant Therapy
TREATS,EC Breast Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,palbociclib,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,pirarubicin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,"Oral drug preparation, NOS",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BYL719,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,alpha-tocopherol succinate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Generic Drugs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Micelles,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,mifepristone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,paclitaxel protein-bound,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,eribulin,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,irradiation modality,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,chrysin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Antibiotic Lock Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Treatment Protocols,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,sodium perborate tetrahydrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anastrozole,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Responsiveness assessment,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Radiotherapy
TREATS,Implants,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,NG-Nitroarginine Methyl Ester,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glucocorticoids,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Conventional Treatment,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Interventional procedure,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Genomic screening,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Chemotherapy
TREATS,Manipulation procedure,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Surgery
TREATS,sphingosine 1-phosphate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Photosensitizing Agents,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,Xanthones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ebastine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Titania,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Proton Therapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,triptolide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Immune checkpoint inhibitor therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Laser treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Cardiovascular therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Exploration procedure,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Active Method,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,thymoquinone,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,morin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,edoxaban,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,DeltaRex-G,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,capecitabine,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Chimeric Antigen Receptor T-Cell Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,3-methylquercetin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pyrotinib,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Anthracycline Antibiotics,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,morusin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Application procedure,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,ubidecarenone,Carcinoma breast stage I,0.0,Female Breast Cancer,Chemotherapy
TREATS,Luteinizing Hormone-releasing Hormone Agonist,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Hormone Therapy
TREATS,Oncolytic Virotherapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Caffeine-based Cream,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,Carcinoma breast stage I,0.0,Female Breast Cancer,Chemotherapy
METHOD_OF,Immunohistochemistry,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,sirolimus,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,kaempferol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,cantharidin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Agomelatine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,palmitic acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,antagonists,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Partial Breast Irradiation,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,leptin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,Genetic screening method,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,Secondary Prevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,sorafenib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Accelerated Partial Breast Irradiation,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Surgery
TREATS,Single Agent Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,sulindac sulfide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Tomotherapy,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Prophylactic oophorectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Anti-HER2 Monoclonal Antibody|ERBB2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,astragaloside IV,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Endocrine drugs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,colloidal silver,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neurostimulation/modulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lipid Nanoparticles,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Thapsigargin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,prevention through information dissemination,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Proton Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,naldemedine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,magnesium monoperoxyphthalate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,denosumab,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,sinapinic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Active monitoring,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Coronavirus vaccination,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oils,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,boswellia preparation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Clinical Breast Examination,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,schizandrin B,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Ceralasertib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Clinical Protocols,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,zinc,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Poly(ADP-ribose) Polymerase Inhibitors,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Hormone Therapy
TREATS,WITHANIA SOMNIFERA,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,Detection,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Rehabilitation therapy,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Radiotherapy
TREATS,Polymers,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,eribulin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Detection,Multifocal breast carcinoma,0.0,Other,Surgery
TREATS,ATR Inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,factor VIII,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Diphosphonates,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Taxanes,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Indazoles,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cadexomer iodine,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Ogivri,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,apigenin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Proton Pump Inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,CT-P6,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Precision Medicine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Induced Hyperthermia,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,prednisolone,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Ingredient,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ezetimibe,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,removal technique,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Valve Replacement,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Elevation procedure,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Ligation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dienoestrol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vitamin D Analog,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glucocorticoids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,B mode ultrasound,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Testosterone Propionate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Guide device,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Thiobarbituric Acid Reactive Substances,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,derivatives,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Prevention,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,taxane,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,"3,3',4,5'-tetrahydroxystilbene",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ketamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"SYSTEM, IMAGING, FLUORESCENCE",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,TES,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,surfactin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"3,3,4,4-tetramethylsuccinimide",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,platycodin D,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,therapeutic use,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,evodiamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,dihydroxyacetone sulfate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Androgen therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Psychosocial care,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Probes,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Preventing pain,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Screens,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Radiotherapy
TREATS,TLK 286,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immunotherapeutic agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,3-(2-phenylethyl)-4-methylsydnone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,indole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pentoxifylline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Focused Ultrasound Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Aspirin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Antipsychotic Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,CCL2 gene|CCL2,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Gene Therapy
TREATS,Duocarmycin Antibiotic,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fluorodeoxyglucose,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,MDX-H210|MAFD2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,RU 58668,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,lycopene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Diazepam,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Maytansine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,stilbostat,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Monoterpenes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Diphosphonates,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Bilateral adrenalectomy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,TP protocol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Intubation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Intrauterine Devices,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cell Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Ovariectomy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Isotretinoin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hormone manipulation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,4-methylcoumarin 7-O-sulfamate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adrenalectomy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Daunorubicin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Thyrotropin-Releasing Hormone,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Hormone Therapy
TREATS,calusterone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Antimetabolites,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,RC 160,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chloroquine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,morpholinoanthracycline MX2,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,hyperthermia treatment,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,thymostimulin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Finasteride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tomudex,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Peripheral blood stem cell harvest,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Vinblastine,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Thyrotropin,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Taxoids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glycyrrhizic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ovariectomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Medical therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Placebos,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Haloperidol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Celiptium,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,CCNU,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antioxidants,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,aspoxicillin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"6-methyl-1,3,8-trichlorodibenzofuran",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Penicillins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cosmetic procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Silicone gel implant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,FT-207,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fazarabine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Fluoxymesterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,2-butene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Danazol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,iproplatin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Stanozolol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Vinblastine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,iproplatin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Conservative therapy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,perfosfamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,low protein,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Mechanotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Carbon dioxide laser device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Anthrapyrazole Antibiotic,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mitomycin D,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Mass Screening Systems,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fluoxymesterone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Cortisone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,Thoracotomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mitomycins,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Psychosocial Rehabilitation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,amonafide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Clomiphene Citrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Putrescine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Endoxan,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,VP 16-213,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Combination Drug Therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Stem cell transplant,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Prosthesis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Androgens,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Luteinizing Hormone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Cefotiam,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Purified Protein Derivative of Tuberculin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Poly A-U,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interferons,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Nitrosourea Compounds,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,aclacinomycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,In Vitro Diagnostics,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,adozelesin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Interferon-alpha,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,bruceantin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,ICRF-187,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
USES,research study,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Antioestrogen therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,disorder control,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"Drugs, Essential",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gossypol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cardioxane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Uracil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bromocriptine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Amifostine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Recombinant human granulocyte colony stimulating factor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Reserpine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Miltex,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Peripheral blood stem cell graft (procedure),Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,CMF regimen,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Amputation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,LY 353381,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cyclooxygenase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Complete axillary lymphadenectomy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Arginine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Strontium-89,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Clodronate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,monoclonal antibody CC49,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,herpes simplex thymidine kinase,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sargramostim,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,MDX-H210,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Hyaluronic Acid,Tubular breast cancer,0.0,Other,Chemotherapy
TREATS,Edrecolomab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Busulfan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Electrocardiographic monitoring,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,E 64,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,testololactone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"Total adrenalectomy, bilateral",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Retinoids,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Grafts, Skin, Biological",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,cyclohexylaminoglutethimide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hematoporphyrin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Metyrapone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Microwave Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Rolls,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,RHENIUM SULFIDE COLLOIDAL,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hormone manipulation,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Hormone Therapy
TREATS,Farnesyl Transferase Inhibitor,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,cycloprodigiosin hydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,exemestane 25 MG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antimetabolites,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Risk Reduction,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,perilla alcohol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Beta-2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mouse monoclonal antibody,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,flavopiridol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dimercaptosuccinic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dopaminergic Agents,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Technetium Tc 99m Sestamibi,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Signal Transduction Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,trilostane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Free testosterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pleurodesis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Catechin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cremophor EL,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,parthenolide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,systemic administration,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Irrigation,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
METHOD_OF,Procedures,breast cancer prevention,0.0,Other,Surgery
TREATS,Tetrahydroisoquinolines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mimosine,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Dose Fractionation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,epothilone B lactam,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Immunomodulators,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,temozolomide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,PHYSICAL PERFORMANCE,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Procainamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alendronate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Hormone manipulation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Lamivudine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,growth-promoting factors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Heparin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Symptom Management,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,ORALIT,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Vancomycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glycine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,17-(allylamino)-17-demethoxygeldanamycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,miltefosine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Proto-Oncogene Protein pp60 (c-src)|SRC,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,taspine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,4-chlorophenyl methyl sulfide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fatty acid glycerol esters,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hormone suppression therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Forequarter amputation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Tunicamycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,vinpocetine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Amides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Creation of ventriculo-peritoneal shunt,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
USES,"Clinical Trials, Phase III",breast cancer prevention,0.0,Other,Chemotherapy
TREATS,chromophore,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Oils, Volatile",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cremophor EL,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Coumarins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Low Dose Radiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,"MAGNET, PERMANENT",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fucoidan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,isoalantolactone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,protein kinase inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thyroid extract,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Reproductive Techniques,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anabolic Agents,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Injectables,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,trabectedin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Ultrasound destruction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Matrix Metalloproteinase Inhibitor,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Estrogen Antagonists,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Anticonvulsants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hampers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Copolymer,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Stretcher,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Emodin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pomolic acid,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,silybin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Protamines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ethyl acetate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Manipulation procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,flavone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alkaloids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,TP53 gene|TP53,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Pyrimidine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ellagic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,flubendazole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,heme 1,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,heme 1,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Selenium,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,stefin,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,polylactic acid-polyglycolic acid copolymer,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,STI571,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Purines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Skin infiltration,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Mica,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,4-anisyltetrazolium blue,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,kahweol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,monomethoxypolyethylene glycol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cyclooxygenase 2 Inhibitors,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,flubendazole,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Microbubbles,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,ABI007,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,diazeniumdiolate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cribs,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,YM 511,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sirolimus (substance),Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,NSC 23766,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Navelbine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,DEC regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Myocet,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Neurotensin|NTS,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Tretinoin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Transfusion, Autologous",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Hysterectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Aspiration of bone marrow from donor for transplant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,autologous tumor cell vaccine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Matrix Metalloproteinase Inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Estramustine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Transducers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Progesterone,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,N-methylsuccinimide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Levonorgestrel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,letrozole,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Interferon Type II,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Shiga-Like Toxin I,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antithrombins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Androgenic steroid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anthracycline Antibiotics,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Thiotepa,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Carbamates,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Imaging Device,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Aromatase,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Depreotide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Gadobenate dimeglumine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Scar management,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Angiogenesis Inhibitors,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Citrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,RAD 001,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,group counseling,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Progesterone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Antidepressive Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Epidermal Growth Factor Receptor|EGFR,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,17-(allylamino)-17-demethoxygeldanamycin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,iso-sulfan blue,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Intravenous therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Operation on brain,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fusion procedure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Radicals (chemistry),Lobular carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,nemorosone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,DMPK|IGHD1-7,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Abraxane,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Propranolol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Progressive muscle relaxation,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Goserelin,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Augmentation procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,internal radiation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,early detection of cervical cancer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Morphine,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Hyperbaric Oxygenation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,peer counseling,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,rituximab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Valproic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic Intervention,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Radiotherapy
TREATS,Magnetic resonance imaging unit,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hemodialysis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Carnitine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Albuterol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Antilipemic Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,"2,3-bis(3'-hydroxybenzyl)butyrolactone",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,oncostatin M|OSM,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mandibular left second premolar abutment,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Premedication,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alternative Therapies,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Operative procedure on coronary arteries,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Ophthalmic examination and evaluation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Injection procedure,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Ficusin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hyaluronic Acid,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Ablation,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Radiotherapy
TREATS,bolus infusion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Epidermal Growth Factor|EGF,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,cervical cancer prevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Self Monitoring,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Zinc,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Estramustine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,N-3 fatty acid supplementation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vitamin D,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Histamine Antagonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Placebos,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Hepatectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Phosphoric Monoester Hydrolases,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Protein Arrays,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast neoplasm screening,Malignant neoplasm of female breast NOS,0.0,Other,Chemotherapy
TREATS,METHYLATE,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Water,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ZOLEDRONIC,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"O,O-diisopropyl-S-benzylthiophosphate",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Positron emission tomography unit,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ribonucleotide Reductase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Total intravenous anesthesia,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fertility counseling,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cardiac Monitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Risk Reduction,Familial cancer of breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Gadolinium DTPA,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vitamin A,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mandibular left lateral incisor abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Velcade,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Trimetrexate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gonadotropin releasing hormone antagonist,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,antagonists,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Dinoprostone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Functional exercises,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"CST6 protein, human|CST6",Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Clomiphene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Epoetin Alfa,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,exemestane,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,rhenium-186 HEDP,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Castor Oil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Zoladex,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gastroduodenoscopy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Botanicals,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,imiquimod,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Group exercise program,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Thiourea,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic vaccine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,ST. JOHN'S WORT EXTRACT,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,PTPN11 gene|PTPN11,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,monolayer,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,eculizumab,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Organic Chemicals,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,icariin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Polymerase,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Multidrug Resistance Modulator,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gemtuzumab ozogamicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,small molecule,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Vitamin supplementation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Angiopoietin-2|ANGPT2|VPS51,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,hydroxytyrosol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,saikosaponin B2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Duodenectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,DNA Methyltransferase Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,diosmetin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Nitric Oxide Donors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bands,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Botulinum Toxins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,malvidin-3-O-glucoside-4 vinyl,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,nimotuzumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cardiac Lead Procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,losartan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,RO 4929097,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Peptides,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,exemestane,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Substance with programmed cell death protein 1 inhibitor mechanism of action (substance),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Estriol Vaginal Gel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Zoledronic acid therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,veliparib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,folic acid,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Immunoconjugates,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Thoracoplasty,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,epigallocatechin gallate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,tetrandrine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Symptom control (regime/therapy),malignant neoplasm of breast staging,0.0,Female Breast Cancer,Radiotherapy
TREATS,fucoidan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,hesperetin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,"N,N-dimethyl-N-hexadecyl-1-octadecylammonium chloride",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,pentoxifylline,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Radiation dose,Right-Sided Breast Neoplasms,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Lymphedema Management,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Perforator flap, free",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,First line treatment,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Selective Estrogen Receptor Down Regulator,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Cold Plasma,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Immune Globulin (Human),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Maytansinoid DM1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,oseltamivir phosphate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,AZD9496,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,telaprevir,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,First line treatment,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,silybin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Partial Breast Irradiation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,citral,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,chlordiazepoxide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,spironolactone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,copper,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Administration of medication,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bilateral salpingectomy with oophorectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,derivatives,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Scalp cooling,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,ospemifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Varlitinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,oridonin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,resistomycin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,metronidazole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,disorder control (procedure),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Systemic Therapy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,CTCb regimen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,aguerin B,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Disease management program (regime/therapy),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,sodium salts,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,flubendazole,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,LETROZOLE/RIBOCICLIB,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,niclosamide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,talazoparib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Clodronate,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Proprioception awareness work,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,podofilox,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,denosumab,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,bufalin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,PECS II block,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,First line treatment,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,"Diet, High-Fat",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,tripterine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,CDK4/6 Inhibition,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cryotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Food Component,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,aminoglutethimide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interventional procedure,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,Neoadjuvant Systemic Therapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Adjuvant Therapy
TREATS,Genomic screening,"Breast Cancer, Familial",0.0,Female Breast Cancer,Chemotherapy
TREATS,phenylacetaldehyde,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,irinotecan liposomal,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,olaparib,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,therapeutic autologous dendritic cells,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Pulmonary Metastasectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Antagonists,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Lead compound,Hormone-Resistant Breast Carcinoma,0.0,Other,Hormone Therapy
TREATS,Triterpenoid Compound,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,shikonin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,bicalutamide,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,cetuximab,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Everolimus/Exemestane Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,zoledronate,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Bilateral salpingectomy with oophorectomy,Carcinoma breast stage I,0.0,Female Breast Cancer,Surgery
TREATS,Triterpenes,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,leptin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Delivery care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mucin-1 Antigen,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,eribulin mesylate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Hormone Therapy
TREATS,Radical therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Immunization,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Thermal techniques,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Exercise Intervention,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Continuous Positive Airway Pressure,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,neratinib,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Debio 0932,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Coagulation procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,"1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,genistein,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Fertility Preservation,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,alpelisib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Cosmetic procedure,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Surgery
TREATS,Matrix Metalloproteinase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Antibodies,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,removal technique,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,metformin,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Cholecystectomy procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,apatinib,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Internalized-arginylglycylaspartic Acid Cyclic Peptide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Anthracycline Antibiotics,Carcinoma breast stage I,0.0,Female Breast Cancer,Chemotherapy
TREATS,calcifediol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,breast implant procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Placebos,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,vinorelbine,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,salubrinal,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,temozolomide,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,glutathione,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interventional procedure,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Surgery
TREATS,Mind/body Exercise,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Poly(ADP-ribose) Polymerase Inhibitors,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Hormone Therapy
TREATS,dexrazoxane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hyperbaric oxygenation therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Basis,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,"Contraceptives, Oral",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,asiatic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Charts (device),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Implants,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Electroconvulsive Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Synthetic drug,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,therapeutic processes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,avelumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Stage 0 Breast Cancer AJCC v6 and v7,0.0,Female Breast Cancer,Radiotherapy
TREATS,Endostatins,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Metal-Organic Frameworks,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Pyrimidine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic Drug Monitoring,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Anthraquinones,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Conventional Treatment,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,dasatinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,palbociclib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Drug Combinations,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Precision Medicine,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Maintenance therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Previous and Current Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,cyclocreatine,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Acceptance and Commitment Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Treatment Protocols,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,arachidin-1,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,gingerol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,lianfang,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Intensity-Modulated Proton Therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Radiotherapy
TREATS,polydatin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,dabigatran,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Annexin A1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pseudomonas aeruginosa Preparation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Systemic Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Adjuvant Therapy
TREATS,ribociclib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,shosaiko-to,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glycemic Control,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,colchicine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,glutamine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
METHOD_OF,Assay,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,Antioxidants,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,etirinotecan pegol,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,dihydroartemisinin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,urokinase,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Social counseling,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interventional procedure,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,lonidamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,losartan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Antiplasmin,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Hydrogel,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Anisomycin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Amcenestrant,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Primary operation,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Elevation procedure,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Cognitive behavioral therapy for insomnia,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,talazoparib,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,protein C,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,dexmedetomidine,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Early Therapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Radiotherapy
TREATS,Biosimilars,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Fluorides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cryptolepine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,T cell therapy,Refractory Breast Carcinoma,0.0,Other,Radiotherapy
TREATS,Operation on lymph node,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Paclitaxel Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Physical therapy exercises,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Luteinizing Hormone-releasing Hormone Agonist,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone Therapy
TREATS,4-coumaric acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,rasagiline,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,treatment guideline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast external beam irradiation,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Radiotherapy
TREATS,cordycepin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,MTOR Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,shikonin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,FGFR Inhibitor,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Compound Kushen Injection,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,folfirinox,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,HSP90 Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Early Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,propranolol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Liposomal Curcumin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,imatinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,letrozole,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Hormone Therapy
TREATS,oxaliplatin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,tanshinone II A,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Active Method,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Local Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Vaginal Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Diphosphonates,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,glucomannan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Microbubbles,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,stavudine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Right-Sided Breast Neoplasms,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,hyaluronic acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,naltrexone,Hormone-Resistant Breast Adenocarcinoma,0.0,Other,Hormone Therapy
TREATS,Mammaplasty,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Whole Breast Irradiation,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Current Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,"MAGNET, PERMANENT",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Janus kinase inhibitor,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,"9,10-Dimethyl-1,2-benzanthracene",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,alpelisib,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,hydroxamate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Phototherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,irinotecan,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,saracatinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Drug Packaging,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tanshinone II A,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ropinirole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Perforator,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,clofibrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,dioscin,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,KPT-330,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Agent,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Radiotherapy
TREATS,CAPTURE,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Prodigiosin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,removal technique,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Kinesio Tape,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,NVP BEZ235,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,catheter device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,"Histamine H1 Antagonists, Non-Sedating",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Duration,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,capsaicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Background Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antiresorptive Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,letrozole,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,palbociclib,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Ablation,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Cardiac Glycosides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lipids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Closure by clip procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Operation on breast,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Sesquiterpene Lactone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,royal jelly,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Xenograft procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Micelles,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,stage-specific embryonic antigen-4,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Drug Repositioning,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Systemic Therapy,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Adjuvant Therapy
TREATS,Lower limb exercises,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Tubulin Binding Agent,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,neoplasm therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,nivolumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Abemaciclib/Letrozole Regimen,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Fertilization in Vitro,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Surgery
TREATS,Treatment modification,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,High intensity focused ultrasound,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,nivolumab,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,epigallocatechin gallate,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Lipid Nanoparticles,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,BARRIER,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,carbamazepine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pembrolizumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anthracycline Antibiotics,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Angiogenesis Inhibitors,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Hormone Therapy
TREATS,Systemic Therapy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,trophoblast protein 1,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Adamantane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cannabidiol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,systemic administration,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,telmisartan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antibody Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,peer support,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Polypharmacy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Controlled ovarian stimulation,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,GSK2801,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,invasive treatment,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Efbemalenograstim alfa,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Partial Breast Irradiation,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Basis,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,pyrotinib,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Methylene blue Injection,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,N-Acetylneuraminic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Drug Tapering,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,delivery method,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mechlorethamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bromocriptine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,EZH2 Inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,"Wig, device",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Brief Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pain chronic management,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Conservative Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Basis,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,anesthesia Techniques,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,abemaciclib,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,complex (molecular entity),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Stage IIIA Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,Phytochemicals,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,astaxanthin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,letrozole,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,ononin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,baicalein,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,130-nm albumin-bound paclitaxel,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Image-Guided Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,RECONCILE,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,lovastatin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,troglitazone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gentian Violet,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sulforafan,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Suction drain,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Piroxicam,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Protein Kinase C Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Nucleic Acids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cobalamins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mafosfamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,costunolide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immunoconjugates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,iron chelation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Cysteine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Disulfides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytochalasin B,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Salicylates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"enterotoxin B, staphylococcal",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cryptotanshinone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Leuprolide,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,piperazine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alkaloids,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,boldine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oprelvekin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,small molecule,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Metronidazole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Immunoglobulins,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,kinase inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Prednimustine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,piperazinedione,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Human Chorionic Gonadotropin|CGA|HTC2|CGB5,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Drug Combinations,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,Ovariohysterectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Stanolone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ancitabine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,polyacrylamide gels,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,hyperthermia treatment,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Bromodeoxyuridine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,DNA topoisomerase II alpha,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oestrogen therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Reinfusion,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Epoprostenol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dinoprost,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Azacitidine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Disulfiram,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Vinorelbine tartrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lymph node revealing solution,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,parathyroid hormone-related protein,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Somatostatin analog|SST,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,11-Deoxy-17-ketosteroid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Manipulation procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Thiethylperazine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anthraquinones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fluoxymesterone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Nitromifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic Abortion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,AM3,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,human leukocyte interferon,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,590-S,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Suramin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Transposition procedure,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Transcatheter arterial embolization,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,COLLAGENASE,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Dexamethasone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,PCNU,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Caffeine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vinca Alkaloids,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,PCNU,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,trioxifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytostatic Agents,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Agar,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Androstenediol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Androstanediol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,rogletimide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Counselling service,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anthracene,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Valproate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Consolidation Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Carubicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Debrisoquin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Venous blood sampling,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pleurodesis,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Growth Inhibitors,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Antimitotic Agents,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,Parenteral therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Rehabilitation therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Immunization,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Androsterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,embryonic antigen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lymphatic Irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Pericardiotomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Stabilization,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Somatostatin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,HYB 165,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Testolactone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Nursing procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Laryngeal Masks,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,recombinant human thrombopoietin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,N-desmethyltoremifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bengamide B,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Radiation-Sensitizing Agents,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,PROTEIN TEST,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Artificial Arm,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hematopoietic Stem Cell Mobilization,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Continuous Intravenous Infusion,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Supplementation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Vasoactive Intestinal Peptide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Eflornithine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Deoxyribonucleases,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Eicosapentaenoic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Suramin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,pemetrexed,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,cobalt bleomycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Indwelling Catheter,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Hydrogen Peroxide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,THERATOPE,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,ukrain,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,intraperitoneal therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Endoxan,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Phenylpropionates,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Cobalt 60 teletherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Forequarter amputation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,abarelix,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,SU 11248,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Epoetin Alfa,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Laser Therapy, Low-Level",Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,ID-1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Blood Transfusion,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Alprazolam,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tacrolimus,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Syngeneic bone marrow transplant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Gemzar,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tPA-PAI complex|AMY2A|EPB42|PRH1|BLOC1S6,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Transmission Electron Microscopes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Duet,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,Risk Assessment,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Recombinant Epidermal Growth Factor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic regimen,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Laser photocoagulation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Maxillary right second molar abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,sargramostim,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,LGD 1069,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
METHOD_OF,Therapeutic Effect,breast cancer prevention,0.0,Other,Radiotherapy
TREATS,Urokinase,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,cyanine dye 5,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Automation Systems,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Riboflavin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,antibody therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,salmon calcitonin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic vaccine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
METHOD_OF,Caloric Restriction,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Chromogranin A,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Steroid therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Systemic Therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,"Hysterectomy, Vaginal",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Music Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,enzyme therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,adduct,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Electroconvulsive Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,Tranilast,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Quercetin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Acupressure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cytarabine liposomal,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Removes,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Neupogen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Toremifene Citrate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Somatomedins,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,halichondrin B,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Controllers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Scissors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Progesterone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,"Receptors, Progesterone",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Familial cancer of breast,0.0,Female Breast Cancer,Hormone Therapy
TREATS,Electroretinographs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,furanodiene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Milk extract,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Mesylates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Drugs, Investigational",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Triethylenetetramine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Niclosamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lycorine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chelating Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Riluzole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pirfenidone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Infusion Pumps, Implantable",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Analog,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Hemostasis procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Taurine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cirsimaritin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ursolic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prevention,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,testosterone undecanoate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,matrine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gamma-Tocopherol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Cyclin-Dependent Kinase Inhibitor 2A|CDK4,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ally,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,letrozole,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,TRANSCRIPTION FACTOR,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Phosphors,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Versed,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Arsenal,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,fisetin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,corrigendum,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Nausea care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Proton Pump Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Transection (procedure),Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Right hemicolectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Superoxide Dismutase,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Interferon-alpha,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Potassium Channel Blockers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thermal techniques,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,combretastatin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Debridement,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oxygen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ZD 0473,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Somatostatin analog|SST,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Antithrombin III,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,hydrocortisone acetate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Deoxycholic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Carbamates,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,hydrochloride,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Autologous bone marrow transplant,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Novobiocin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Seldinger technique,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,"5,6-dihydro-5-azacytidine",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Doxil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast neoplasm screening,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Conservative therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Local Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,low protein,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Activins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,adenovirus p53,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Boards,Carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Therapeutic procedure,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Radiotherapy
TREATS,Plant Preparations,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Metoclopramide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antioestrogen therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Aredia,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Manipulation procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,gefitinib,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Biofeedback,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Orathecin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Guidelines,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Vaccine Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Triage,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Hip Replacement, Total",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Applicator - device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,ERBB3 gene|ERBB3,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,NECK IRRADIATION,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,taxane,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Progesterone,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Drainage procedure,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,zoledronic acid,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Goserelin Acetate|EREG|ESR1,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Adrenergic beta-Antagonists,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Hooked wire,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Dichloroacetate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic Touch,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Charts,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Phosphorus,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Angiogenesis Inhibitors,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Hormone Therapy
TREATS,Nephrectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Therapeutic Intervention,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Radical therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Treatment Protocols,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Chemotherapy
TREATS,Minoxidil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,podophyllotoxin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Preservative free ingredient,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Acetate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Charcoal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Endometrial ablation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Epidermal growth factor receptor inhibitor,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Oxycodone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,gemifloxacin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Valine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,indoleamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Insulin, Glargine, Human",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Induced Hyperthermia,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Fentanyl,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Parathyroid Hormones,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,epigallocatechin gallate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,donepezil,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Laparoscopic-assisted vaginal hysterectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,docetaxel,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Protein Kinase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,mangostin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,geldanamycin analogue,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Skin marker,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Urokinase|PLG,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Samarium SM 153 lexidronam,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Flexor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dyes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Exploration procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Compete,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Linear accelerator electrons procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Matrix Metalloproteinase Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Peripherally inserted central catheter,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"TIMP2 protein, human|TIMP2",Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Saline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dandelion Extract,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Glycosylation End Products, Advanced",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Signal Transduction Inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Screening mammography,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,anastrozole 1 MG,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Pain rehabilitation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ibandronic acid,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Cellulose sodium phosphate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cancer prevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Exogenous hormones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chelating Agents,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Hypothalamic inhibiting factor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gadolinium,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Debulking - action,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ginsenoside Rk1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,NanoGel,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,EMBRYO EXTRACT,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,treatment follow-up,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Hormone Therapy
TREATS,schisandrin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mandibular left second molar abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Eye Movement Desensitization Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,anticoagulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,kaempferol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Liposomes,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Cartridges,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oral medication,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Salvage Therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Adjuvant Therapy
TREATS,Anti-diabetic Agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pertuzumab|EREG|ESR1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lymphatic Irradiation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Amygdalin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Polysaccharides,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Systemic Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,atezolizumab|CD274,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,dan-shen root extract,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Novantrone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Heterocyclic Compounds,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,chlorodihydroxypyridine/potassium oxonate/tegafur,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Lipopolysaccharides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,other medicated shampoos in ATC,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Phosphatidylinositide 3-Kinase Inhibitor,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Rechallenge,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic regimen,Triple-Negative Breast Carcinoma,0.0029970029970029,Female Breast Cancer,Chemotherapy
TREATS,Breast Cancer Therapeutic Procedure,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Radiotherapy
TREATS,everolimus,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,removal technique,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Duration,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Chemotherapy
TREATS,Prescription Drugs,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Implantable Injection/Infusion Ports,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Aromasin,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,AZD5363,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Nelipepimut-S,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Maytansinoid DM1,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Extraction,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,TAC Regimen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Antibiotics,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Estriol Vaginal Gel,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Dialysis procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,cabozantinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Hand therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Polyamines,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Stage IIIA Breast Carcinoma,0.0,Other,Radiotherapy
TREATS,"Administration, Oral",Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Osteotomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pegfilgrastim,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,topotecan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,palbociclib,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Benzopyrans,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,oleandrin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fourth-Line Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,CIGB-300,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dietary Modification,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,"Hyperthermia, Local",Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,berberine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Local Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,8-chloroadenosine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,turmeric extract,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tomotherapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,"Tubes, Blood Collection",Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Interventional procedure,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,valeric acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radiation dose,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,chlorogenic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Buparlisib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,palbociclib,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,disorder control (procedure),Refractory Breast Carcinoma,0.0,Other,Surgery
TREATS,Clinical Treatment,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,novel AODU treatment method,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Precision Medicine,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Resatorvid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,germine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dose Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,oleanolic acid,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Platinum Compounds,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,notoginsenoside R1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fluorodeoxyglucose F18,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Fertility Preservation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Letrozole/Palbociclib Regimen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,prednisolone,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Chimeric Antigen Receptor T-Cell Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Intravenous therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Constriction procedure,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,edelfosine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Carbon Dioxide Lasers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ovarian ablation,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Metastasectomy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,BARRIER,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,veliparib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Prophylactic treatment,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,toremifene,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Diterpenes,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Laser ablation,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,glucose,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prophylactic treatment,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,9-anilinoacridine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inosine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,rasagiline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Therapeutic procedure, one or more areas, each 15 minutes; massage, including effleurage, petrissage and/or tapotement (stroking, compression, percussion)",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Prophylactic treatment,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,First line treatment,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,paclitaxel protein-bound,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Whole Breast Irradiation,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,lecithin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Cannabidiol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,FAPI-04,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pegfilgrastim-cbqv,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dihydroorotate Dehydrogenase Inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,water,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cardiovascular Agents,Multicentric Breast Carcinoma,0.0,Other,Pharmacotherapy
TREATS,Breast Cancer Therapeutic Procedure,"Breast Cancer, Familial",0.0,Female Breast Cancer,Radiotherapy
TREATS,hydroxychloroquine,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Peripherally inserted central catheter (physical object),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Clinical Treatment,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,elacestrant,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Adjunctive Orthodontic Procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,tetrathiomolybdate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,durvalumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Chronotherapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,MDM2 Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Epidermal growth factor receptor inhibitor (product),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,130-nm albumin-bound paclitaxel,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Angiotensin II receptor antagonist,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Interventional procedure,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,IPI-549,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,oleylamine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,phytochlorin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,apigenin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Small Molecule,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,family intervention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Current Therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,"1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Implants,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Phosphatidylinositide 3-Kinase Inhibitor,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,voacamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast Cancer Therapeutic Procedure,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,colloid sulfur,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,diallyl disulfide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic immunosuppression,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,venetoclax,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,andrographolide,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Glycome,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Primary operation,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Alpelisib/Fulvestrant Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,dibenzyl trisulfide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,evodiamine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Cancer Therapeutic Procedure,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,pertuzumab,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,removal technique,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Angiogenesis Inhibitors,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Hormone Therapy
TREATS,atezolizumab,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Encequidar,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Genetic Counseling,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Chemotherapy
TREATS,pigment blue 16,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,delphinidin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,etoricoxib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BIX 02189,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,afatinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic Intervention,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,PARP inhibitor therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,cancer care,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,omega-3 fatty acids,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,indocyanine green,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,BMS202,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Amino Acids,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Giredestrant,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Expression procedure,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,laser irradiation,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Oxaliplatin Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Manual Lymphatic Drainage,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Salpingo-oophorectomy,Carcinoma breast stage I,0.0,Female Breast Cancer,Chemotherapy
TREATS,margetuximab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gallic acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Tomotherapy,contralateral breast cancer,0.0,Female Breast Cancer,Surgery
TREATS,Therapeutic procedure,Luminal B Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Current Therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Adjuvant Therapy
TREATS,protodioscin,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Taselisib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,anemoside A3,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,chlorodihydroxypyridine/potassium oxonate/tegafur,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,dipyrromethene,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Third line treatment,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Desensitization,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,dioscin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Thyroid Hormones,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,chamomile flower oil,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,furosemide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,dopamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Functional rehabilitation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,fosbretabulin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,glyceollin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,gambogic acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,denosumab,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Century (brand of multivitamin),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Encequidar,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,letrozole,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,mangostin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,starch,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Basis,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,hydrocortisone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Diet, Mediterranean",Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Isatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Endocrine drugs,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel protein-bound,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,utomilumab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,monalizumab,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Infiltration (procedure),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Mammaplasty,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,kinase inhibitor,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,sacubitril / valsartan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,novel AODU treatment method,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,anastrozole,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Exploration procedure,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,sesame oil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BARRIER,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,ropivacaine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,protopine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,afimoxifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Epoxyeicosatrienoic Acid,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Fulvestrant/Palbociclib Regimen,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Ovarian ablation,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Datopotamab deruxtecan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,systems therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,"Analgesics, Opioid",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thoracoplasty,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,ribociclib,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Antiandrogen therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Hormone Therapy
TREATS,lasiokaurin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,carmustine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,MCC protocol,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Neoadjuvant Systemic Therapy,Carcinoma breast stage I,0.0,Female Breast Cancer,Adjuvant Therapy
TREATS,Pain relief,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,gaillardin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,adapalene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fluorodeoxyglucose F18,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,dacarbazine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Poly(ADP-ribose) Polymerase Inhibitors,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Hormone Therapy
TREATS,First line treatment,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Ipilimumab/Nivolumab Regimen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Oxindoles,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,High intensity focused ultrasound,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,SGN-LIV1A,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,serine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,derivatives,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thiosemicarbazones,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,zalcitabine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cholesterol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,acetaminophen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,autophagy inhibition therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,dextran 40,Triple-Negative Breast Carcinoma,0.0029970029970029,Female Breast Cancer,Chemotherapy
TREATS,Traditional therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Non-Viral Vector,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,stem cell therapy,Familial cancer of breast,0.0,Female Breast Cancer,Surgery
TREATS,andrographolide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,CDRI 85-287,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chinese herbs,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Fenestration procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Uncoupling Agents,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Induced Hyperthermia,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Coumaric Acids,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Induction,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Deamino Arginine Vasopressin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lecithin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cucurbitacin D,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,limonene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Testing,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Camptothecin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Dilatation and Curettage,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,trabectedin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ursolic acid,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,adalimumab,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Drug eluting stent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,EGFR gene|EGFR,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,hepatic arterial infusion,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,prenyl,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Cesarean section,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Mandibular left third molar abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Levodopa,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lovastatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Altretamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic Corynebacterium Parvum,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Somatotropin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cordotomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,3MC,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antihormone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Muramidase,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Strontium-89,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,particle,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Autologous bone marrow transplant,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,port-a-cath,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Structural analysis,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Combined Modality Therapy,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Radiotherapy
TREATS,Cyproterone Acetate,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,PRESERVATIVE,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bromocriptine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Testosterone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Wedge resection - action,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gallium nitrate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Mouse monoclonal antibody,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,elliptinium acetate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Recombinant Interferon,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bis(bromoacetyl)hexestrol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anabolic steroids,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Interferons,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Nolvadex,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,pheophorbide a,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,gut hormone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,trilostane,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Castration,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Laser Irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Teniposide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Ovariectomy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,methylurea,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,rhizoxin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Transsphenoidal hypophysectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Compresses,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,maxacalcitol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,dromostanolone propionate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,calusterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oxyphenbutazone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Amsacrine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Stem cell transplant,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Hypophysectomy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Levamisole,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Prostaglandins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mantle field irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,vitamin analog,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Toremifene Citrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,MDL 101731,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Removes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,camptothecin-11,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mistletoe preparation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Triptorelin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Urokinase,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Orchiectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Luteinizing Hormone-releasing Hormone Agonist,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Floxuridine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pentetic Acid,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Somatostatin|SST,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,8-chloro-cyclic adenosine monophosphate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Toremifene 60 MG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,yuehchukene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,local drug administration,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Adrenal Cortex Hormones,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Cobalt 60 teletherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Mental health care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Somatotropin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Daunorubicn liposome,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Farnesyl Transferase Inhibitor,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,pegfilgrastim,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Toremifene,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Ethionine,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,irinotecan,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Cyclooxygenase Inhibitors,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Hormone Therapy
TREATS,CI1033,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Assessment procedure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,TNFRSF10B gene|TNFRSF10B,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Agent,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,bexarotene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,indole-3-carbinol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Radiation-Sensitizing Agents,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,Protein Microarrays,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cyclooxygenase 2 Inhibitors,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Hormone Therapy
TREATS,ICI 182780,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine/oxaliplatin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Extrapleural pneumonectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oral phenobarbitone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,zoledronate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,dehydroxymethylepoxyquinomicin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
METHOD_OF,Screening procedure,breast cancer prevention,0.0,Other,Surgery
TREATS,imiquimod,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Ro 5-4864,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Electrocoagulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gallic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chest Weights,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Esophagectomy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Lysine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oral form dexamethasone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Carboxymethylcellulose Sodium,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BMS 310705,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vitrectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Salvage procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,icaritin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,phthalocyanine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cyclooxygenase 2 Inhibitors,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Aromatase|CYP19A1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Aldosterone Synthase|CYP11B2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Guaifenesin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radium,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Tretinoin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,benzyl isothiocyanate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Goserelin 3.6 MG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glutaral,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,diisopropylamine dichloroacetate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lingzhi,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Polyethyleneimine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Scopolamine Hydrobromide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Imaging Techniques,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Aloe Emodin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Polycyclic Hydrocarbons, Aromatic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Minocycline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,germacrone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Iridoids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,SLC5A5 gene|SLC5A5,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Thyroxine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,EUK-134,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ST 1926,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Esophagectomy,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Fluoxetine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gases,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Closure by suture,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Antiinflammatory therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Adjuvant Therapy
TREATS,Sirolimus (substance),Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,exemestane,Stage IIB Breast Cancer,0.0009990009990009,Other,Chemotherapy
TREATS,hispolon,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Genes, Viral",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,goniothalamin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Edema control assessment,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,LipoDox,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Nelfinavir,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Natural Remedies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prophylactic Cranial Irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,dihydroquinghaosu,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,benzothiazole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ultra,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Annexin A1|ANXA1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,IgG1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Sperm Injections, Intracytoplasmic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Contrast Media,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,pyrrolidine hydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fluorides,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Continuous Intravenous Infusion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,phthalates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ras Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Protective cup,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bromelains,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Phenprocoumon,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,prevention of disorder,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Modest-Temperature Hyperthermia,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Drainage procedure,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Secoiridoids,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Bilateral augmentation mammoplasty,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Phenolics,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,crystalloid,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Octreotide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,chloroethylnitrosourea,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Virulence Factors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,alitretinoin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Amifostine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,marimastat,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Allografting,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Somatostatin analog,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Evacuation procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Polyamines,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,gabapentin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ICI 182780,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Halotestin,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Fenretinide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,piroxantrone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,P-2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chest wall reconstruction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Effleurage,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Reduced Glutathione,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,SESTAMIBI,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Care provision regimes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Leptin|LEP,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Astemizole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pyridoxine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Octreotide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mesylates,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Brain natriuretic peptide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,"1-phenyl-3,3-dimethyltriazene",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,PAMAM dendrimer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Warfarin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Guidelines,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,astragaloside IV,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Antiplatelet therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Maxillary left first premolar abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,infliximab,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anacardic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,vulpinic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glucose,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Influenza vaccination,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,dimer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"9-methoxy-N,N-dimethyl-5-nitropyrazolo(3,4,5-k)acridine-2(6H)-propanamine",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Antihormone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Reproductive Technology, Assisted",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,celecoxib,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Antithrombin III,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Transurethral Resection of Prostate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Farnesyl Transferase Inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,ramosetron,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Hepatectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Ellence,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tags,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Metformin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Mammaplasty,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,carvedilol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,VEGF gene|VEGFA,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fluorodeoxyglucose F18,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Retreatment,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Lipectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,combretastatin A4 phosphate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Alar,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cetuximab,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Decompressive incision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Interstitial Collagenase|MMP1,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Bolero,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,reproductive hormone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,"TIMP2 protein, human|TIMP2","Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Granulocyte Colony-Stimulating Factor,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Sex Hormone-Binding Globulin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,CI 1040,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prevention,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Strut,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Salvage Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,cancer care,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,MFG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Compete,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Paravertebral anesthesia,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bone Wires,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Replacement therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Mylotarg,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tooth Extraction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,oleocanthal,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Perforators,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pyrrolidinedithiocarbamate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Hyperthermia, Local",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,thioredoxin peroxidase,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Craniotomy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Sirolimus (substance),Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,coenzyme Q10,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Arthroplasty,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,exemestane,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,eribulin,Triple-Negative Breast Carcinoma,0.0029970029970029,Female Breast Cancer,Chemotherapy
TREATS,Uprosertib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,liposomal honokiol,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Anthracycline Antibiotics,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Conventional Treatment,Refractory Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,Therapeutic regimen,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Genetic Counseling,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,immune checkpoint inhibitor therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,CUDC-907,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,neplanocin A,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Free Tissue Transfer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,prexasertib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,tocilizumab,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
METHOD_OF,Sequence Analysis,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,curcumin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,testosterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bruceine D,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Primary operation,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,citronellol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pedometer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,berbamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adagloxad Simolenin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Fulvestrant/Palbociclib Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Investigational New Drugs,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,niraparib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anti-Fungal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fibrinogen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Drug Repositioning,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,durvalumab,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,"Fatty Acids, Volatile",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,jaceosidin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CDK4/6 Inhibition,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Indazoles,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Recombinant Interferon-gamma,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Imaging Device,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,delta1-Dihydrotestosterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Partial Breast Irradiation,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Tomotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ritonavir,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,cinnamic aldehyde,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,triptonide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,tucatinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ritonavir,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Compression garment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Synthetic antiestrogen, NOS",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ciclopirox,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,High-Intensity Interval Training,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,sunitinib,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Hinge (physical object),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Intramedullary rod,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,copanlisib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,BARRIER,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Bone marker,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,removal technique,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,verapamil,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,nivolumab,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,warangalone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,carnosine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Genomic screening,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Histone deacetylase inhibitor,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,triclosan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Seed Implantation,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Surgery
TREATS,"Hyperthermia, Local",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,"Tubes, Blood Collection",Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,mebendazole,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Operation on lymph node,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,RO5126766,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Fourth-Line Therapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,Zinostatin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,complex (molecular entity),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Stage 0 Breast Cancer AJCC v6 and v7,0.0,Female Breast Cancer,Chemotherapy
TREATS,Lipopeptides,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
METHOD_OF,Weight Reduction Programs,Breast Cancer Prevention,0.0009990009990009,Other,Surgery
TREATS,CPG-ODN,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Biopharmaceuticals,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Steroidal estrogen preparation,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,vinblastine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fatty Acids,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,lurbinectedin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,elacestrant,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Molecular Target,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Small Molecule,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Androgens,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Pheophytins,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Active Method,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Small Molecule,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Percutaneous Coronary Intervention,Right-Sided Breast Neoplasms,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,gypenoside,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Proton Therapy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Adjuvant Therapy
TREATS,alpelisib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Implants,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,corynoline,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,fulvestrant,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,early identification,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,apatinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fucoxanthin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Precision Medicine,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,cannabidiol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cosmetic procedure,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Yoga,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,SARS-CoV-2 vaccination,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Binder, device",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Re-Irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Injection of anesthetic agent into stellate ganglion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,beta-escin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,proxalutamide,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,APR-246,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Precision Medicine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,lactoperoxidase,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Poly(ADP-ribose) Polymerase Inhibitors,"Breast Cancer, Familial",0.0,Female Breast Cancer,Hormone Therapy
TREATS,dimethyl fumarate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Constrained knee prosthesis,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,paclitaxel,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,2'-O-methyladenosine,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,MSX-122,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,removal technique,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Metric (substance),Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,IR 780,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Vein implantation,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Surgery
TREATS,Purine nucleoside phosphorylase inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,aquatic Exercise Therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Platinum Doublet,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,turmeric oil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,withaferin A,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Retaspimycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Iron Chelating Agents,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,Ganetespib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Primary operation,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,zoledronic acid,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Lesion Localization Wires,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,carvacrol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tomotherapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Gases,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Operation on breast,Papillary carcinoma of the breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,complex (molecular entity),Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,amygdalin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Single Agent Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Accelerated Partial Breast Irradiation,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Surgery
TREATS,Repositioning (procedure),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Caffeic Acid Phenethyl Ester,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,polysialic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Postoperative rehabilitation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,novel AODU treatment method,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,simvastatin,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Liposomes,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,"Blood Patch, Epidural",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mifepristone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Salpingo-oophorectomy,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Chemotherapy
TREATS,Transection (procedure),estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Mepitel Film,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Topoisomerase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Transection (procedure),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Bridge Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Antibodies,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,simvastatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,glutathione,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Drugs and Biologicals,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Exploration procedure,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Immunotoxins,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,metformin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,pralsetinib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ONC201,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Natural Killer Cell Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,GDC-0810,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prodigiosin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Alleviating anxiety,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mirror movements therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Neoadjuvant Systemic Therapy,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Adjuvant Therapy
TREATS,riluzole,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,rutecarpine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Antibody-Drug Conjugates,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,venetoclax,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,boric acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adjuvant Analgesic,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Partial nephrectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,sulforafan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Low-Dose Aspirin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,thrombin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Interferon-alpha|IFNA1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,kahweol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Partial Breast Irradiation,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Surgery
TREATS,Cymarine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,polyphyllin II,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,stypoldione,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Dalpiciclib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Creatine Supplementation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tipiracil / trifluridine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Protein-tyrosine kinase inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Pectins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Viscum album preparation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,hydroxypropylbetadex (0.58-0.68 MS),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,vorinostat,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,therapeutic autologous dendritic cells,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
METHOD_OF,Randomization,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,Cyclooxygenase 2 Inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,5-dimethylamiloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Split thickness skin graft procedure,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Cyclooxygenase Inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,Esters,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Injection of therapeutic agent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adebrelimab,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Ladiratuzumab vedotin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,minocycline,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,isobavachalcone,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Adagloxad simolenin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Motivational Interviewing,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,B-cell lymphoma 2 inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Caloric Restriction,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,schizandrin B,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tumor removal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Elimusertib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Monoclonal Antibody Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Antibiotics,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,"Infusions, Regional Arterial",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Educational Intervention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Molecular Target,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Tannic Acid,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Endostatins,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,glabridin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prevention,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,naringin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Stabilizing Agents,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,"EPIDERMAL GROWTH FACTOR, HUMAN|EREG|ESR1",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,fotemustine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,everolimus,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Tretinoin,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Probes,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,triptolide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cell Therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
USES,Surveys,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Quinazolines,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Durapatite,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,diallyl disulfide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Rubidazone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,letrozole,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Suction Lipectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ESTROGENIC SUBSTANCES,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Methylprednisolone 40 MG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gamma-tocotrienol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Methylprednisolone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Danazol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Busulfan,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Coumestrol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,ukrain,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Analog,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Human rabies vaccine|HDC,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,polychlorinated dibenzofurans,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Corticotropin|POMC,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Retinoids,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Antithymoglobulin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Transcutaneous Acupoint Electrical Stimulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hysterectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Octreotide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,leukocyte therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,didemnin B,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Difluoromethylornithine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Indomethacin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vaccination against tuberculosis,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,platinum transferrin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fludarabine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Implants,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Muramidase|LYZ,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,VM-26,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Dipyridamole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Whole-Body Irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,miltefosine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Antispasmodics,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,ICI-118630,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,PCNU,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,lipid-associated sialic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Flutamide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Thymopentin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Procarbazine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Lentinan,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,acivicin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Zoladex,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Fenretinide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Ftorafur,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Nimustine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Isoproterenol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,ellipticine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Laxatives,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Collapse Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Ftorafur,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Estramustinphosphate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,IGF1 gene|IGF1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Compresses,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antihormone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Hydrocortisone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"9,10-Dimethyl-1,2-benzanthracene",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Androgen therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,multimodality cancer therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Mitolactol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,testololactone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Mitomycins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cyproterone Acetate,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Tanderil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,acivicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Dinitrochlorobenzene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,adjuvant P40,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glucocorticoids,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Calcitonin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,bruceantin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,festal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
USES,Biological Assay,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Simonton technique,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Arimidex,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,allogeneic tumor cell vaccine,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Medrogestone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Methyl-gag,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Androstenediols,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hycanthone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Peptichemio,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Antagonists,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Enzymes,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Nolvadex,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Corticotropin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Melphalan|PAM,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Myocutaneous flap procedures,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Compression bandaging,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,thymalfasin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Continuous infusion,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Leukapheresis,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Fadrozole,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,MST 16,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Intra-Arterial Infusions,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,molgramostim,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Cholecystectomy, Laparoscopic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Whole blood transfusion,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,WARFARIN TREATMENT,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Somatuline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Stem cell transplant,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Surgery
TREATS,Autologous bone marrow transplant,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Acetate,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Hormone Therapy
TREATS,Biological Products,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Immunotherapy
TREATS,Folic Acid Antagonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lonidamine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Gonadal Steroid Hormones,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Adrenalectomy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,YM 511,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Neovastat,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tropisetron,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,1-(2-nitro-1-imidazolyl)-3-fluoro-2-propanol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Filgrastim,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Antioestrogen therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,"2,5-dichloro-4-bromophenol",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Lead compound,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Tyrphostins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Multidrug Resistance Modulator,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Domperidone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Procedure on spinal cord,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Reduction mammaplasty,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Disease management program,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Microbicides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"N,N-Dimethyltryptamine",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,receptor,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Nicotinic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anthroposophical medicine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cognitive technique,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chest wall reconstruction,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Anesthetics,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Reframing,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Protease Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hemostasis procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Gastrin releasing peptide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"VEGF protein, human|VEGFA",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Emotional support,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Chemotherapy
TREATS,ORALIT,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
METHOD_OF,Ovariectomy,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,epothilone B,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,P-2,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,formononetin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Communication interventions,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,PK 11195,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ketones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pancreatic Polypeptide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thermoablation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Hormone Therapy
TREATS,sinomenine hydrochloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Daclizumab,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Chloroform,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
METHOD_OF,dietary intervention,breast cancer prevention,0.0,Other,Chemotherapy
TREATS,Methanol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tolerogen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Anesthesia, Conduction",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Isotonic exercise,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment Guidelines,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,Disulfiram,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Treadmill,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Craniotomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Norepinephrine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antimetastatic Agent,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,parecoxib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pyrimethamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Preoperative hormone treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Anchoring,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Flavones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Organic solvent product,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,SERPINE1 gene|SERPINE1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,CD44 gene|CD44,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Dendritic Cell Vaccine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Dihydrofolate Reductase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,kadsurenone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Prophylactic treatment,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Manifolds,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Goserelin Acetate|EREG|ESR1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Chloroquine,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Mammaplasty,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Boards,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,CpG 7909,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Needle device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Imaging Device,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,borrelidin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Intervention regimes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ZD 6126,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Mianserin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mifepristone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,exemestane,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Extracorporeal immunoadsorption,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Antibiotics, Antineoplastic",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Pharmacotherapy
TREATS,Somatomedins|BP3,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Serotonin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,oblimersen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tumor destruction,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Curcumin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,benzophenone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anti-Anxiety Agents,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,Experimental drug,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Cognitive restructuring,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Ciprofloxacin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Depreotide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Early Intervention (Education),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,brivudine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,early detection of colorectal cancer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Procedure on axilla,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Palliative procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,Recombinant Erythropoietin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Herbal supplement,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pioglitazone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lidamycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Estramustine Phosphate Sodium,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Angiopoietin-2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Diclofenac,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Compete,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,inhibin B,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vascular Access Device Placement,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Polypharmacy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,wogonoside,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Microdochectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,letrozole,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Intravenous therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Metoclopramide,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Total Estrogen Blockade,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,5-hydroxymethyl-2'-deoxyuridine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Systems therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Radical prostatectomy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,CYTOKERATINS,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Amidone brand of methadone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,talaporfin sodium,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Receptor Protein-Tyrosine Kinases,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,celecoxib,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,VBM protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"5,6-dimethylxanthenoneacetic acid",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Freund's Adjuvant,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Sufentanil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Losartan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,temozolomide,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Toremifene,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Caelyx,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Angiogenesis Inhibitors,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone Therapy
TREATS,tetrahydrocurcumin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Emetine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Phosphotransferases,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Glycerol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cognitive Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,letrozole,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,connective tissue-activating peptide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Orthopedic inserts,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Isoflavones,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Vaginal Rings,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Reframing,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Recombinant Follicle Stimulating Hormone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Psychological counseling,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gelatinase A,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Gelatinase A,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,DNA Sequencers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Stereotactic ablation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Castor Oil,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,amidronate,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,BETA BLOCKER TREATMENT,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oral medication,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sinomenine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,S100A12 gene|S100A12,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Gene Therapy
TREATS,Diethylhexyl Phthalate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,garenoxacin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lymphovenous anastomosis,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Fenofibrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lasofoxifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Calcifediol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Explorers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thermal techniques,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Metric,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Sulpiride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Fatty Acids, Omega-3",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cardiotonic Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Stabilizing Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,Spironolactone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,LG 100268,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Endocannabinoids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vitamin K 2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Traps,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Propranolol,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Advance,Familial cancer of breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Logotherapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Open approach,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Dexmedetomidine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,removal technique,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,immune checkpoint inhibitor therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,proxigermanium,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ixabepilone,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Cardiovascular Agents,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,afatinib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,arsenite,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Proton Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Immune Checkpoint Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Navelbine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,tranexamic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sacituzumab govitecan,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,antineoplaston A10,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Chemotherapy
TREATS,pseurotin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mandibular left second molar abutment,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Recombinant Human Endostatin,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,desloratadine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CDK4/6 Inhibition,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,MLN4924,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Lasers, Semiconductor",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,portable biomedical equipment,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,ABT 263,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Definitive Treatment,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,hydroxyurea,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Current Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Focused ultrasound ablation using magnetic resonance imaging guidance,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,LETROZOLE/RIBOCICLIB,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,polyphenols,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,EC Breast Regimen,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Basis,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Breast external beam irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,First line treatment,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Huaier Extract Granule,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gold,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,arglabin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Spinal instrumentation,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Combination Drug Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Partial Breast Irradiation,Carcinoma breast stage I,0.0,Female Breast Cancer,Surgery
TREATS,talazoparib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Cardiac pacemaker replaced,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Creation of ventriculo-peritoneal shunt,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,early/brief intervention/therapy (treatment),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Mammaplasty,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,inhibitors,Luminal B Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,Combination Drug Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Hematoxylin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,PI103,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Peptides,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Treatment Protocols,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,arctigenin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,gamma-linolenic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Duration,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Ablation,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Interventional procedure,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,"Eosinum, eosin, Homeopathic preparation",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Antibodies, Bispecific",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Cold Plasma,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Luteinizing Hormone-releasing Hormone Agonist,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Hormone Therapy
TREATS,sirolimus,progesterone receptor-positive breast cancer,0.0,Other,Chemotherapy
TREATS,Combined Modality Therapy,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Radiotherapy
TREATS,pentoxifylline,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
METHOD_OF,Current Therapy,Breast Cancer Prevention,0.0009990009990009,Other,Radiotherapy
TREATS,Interventional procedure,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Promegapoietin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,PAMAM dendrimer,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Bypass,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,propranolol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Nerve Block,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,sesamol,estrogen receptor-negative breast cancer,0.0,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic immunosuppression,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,"Breast reconstruction with latissimus dorsi flap, without prosthetic implant",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,chlorodihydroxypyridine/potassium oxonate/tegafur,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ceramides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Breast tissue expander,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gefitinib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,GT0918,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Second line treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,amentoflavone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dipeptidyl-Peptidase IV Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,systemic administration,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Stabilization,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chk1 Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Androgen Suppression,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Screening for malignant neoplasm of breast,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,halofuginone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,folic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anthracene,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,genistein,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,AS 1411,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BARRIER,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Gamma Secretase Inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,isoeugenol,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Innovative Therapies,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,isoeugenol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Detection,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,lysophosphatidic acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Everolimus/Exemestane Regimen,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,muconomycin A,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,desethylamiodarone,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Medical Devices,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Recombinant human granulocyte colony stimulating factor|CSF2|LAMC2,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,pheophorbide a,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Indirect Treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,TAC Regimen,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Ablation,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Implants,Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Complex Decongestive Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Enzyme Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,silicon phthalocyanine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
METHOD_OF,univariate statistics,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,Whole Breast Irradiation,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Hormone Therapy
TREATS,Cancer Therapeutic Procedure,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Radiotherapy
TREATS,von Willebrand factor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pyrotinib,Stage IIIA Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,Diterpenes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,acarbose,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,adenosine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,phenelzine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,artesunate,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,iron,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,cabazitaxel,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,lurbinectedin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,naringenin,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Purines,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,trilaciclib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic Drug Monitoring,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Maintenance therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,DCC-2036,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,CP 466722,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oxadiazoles,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Mind-Body Therapies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gamma Irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Ganetespib,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Fibrin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Implants,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Matrix,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Hormone Therapy
TREATS,erucylphosphocholine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,niclosamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Synthetic Drugs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Active ingredient,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lipegfilgrastim,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,acetylcarnitine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Single Agent Therapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Lobectomy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Ovariectomy,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,diethyldithiocarbamate,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,hesperidin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BARRIER,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,bosutinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,carbopol 934,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,nicotinamide adenine dinucleotide (NAD),estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
METHOD_OF,Immunocytochemistry,Breast Cancer Genetics,0.0,Other,Chemotherapy
TREATS,altretamine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,4-hydroxy-2-nonenal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,galangin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ultrasonography guided erector spinae plane block,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,RID,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alkylating Agents,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,genistin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anastrozole/Palbociclib Regimen,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,vorinostat,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,breviscapine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,brucine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Second line treatment,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Screening mammography,Carcinoma breast stage I,0.0,Female Breast Cancer,Chemotherapy
TREATS,quercetin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Conservative Treatment,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Molecular Target,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Intensity-Modulated Proton Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Generic Drugs,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,gonadorelin|GNRH1,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Amcenestrant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,oxymatrine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Fluoropyrimidine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,"Catheter guide wire, device",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,LY 255283,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,calcium carbonate / magnesium carbonate,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,durvalumab,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,adjunctive treatment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Poziotinib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,disorder control (procedure),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,nitric oxide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Prophylactic treatment,"Breast Cancer, Familial",0.0,Female Breast Cancer,Surgery
TREATS,methamphetamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thiazoles,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ruxolitinib,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Tensionless Vaginal Tape,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,baicalin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alternative Therapies,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Antibody-Drug Conjugates,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Boron Neutron Capture Therapy,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Radiotherapy
TREATS,omega-3 fatty acids,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,"Hyperthermia, Local",HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Surgery
TREATS,Application procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Methionine gamma-lyase,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,tetraxetan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,piperic acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Innovative Therapies,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Folic acid supplementation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,5-Trimethoxyamphetamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Dichloroacetate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Niacinamide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fenclonine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,paclitaxel liposome,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Chlorpromazine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,monomer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Autogenic Training,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Targeted Toxins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,atorvastatin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,PD 150606,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lomustine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Punch,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Placebos,Lobular carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,Anisomycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Diosgenin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Clomiphene,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,flavone acetic acid,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic immunosuppression,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Adrenalectomy,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,CI 973,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Transethmoidal hypophysectomy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,squalamine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Deca-Durabolin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,nandrolone decanoate,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Zitazonium,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,TP protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prevention,Familial cancer of breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,"1-phenyl-3,3-dimethyltriazene",Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Allopurinol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,antagonists,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Technetium Tc 99m Pyrophosphate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Talc,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,agonists,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,timoptin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,interferon therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Mitoguazone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Ellence,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Cytometers, Automated, Flow",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,chlorozotocin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Artificial cardiac pacemaker,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pirarubicin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Metergoline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Intravenous infusion procedures,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Daunorubicin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Radical therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Reinfusion,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,LY-156758,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Pain control,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vindesine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Silicone gel implant,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Thyrotropin-Releasing Hormone|TRH,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Xenograft procedure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,homoharringtonine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bypass,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Whole-Body Irradiation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,methanol extraction residue (MER) tubercle bacillus fraction,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Curettage procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Recombinant Interferon,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,VP-16,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,pyrogenal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antioestrogen therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Adjuvant Therapy
TREATS,treatment method,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Ethane,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Adriablastine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Strontium 89 therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,fibrinolysis inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Urokinase|PLG,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Androstadienes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Miscleron,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Recombinant Granulocyte-Macrophage Colony-Stimulating Factors|CSF2|LAMC2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,antitumor agent,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,targeted prevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Targeted Therapy
TREATS,Biliary dilatation,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,FMC protocol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,SCP 1,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"Hydrocarbons, Chlorinated",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,liarozole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Endoxan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hexestrol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Blood product,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Radium therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Mechlorethamine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,ALIMTA,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Androstanes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Selective Estrogen Receptor Modulators,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,erbB-2 Receptor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sequential Treatment,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Ceftazidime,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CT protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Gemzar,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,gamma-Linolenic Acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,geldanamycin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Doxazosin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,anthracene,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,ICI-46474,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,PD 166793,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,indole-3-carbinol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,5-lipoxygenase inhibitor,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Elective procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Buprenorphine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,GG918,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Reparative closure,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Contraceptive Agents,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Pharmacotherapy
TREATS,Recombinant Antibody,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Urokinase,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Manual Therapies,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cyclooxygenase 2 Inhibitors,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Boron Neutron Capture Therapy,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Adjuvant Therapy
TREATS,Stellate ganglion block,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,angiogenin|ANG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,magnolol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Transjugular intrahepatic portosystemic shunt procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Screening mammography,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,kamisyoyo san,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,General Anesthesia,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,CPG-ODN,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,polyphenon E,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Avastin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Hormone suppression therapy,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Hormone Therapy
TREATS,Fusion procedure,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Diphosphonates,Malignant neoplasm of female breast NOS,0.0,Other,Chemotherapy
TREATS,Catheterization,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,honokiol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,norcantharidin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chinese herbs,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Melanocyte stimulating hormone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,beta-hederin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Escitalopram,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,toosendanin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Propolis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Seed Implantation,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Surgery
TREATS,Lactones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Intramedullary rod,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,functional group,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,ailanthone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,NanoGel,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Tocotrienols,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,everolimus,Stage IIB Breast Cancer,0.0009990009990009,Other,Chemotherapy
TREATS,Buformin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Protein Microarrays,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Gene Transduction Agent,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Penfluridol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,peoniflorin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Oncolytic Virotherapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,camptothecin-11,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Exeresis,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Erythropoietin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,DVT prophylaxis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,PS 341,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Interferon-beta|IFNA1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Supervision,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Strogen,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Denervation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,heme d,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sulindac sulfone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,marimastat,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Local anesthesia,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Filgrastim,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Dihydropyrimidine Dehydrogenase Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CEA scan|CEACAM5|CEACAM3|PSG2,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,hydroxyurea,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"3,4-Methylenedioxyamphetamine",stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,Lymphazurin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prostatectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cryoprobe,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,"N(1),N(11)-diethylnorspermine",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Injection procedure,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,ZD 6474,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Peritoneal lavage,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Traction,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Signal Transduction Inhibitor,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Bilirubin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"ESR1 protein, human|ESR1",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Problem solving therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Laughter Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Syringes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Blood product,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,elsamicin A,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Vitamin A,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Immune Sera,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cosmetic procedure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Chinese herbs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Topoisomerase-II Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tegafur-uracil,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,INTRAVENOUS DRUG,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Recombinant Granulocyte Colony Stimulating Factor|CSF2|LAMC2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Maxillary left lateral incisor abutment,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,4-Butyrolactone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Light Sources, Flash",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Steroid prophylaxis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tangeretin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Itraconazole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Frame,Sporadic Breast Carcinoma,0.0,Female Breast Cancer,Chemotherapy
TREATS,Fine needle,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,mullerian-inhibiting hormone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,trabectedin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,terminal patient care,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Memantine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Scales, Clinical",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Procarbazine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cancer Treatment,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Urokinase,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Breast neoplasm screening,Familial cancer of breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Dance Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Advance,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,PET protocol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Oral form morphine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Genexol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Lutein,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Sodium Selenite,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sodium Nitroprusside,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,cDNA Microarray device,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,hydroxamate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Zinc,Malignant neoplasm of female breast NOS,0.0,Other,Chemotherapy
TREATS,exemestane 25 MG,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Nitric Oxide Synthase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Injection of anesthetic agent into suprascapular nerve,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Endocrine monitoring NOS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tertiary prevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Therapies, Investigational",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Ablation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Oocyte recovery NOS,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,2-benzyl-3-formylpropanoic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Resins, Plant","Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Operation on liver,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Thoracoscopic pleurodesis,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Patient observation,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,topical application,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,treosulfan,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,4-vinylphenol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Operation on liver,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lutetium ethylenediaminetetramethylene phosphonic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tissue-Inhibitor of Metalloproteinase-1|TIMP1,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,acridone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,saikosaponin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tissue-Inhibitor of Metalloproteinase-1|TIMP1,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Stereotactic ablation,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Radiotherapy
TREATS,Hydroxychloroquine,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,resiquimod,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Post Technique,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,moxifloxacin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Salpingo-oophorectomy,Familial cancer of breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Pulse Generators,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sequential Treatment,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Intrinsic factor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,zoledronic acid,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,capecitabine,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Mammaplasty,Inflammatory carcinoma of breast stage III,0.0,Other,Chemotherapy
TREATS,Daunorubicn liposome,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Somatropin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,invasive treatment,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,hyaluronic acid,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,polyethylene glycols,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Intensity-Modulated Proton Therapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,selenite,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Blood Component Transfusion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Treatment modification,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,CK 17,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,hydrocortisone,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Basis,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Zometa,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Metric (substance),Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Microwave destruction - action,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Nodule removal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,P-glycoprotein Inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Iniparib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,lithium,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,rucaparib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,purpurin 18,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,PET/MRI system,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,systemic administration,"Breast Cancer, Familial",0.0,Female Breast Cancer,Chemotherapy
TREATS,"2,4-Dinitrophenol",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,everolimus,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Deoxyglucose,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ipatasertib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,disulfiram,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tumor removal,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Diphosphonates,contralateral breast cancer,0.0,Female Breast Cancer,Surgery
TREATS,Nitric oxide therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,telmisartan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Hemodialysis,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Aurora Kinase Inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,bis(beta-carboxyethyl)tin dichloride,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,odanacatib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,chloroquine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,cryptotanshinone,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,"Embolization, Therapeutic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Type of bridge device,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Extracorporeal Shockwave Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,ivermectin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,enzalutamide,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,sanguinarine,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,mTOR Inhibitor,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,progesterone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Clodronate,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,chitosan,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,guanabenz acetate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Basis,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Nocodazole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Patch Dosage Form,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Tomotherapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Fluorenes,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,tucatinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Folic Acid Antagonists,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Protease Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Dihydrotestosterone,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,HSP90 Inhibitor,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Ingredient,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hyperbaric oxygenation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,zoledronic acid,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,azacitidine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,systemic administration,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,exemestane,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,IDO Inhibitor,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,First line treatment,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Hormone Therapy
TREATS,Metric (substance),Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Bone Wires,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,FEC protocol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Automated endodontic technique,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,First line treatment,Stage 0 Breast Cancer AJCC v6 and v7,0.0,Female Breast Cancer,Chemotherapy
TREATS,elective nodal irradiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,removal technique,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,reishi mushroom preparation,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Agent,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,rucaparib,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Combination Drug Therapy,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Dendritic cells vaccine,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Estrogen Receptor Antagonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Infertility therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Transverse rectus abdominis myocutaneous flap,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,opium alkaloids and derivative combination cough suppressants,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Microspheres,Refractory Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,vitamin E,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Beam Radiation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,macitentan,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,betadex,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antibody Therapy,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,capecitabine,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Telaglenastat,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Estrogen Antagonists,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Berberine Alkaloids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,thioctic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,urokinase,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Antiresorptive Agents,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Pharmacotherapy
TREATS,artesunate,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,green tea extract,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sodium alginate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Stabilization,Refractory Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,abemaciclib,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,collagen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Operative procedure on spine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Application of bandage (procedure),Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Magnet Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Central venous cannula insertion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Protein-tyrosine kinase inhibitor,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,pamidronate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Ganetespib,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Single Agent Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,Microspheres,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,quetiapine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inhibitors,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Hormone Therapy
TREATS,Estrogenic,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Integrative Oncology,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,letrozole,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,systemic administration,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,NGR peptide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bintrafusp alfa,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,minoxidil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sulfoenolpyruvate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Elevation procedure,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,gallic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Boards (medical device),Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Statin prophylaxis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Rechallenge,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Alkaloids,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,bufalin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fulvestrant/Palbociclib Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Adrenergic beta-2 Receptor Antagonists,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Placebos,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,letrozole,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Preparation of patient,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Drug Tapering,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,dihydroartemisinin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,RM-581,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,trilaciclib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bilateral salpingectomy with oophorectomy,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Emodin,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Oncolytic Virotherapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Tilmanocept,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,garlic preparation,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,ALK Inhibitor,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,gedatolisib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,omega-3 fatty acids,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,2-aminoethanethiosulfonic acid,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Bilateral complete salpingectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Group exercise program,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Surgery
TREATS,Group counseling,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"SUPPLY, NOT OTHERWISE SPECIFIED",Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Freund's Adjuvant,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Local advancement flap,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Mobility aid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Antimetabolites,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ipilimumab,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Treatment Protocols,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,pimavanserin tartrate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Administration procedure,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Eating practice,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Particle,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,systems therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Cancer Therapeutic Procedure,Carcinoma breast stage I,0.0,Female Breast Cancer,Radiotherapy
TREATS,Breast Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,Obstetric Delivery,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,carbetocin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Antidiabetics,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,casticin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,celecoxib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,ginsenoside Rh2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mitiglinide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,opium alkaloids and derivative combination cough suppressants,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,artesunate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic Intervention,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Combination Drug Therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Radiotherapy
TREATS,Anesthesia procedures,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Surgery
TREATS,medical treatment method,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,entinostat,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,topical application,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Mandibular right second premolar abutment,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Precision Medicine,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,digoxin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Pain relief,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Blood Component Transfusion,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Antibiotics,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,Boron Neutron Capture Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Pancreatectomy,Invasive Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,phosphatase inhibitor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fluvastatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"RETN protein, human|RETN",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Biological Response Modifier Therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Immunotherapy
TREATS,Glucosamine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sulforafan,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Acetate,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Hormone Therapy
TREATS,fangchinoline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Flax Seed Oil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ZNF35,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,MS 275,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Etodolac,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Benzoates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,treatment method,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Proximal subtotal gastrectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Minims Stains,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Androgens,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,Nafoxidine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,L 744832,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,treatment method,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Estrogen Antagonists,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Progynon-Depot,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Calcitonin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,carbon-11 methionine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Neupogen,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Skin Thermometers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Psychotropic Drugs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Altretamine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,miltefosine,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Pedicle graft,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CYTOKERATINS,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Verapamil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,molgramostim,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Relate,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,formate,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Tetracycline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Thiotepa,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,"Therapies, Investigational",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,elliptinium,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,prednisolone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,CB 3717,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Bilateral subcutaneous mammectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,dietary intervention,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Miconazole,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CI 941,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Metergoline,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Intra-Arterial Infusions,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Sulfamethazine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Spermine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Isotretinoin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Large intestine anastomosis,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Rehydration,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Elastica,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Transcatheter arterial embolization,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Binder,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Pneumonectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Iodoacetamide,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Hexestrol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,FT-207,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,spirogermanium,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,VP 16-213,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,perilla alcohol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Therapeutic Intervention,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Autologous bone marrow transplant,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Behavior Therapy,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Adjuvant Therapy
TREATS,Technetium Tc 99m Sestamibi,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,incadronate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,coumarin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Phenformin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,drug modulation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Difluoromethylornithine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,doxifluridine,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,CMF protocol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Methylcholanthrene,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,DaunoXome,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Progestational Hormones, Synthetic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,prednisolone,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,Ovulation Induction,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,TAP-144|SCTR,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Protamines,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,breast cancer prevention,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Bezafibrate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,annamycin liposomal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Delalutin,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,17-Ketosteroids,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,Myocet,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,adrenomedullin|ADM,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,5-aza-2'-deoxycytidine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Laser photocoagulation,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,CMF protocol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sulfonylurea Compounds,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Collectors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,hecate-chorionic gonadotropin beta-subunit conjugate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,breast cancer prevention,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,THERATOPE,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Allografting,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Camera,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,antibody therapy,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Adjuvant Therapy
TREATS,Procedure on axilla,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,efaproxiral,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,solamargine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,xanthohumol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,prevention through alternative activities,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chambers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Tyrosine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,DNA,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Transducers,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Follicle Stimulating Hormone|BRD2,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Hormone Therapy
TREATS,Derivation procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Multiple specialties,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cancer Treatment,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,tripterine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Binder,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,differentiation therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Recombinant Antibody,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,letrozole,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,rhodioloside,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Antiretroviral Therapy, Highly Active",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Double lung transplant,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,ellipticine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Antral,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Amyloid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Isolation procedure,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Surgery
TREATS,tectorigenin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Reproductive Techniques, Assisted",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,aceclofenac,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Epinephrine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Free skin graft,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,mangiferin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Glucose,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Propofol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Primary Prevention,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Risk Reduction,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,cirsimaritin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"3-(cyclopropylmethoxy)-4-(4-methylsulfonylphenyl)-5,5-dimethylfuranone",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytosine deaminase,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,exenatide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Ovarian ablation,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Radiotherapy
TREATS,S-Adenosylmethionine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Stage IIB Breast Cancer,0.0009990009990009,Other,Radiotherapy
TREATS,jolkinolide B,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Silver dressing,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Chitosan,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Cancer Treatment,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,elastase inhibitor,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,"1-phenyl-3,3-dimethyltriazene",Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Polyethyleneimine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Frozen embryo transfer,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Metal stent,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gadobutrol,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Surgery
TREATS,Cautery operation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,satraplatin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,crocin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Blood Component Removal,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,Oligonucleotide Arrays,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,isobavachalcone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Analyzers, Laboratory, Immunoassay, Chemiluminescent",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Dextromethorphan,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Homeopathic medicine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,vinorelbine,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,anastrozole 1 MG,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Retractor, device",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Symptom control,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Treatment Guidelines,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,"2,5-dichloro-4-bromophenol",Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,LY353381hydrochloride,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Follicle Stimulating Hormone,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Hormone Therapy
TREATS,Cyclophosphomide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Sulfones,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,lanreotide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Megestrol,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Hormone Therapy
TREATS,TNP 470,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Progesterone, injectable",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Clip,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Estramustine,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Etanercept,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Imaging Techniques,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Doxycycline,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Choline,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,TNFSF10 gene|TNFSF10,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Gene Therapy
TREATS,ZD1839,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,piroxantrone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Halotestin,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,MV protocol 2,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Recombinant Erythropoietin|EPO,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Recombinant Interferon-gamma|IFNG,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,isotope therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Taxoids,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Gonadal Steroid Hormones,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Tumor Antigens,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,high-LET neutron therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Gamma Cameras,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Natriuretic Peptides,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,peer intervention,Breast cancer recurrent,0.0219780219780219,Recurrent Breast Cancer,Chemotherapy
TREATS,CI1033,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,efaproxiral,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Carnoy's solution,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Lupron,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"9 alpha,11 alpha,15 alpha-trihydroxy-16-phenoxy-17,18,19,20-tetranorprosta-4,5,13-trienoic acid",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,coenzyme Q10,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Splenectomy,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Computer Aided Detection Systems,Contralateral breast cancer,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,NS-1,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Music Therapy,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Radiotherapy
TREATS,Rhenium compound,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cyclooxygenase 2,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alteplase,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pancreatic Polypeptide,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Gentle,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,onapristone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Catheter Injection Ports,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Appendectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anticipatory guidance,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fixation - action,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anticoagulants,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Endostatins,Ductal Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Thiotepa,stage IIIB breast cancer,0.0,Other,Chemotherapy
TREATS,"pregna-4,17-diene-3,16-dione",Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,rosiglitazone,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Injection procedure,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Progressive muscle relaxation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,coptisine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Computed Tomography Scanning Systems,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Combination Drug Therapy,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Radiotherapy
TREATS,Thyroid Hormones|TH,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,AB 2,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Phosphorus,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Helixor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Famotidine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,alpha 1-Antitrypsin|ADRA1D,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,tumor necrosis factor therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Carbonic Anhydrase Inhibitors,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Hormone Therapy
TREATS,Paclitaxel,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
ADMINISTERED_TO,Recombinant Interferon-gamma|IFNG,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Radiotherapy
TREATS,Accelerometers,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Hormone Therapy
TREATS,Prophylactic treatment,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Process training,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ALPHA-AMYLASE,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Acolbifene,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,flavopiridol,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Breast Cancer Treatment,Breast cancer invasive NOS,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,ovarian cancer prevention,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,terminal patient care,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Taurine,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Conservative therapy,Stage IIA Breast Cancer,0.0019980019980019,Other,Radiotherapy
TREATS,Protein supplement,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Seed Implantation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,"Diet, Fat-Restricted",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Psychological therapies,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Ibandronate,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Factor IX,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,"Scanning Systems, Ultrasonic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gemcitabine,"Carcinoma, Ductal, Breast",0.0049950049950049,Female Breast Cancer,Chemotherapy
TREATS,Ovarian Stimulation,Breast cancer stage III,0.0079920079920079,Female Breast Cancer,Chemotherapy
TREATS,TimeLine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Cytochrome P450 3A4|CYP3A4,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cinobufotalin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Selective Estrogen Receptor Down Regulator,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,"Antibodies, Anti-Idiotypic",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic regimen,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Fenoldopam,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,combretastatin A-4,Breast cancer metastatic,0.0419580419580419,Female Breast Cancer,Chemotherapy
TREATS,Incision of axilla,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Rose Bengal,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Elevation procedure,Carcinoma in situ of breast,0.0,Female Breast Cancer,Surgery
TREATS,"N',N''-diacetylspermine",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,sirolimus,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,andrographolide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Prosthesis,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,nandrolone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,mycophenolic acid,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,docetaxel,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,elements of cancer genetics risk assessment and counseling,Hereditary Breast and Ovarian Cancer Syndrome,0.0,Female Breast Cancer,Chemotherapy
TREATS,Volumetric-Modulated Arc Therapy,bilateral breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Investigational New Drugs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Recombinant Antibody,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,ramipril,Malignant neoplasm of female breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,arsenic trioxide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Oncolytic Virotherapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Current Therapy,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Hormone Therapy
TREATS,Scalp cooling system,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
METHOD_OF,Intervention regimes,Breast Cancer Prevention,0.0009990009990009,Other,Chemotherapy
TREATS,trebananib,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,darolutamide,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Administrative record,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Pain relief,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Hypolipidemic Agents,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,Transection (procedure),Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Surgery
TREATS,Biological Response Modifier Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Immunotherapy
TREATS,olaparib,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,CDK4/6 Inhibition,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Acetoacetates,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,ethanol,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,goserelin,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,sulfasalazine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Quinazolines,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Insulin,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Tissue Expansion Devices,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Pain management,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,Lead compound,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,Segmentectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,leptin,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Tissue Expansion Devices,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,wound care,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Chemotherapy
TREATS,EC Breast Regimen,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Selective Androgen Receptor Modulator,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Hyaluronidase Injection,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Acceptance and Commitment Therapy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Radiotherapy
TREATS,Agent,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,dexamethasone,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Fulvestrant/Ribociclib Regimen,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Indoximod,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,opium alkaloids and derivative combination cough suppressants,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Interventional procedure,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Pericardiostomy,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,PD-L1 Inhibitors,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Hormone Therapy
TREATS,Anthracycline Antibiotics,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,sanguinarine,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,fulvestrant,Carcinoma of Male Breast,0.0069930069930069,Male Breast Cancer,Surgery
TREATS,ponatinib,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Complete axillary lymphadenectomy (procedure),Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,fluvastatin,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,IMC-A12,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,"Steroid, Systemic",Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,"Heparin, Low-Molecular-Weight",Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Antibodies,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,Drug Tapering,Left-Sided Breast Neoplasms,0.0019980019980019,Other,Radiotherapy
TREATS,Systemic Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,cefadroxil,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,bisphenol A,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Long-term drug therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,ruxolitinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Substance with phosphoinositide 3 kinase inhibitor mechanism of action,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,LTX-315,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,jolkinolide B,Luminal B Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,"Binder, device",Malignant neoplasm of female breast,0.0,Female Breast Cancer,Chemotherapy
TREATS,Letrozole/Palbociclib Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,polyethylene glycol 4000,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,CYH33,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,leuprolide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Suppressor,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,Basal-Like Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Legend,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,rutecarpine,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Placebos,Stage 0 Breast Cancer AJCC v6 and v7,0.0,Female Breast Cancer,Chemotherapy
TREATS,Combined Modality Therapy,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Radiotherapy
TREATS,shiunko,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Preoperative Exercise,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,beta-Aminoethylisothiuronium Dihydrobromide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Antibody-Drug Conjugate Therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Psychoactive substance,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Incretins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,fructose,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Anti-HER2 Antibody-drug Conjugate|ERBB2,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Transarterial embolization,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,sphingosine 1-phosphate,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,ursolic acid,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,fosbretabulin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,evodiamine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,carprofen,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,taxane,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,biochanin A,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,biguanide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,capecitabine,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,Radical therapy,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Targeted Therapy
TREATS,Duration,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Thoracoplasty,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,propolin G,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,sirolimus,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,berzosertib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,taurine,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Poly(ADP-ribose) Polymerase Inhibitors,"BREAST CANCER, SOMATIC",0.0,Other,Hormone Therapy
TREATS,Paravertebral Block,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,famitinib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,pixantrone,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Schiff Bases,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,inermin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Therapeutic procedure,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Radiotherapy
TREATS,niraparib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Interferon Type I,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,Chest wall reconstruction,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,Stilbenes,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,niraparib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Cell Death Inducer,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Surgery
TREATS,Photothermal Therapy,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Operation on breast,Stage IIA Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,cinnamomi cortex,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,letrozole,malignant neoplasm of breast staging,0.0,Female Breast Cancer,Chemotherapy
TREATS,Stabilizing Agents,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Pharmacotherapy
TREATS,Tonsillectomy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,methylene dimethanesulfonate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Micelles,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,removal technique,Luminal B Breast Carcinoma,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,"Heparin, Low-Molecular-Weight",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Differentiation Therapy,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Radiotherapy
TREATS,Retrieval - procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,dexamethasone,estrogen receptor-positive breast cancer,0.0139860139860139,Female Breast Cancer,Chemotherapy
TREATS,"bis(tri-n-hexylsiloxy)(2,3-naphthalocyaninato)silicon",Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,BARRIER,Female Breast Carcinoma,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,pitavastatin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cognitive rehabilitation,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Procedure on spinal cord (procedure),Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Glycol,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,pembrolizumab,HER2-negative breast cancer,0.0019980019980019,Female Breast Cancer,Chemotherapy
TREATS,Administration of medication,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,TAK-243,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Suppressor,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,kalkitoxin,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,Peritoneal Dialysis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,gonadorelin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Permanent pacemaker insertion,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radicals (chemistry),Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,Urgent Procedure,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Proton Therapy,Locally advanced breast cancer,0.0009990009990009,Female Breast Cancer,Radiotherapy
TREATS,Oral Anti-Cancer Drugs,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Alpelisib/Fulvestrant Regimen,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,methylate,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,maspin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,MTOR Inhibitors,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Hormone Therapy
TREATS,Volatile Organic Compounds,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,Controlled-Release Preparations,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Pharmacotherapy
TREATS,taxane,Invasive carcinoma of breast,0.0009990009990009,Female Breast Cancer,Surgery
TREATS,olaparib,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Surgery
TREATS,ABT 263,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,crassolide,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,enzalutamide,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Lactates,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Perfusion (procedure),Unilateral Breast Carcinoma,0.0019980019980019,Female Breast Cancer,Surgery
TREATS,paclitaxel,Early-Stage Breast Carcinoma,0.0059940059940059,Female Breast Cancer,Chemotherapy
TREATS,myricetin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,enasidenib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,fulvestrant,Refractory Breast Carcinoma,0.0,Other,Chemotherapy
TREATS,Second line treatment,hormone receptor/growth factor receptor-negative breast cancer,0.0019980019980019,Other,Hormone Therapy
TREATS,capivasertib,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,congener,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,lonidamine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Thiazoles,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Radiation-Sensitizing Agents,Secondary malignant neoplasm of breast,0.0019980019980019,Female Breast Cancer,Radiotherapy
TREATS,graphitic carbon nitride,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Lymphovenous anastomosis,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,CB-103,Recurrent Breast Carcinoma,0.0,Recurrent Breast Cancer,Chemotherapy
TREATS,hydnocarpin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,poloxamer 188,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,4-toluenesulfonamide,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,treatment guideline,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Lipid Peroxides,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Amcenestrant,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,cyclodextrins,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,cyclosporine,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,(18F)FES,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Ozone therapy,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Radiotherapy
TREATS,Operation on lymph node,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Surgery
TREATS,Recombinant Immune Globulin,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Chemotherapy
TREATS,palbociclib,Breast cancer stage II,0.0099900099900099,Female Breast Cancer,Chemotherapy
TREATS,Selective Estrogen Receptor Modulators,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Chemotherapy
TREATS,Reintervention,Noninfiltrating Intraductal Carcinoma,0.0129870129870129,Female Breast Cancer,Surgery
TREATS,GV1001,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,streptozocin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,PD-L1 Inhibitors,HER2-positive carcinoma of breast,0.0089910089910089,Female Breast Cancer,Hormone Therapy
TREATS,Danggui Buxue Tang,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,capivasertib,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Biologic Disease-Modifying Antirheumatic Drug,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,Amine and amine derivative,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,buyang huanwu,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,2-ethyl-2-oxazoline,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,adenosine triphosphate,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Proton Therapy,Stage IIA Breast Carcinoma,0.0,Other,Radiotherapy
TREATS,sunitinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Erianin,Triple Negative Breast Neoplasms,0.0439560439560439,Female Breast Cancer,Chemotherapy
TREATS,Eye Movement Desensitization Reprocessing,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
TREATS,JAK1 Inhibitor,Inflammatory Breast Carcinoma,0.0109890109890109,Female Breast Cancer,Chemotherapy
TREATS,Chalcone,Breast Carcinoma,0.0379620379620379,Female Breast Cancer,Surgery
TREATS,futibatinib,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,CT-P6,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,Prodrugs,Carcinoma breast stage IV,0.0289710289710289,Female Breast Cancer,Chemotherapy
TREATS,beta-thujaplicin,Malignant neoplasm of breast,0.1928071928071928,Female Breast Cancer,Chemotherapy
